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Background: Stroke is a leading cause of death and morbidity in all
countries, yet treatment options are few. Numerous agents that were successful
in animal models, failed in humans. Establishing the cause of stroke in the
individual patient from the heterogeneous stroke mechanisms and
measurement of clinical deficit including cognitive impairment in stroke are
pivotal in successful treatment. An indigenous stroke data bank was established
with specific emphasis on aetiology of stroke and higher cortical function
measurement.
Aim:
1. Establishment of an indigenous stroke data bank using contemporary
neuroinvestigative modalities to determine stroke mechanism as precisely as
possible.
2. To determine in this population, the frequency and extent of cognitive
disorders in the acute and subacute stroke period, using a battery of
predefined higher cortical function tests applied to all patients.
3. Collation of a comprehensive array of epidemiological, clinical,
investigative and prognostic variables in complete digitised storage form.
Methods: The patient population was a hospital based consecutive case series
with an inpatient and outpatient stroke service in association with an acute
stroke unit. A three tier investigative protocol was devised to incorporate
contemporary neuroinvestigative modalities. All patients had mandatory
investigations of stroke relevant blood tests, electrocardiogram, chest
radiograph and brain scan. All patients were evaluated with a comprehensive
X X I
battery of predefined, bedside higher cortical function tests. Standardised
neurological deficit, clinical stroke scales, aetiological scales and disability
scales were incorporated to quantitate deficit, stroke subtype and handicap at
presentation. All patients were evaluated by the author and all information
digitised by the author into the computerised registry - Durban Stroke Data
Bank (DSDB).
Results
1. Stroke Data Bank Issues: The first 1000 patients evaluated comprised
of 561 men, 439 women, 781 Whites, 103 Asian Indians, 100 Blacks, 14 of
Mixed Race and 2 other race groups. All patients had either a CT brain scan
(698;69.8%), MRI brain scan (426;42.6%) or both (124;12.4%). Single
Photon Emission Computed Tomography scans were performed in 104
(10.4%). Among the 23 different symptoms coded for, long tract signs, vision
abnormalities and speech impairment predominated but 150 (15%) had
additional other symptoms not coded for. Among the 29 different risk factors
coded for, hypertension (42.1%), smoking (26.7%), cardiac illness (17.7%),
Diabetes Mellitus (10.4%) and carotid stenosis (25.1%) were the most
numerous. Approximately 96 different causes and possible causes of stroke
were identified. The clinical ischaemic stroke classification (OCSP) revealed
partial anterior circulation strokes in 447 (44.7%), posterior circulation in
258 (25.8%), total anterior circulation in 185 (18.5%) and lacunar in 82
(8.2%). The aetiological classification identified a large proportion of strokes
due to "other" (253;25.3%) causes as opposed to large (264;26.4%) and small
vessel disease (262;26.2%) or cardioembolism (122;12.2%). In 99 (9.9%)
patients no cause could be established. The haemorrhage group was small
(48;4.8%). Comparison of the clinical and aetiological classifications showed
a significant difference overall (Chi square p-value=0.001). Black race had
relatively higher other causes (39%) and unknown (20%) causes as did the
young stroke (8-49 years) population; other (46.5%) and unknown (19.1%).
Final aetiological classification differed significantly in young versus old in all
XXII
categories (p=0.001) except cardioembolism (p=0.884). Admission
neurological deficit (CNS) score compared to admission disability score
(Rankin) showed moderate correlation with a Kappa value of 0.543.
2. Cognitive issues: One or more higher cortical function abnormalities
was detected in 60.7% of non drowsy (drowsy, coma or delirious n=45)
patients. The most numerous categories were aphasias (25.2%), apraxias
(14.5%), amnesias (11.6%) and frontal systems syndromes (9.2%). In 76
patients, neuropsychological testing, (used as the gold standard) was
performed and comparison to the HCFD test revealed a sensitivity of 80.2%
(CI: 72-88%) and specificity of 100%. Cognitive impairment occurred
without elementary neurological deficits (motor, sensory or visual
i mpairment) in 137/608 (22.5%). Univariate and multivariate analyses of risk
factors and likelihood of developing a HCFD revealed that increasing age,
black race, being overweight and recent infection were independent variables
at a p value of 0.05. HCFD did not differ significantly in younger versus older
patients (p=0.194). Frontal system syndromes were more common in
subcortical (32.3%) versus cortical (23.5%) lesions and more common in
younger versus older patients (p=0.001)
Conclusions:
I. Cognitive disturbance is present in the majority of all types of stroke. This
necessitates a reliable appraisal of this form of neurological deficit in all
stroke patients in order to measure the true extent of deficit and monitor
treatment and rehabilitation. This has important consequences for acute
treatment trials that depend on changes in quantifiable deficit.
2. At times cognitive disturbance may be the sole presentation of stroke,
unaccompanied by long tract signs. Therefore inadequate HCFD assessment
may miss the deficit altogether.
X XIII
3. Subcortical stroke is commonly associated with cognitive impairment -
usually of a frontal system impairment. Such deficits are best correlated with
functional brain scanning and not anatomical brain scanning. This is consistent
with the network theory of brain functioning.
4. Risk factors for developing cognitive impairment in the indigenous stroke
population included increasing age, black race, overweight body habitus and
recent infection. This is an important message for the local population as the
latter two are amenable to preventative measures.
5. In the young stroke population, although causes of stroke were numerous,
prothrombotic states, infection associated strokes and dissection were the most
numerous. All are amenable to primary preventative measures and treatable in
the acute phase of stroke.
6. The Durban Stroke Data Bank showed that at least two dozen symptoms in
stroke are important. In some instances, the diagnosis of stroke may be missed
altogether if a wide array of symptoms are not entertained on presentation.
7. There were important black white differences in stroke with black people
being younger with an increasing rate of HIV associated stroke being,
documented.
8. Clinical and aetiological post investigative classification is useful in the
management of stroke patients with significant differences found in all
subgroups. This guides early, emergent stroke investigations and management.
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1.0 INTRODUCTION
Stroke is a major cause of death and morbidity with few treatment options at
the present time. Having to date suffered from therapeutic nihilism and
consequently unenthusiastic diagnostic, stroke as a disease entity, is moving
towards medical emergency status. Numerous therapies have been shown to
work in animal models [1,2] but their application thus far to humans has been
fraught with difficulty and largely negative results [3]. The few successes have
been possible only with the identification of specific subgroups of stroke
populations; anti coagulation in nonvalvular atrial fibrillation [4], carotid
endarterectomy in greater than 70% symptomatic carotid stenosis [51 and
nimodipine in acute stroke of less than 12 hours of onset of symptoms [6].
More recently, the thrombolytic agent tissue plasminogen activator has been
heralded as the first real acute stroke therapy albeit in a strictly defined
subgroup of patients [7]. Because both presentation and the aetiology of stroke
is protean and heterogeneous, a large number of variables need to be collated
for each patient.
Higher function deficits in particular need to be carefully assessed together
with the more traditional and elementary neurological deficits such as long
tract signs. So called silent infarcts are being increasingly recognised. This
may be due to the patient not having reported the event or the attending doctor
dismissing such a deficit or not identifying it. It may be said that a "limping
brain is more difficult to identify than a limping leg" [8]. Many silent infarcts
occur in the frontal and parietal lobes, areas that need specific testing for
higher function deficits. Patients tend not to volunteer such deficits.
Traditional testing, using a battery of higher cortical function is time
consuming and impractical. In depth neuropsychological testing is not suited to
bed side assessment that often needs to be done rapidly in order to diagnose
stroke or an evolving stroke. The assessment therefore needs to be done in a
hierarchical manner from high sensitivity to high specificity with
progressively more in depth assessment only as required [8].
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Several stroke data banks have been designed and have each contributed the
most valuable data on stroke populations because of systematic uniform
compilation of data, power in numbers and by virtue of being population
based [9-31]. This has often led to the establishment of stroke units at such
centres. Others have also shown improved outcome to patients in terms of
morbidity and mortality when admitted to such a unit without the application
of specific treatment modalities [32,33].
As treatment of acute stroke seems imminent [1,2,6,7] the value of having a
rigorous method of defining the different subgroups of stroke patients by
means of a SDB is self evident. This system can subsequently be applied to all
patients with stroke.
There are several unique features to the Durban Stroke Data Bank (DSDB)
1. The DSDB is a hospital based, prospective study of first ever stroke patients
according to the WHO definition of stroke with a 100% brain scan
confirmation of stroke.
2. The DSDB incorporates 6 standardised scales allowing quantitative
measurement of impairment, disability, handicap, aetiology and
prognostication.
3. It is one of the few stroke data banks using the full complement of
contemporary investigative modalities in a tailored protocol 19-31].
4. The DSDB was designed with specific questions in mind, unlike most of the
previous stroke data banks in existence [9-29]; namely the extent and variety
of cognitive disturbance in acute stroke and the variety of causative stroke
mechanisms. As a corollary it also provided a database for cognitive
syndromes.
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5. A state of the art relational database software program was used to digitise
all data collected. This included digitisation of all clinical and investigative
information and where appropriate digitisation of radiographic, photographic
and acoustic data.
6. A major concern expressed by the investigators of the two largest and also
most comprehensive stroke registries (Mohr JP of the NINCDS Stroke Data
bank; n=1805 and Bogousslaysky J of the Lausanne Stroke Registry n=>3000)
[9,10,16,17] was the reliability of assessment and the recording of information
in the registry.
The DSDB represents a personal series (n=1000) with all patients evaluated by
the author, all information digitised by the author and more than 90% of
patients managed clinically by the author.
7. Adaptable design allowing new data field incorporation such as newer
scales, investigations and risk factors to be added.
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2.0 REVIEW OF THE LITERATURE
2.1 Rationale for emphasis of Higher cortical function impairment
in stroke.
Cognitive impairment in the acute stroke situation may be the sole clinical
neurological deficit in a cerebrovascular episode [1,2]. Subtle or covert
mentation disturbances, both for practical and traditional reasons, do not have
the same import for lesion localisation as do "classic" neurological symptoms
or signs [3,4]. The diagnosis and localisation of stroke is facilitated when
heralded by elementary neurological deficits such as hemiparesis,
hemihypesthesia or hemianopia [5,61, but good clinical acumen is required for
the patient without long tract signs who either fails to volunteer or even
actively denies the presence of neurological symptoms because of a neglect,
agnosic or alexic syndrome.
A high index of suspicion is required for the diagnosis of a higher cortical
function deficit (HCFD) in stroke patients, as their affliction may be labelled
as "confusion" to the casual observer. The differential of an acute confusional
state prominently features metabolic, infectious, toxic or drug etiologies,
whereas stroke is rarely placed high on the list [6]. For example, an isolated
sensory aphasia may be mistakenly diagnosed as a delirious state [3].
Moreover, the delirious or agitated behaviour of some stroke patients,
especially with right hemisphere involvement, may also preclude adequate
assessment of sensorimotor deficits, the traditional hallmark of stroke. It is not
uncommon for a behavioural neurological syndrome to manifest in the
absence of any other abnormality on neurological examination 15].
A variety of neurocognitive deficits need to be considered in evaluating
patients with stroke which require specific tests, methods of elicitation and an
appreciation of their co-occurrence as predicted by the contemporary
"network" theory of brain behaviour function [7]. Specific testing is especially
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important as brain imaging may fail to demonstrate the lesion or depict
clinically irrelevant lesions [8]. Finally, studies of patients with
cerebrovascular disease provide superior clinicoradiologic and
clinicopathologic associations, as opposed to either neoplastic or traumatic
lesions, since mass effect and contrecoup effects, respectively, detract from
correlative precision [5]. The frequency of HCFD, has not been addressed in a
large stroke population [9-20]. The DSDB provides an opportunity to
investigate the importance of HCFD in a prospectively evaluated stroke patient
cohort.
2.2 Rationale for using stroke to study cognitive deficits
Stroke is widely regarded as the best neurological process to study brain
behaviour relationships. The disease process is unique in that it is rapid in
onset, circumscribed anatomically and mostly presents with relatively
stereotyped clinical presentations limited by cerebral vascular territories. In
addition the degree of oedema contributing to the clinical deficit is minimal
with strokes, multiple lesions are uncommon and mass effect is rare. These
characteristics, most notably the discreet, relatively clean lesion process of
stroke make it the most ideal cerebral disorder for the study of cognition
which is contained in complex widely distributed networks [7J.
2.3 Overview of Stroke Data Bank design
Many stroke data banks are in existence, but it has been noted that fewer than
10 such computerised registries fulfil the ten criteria for optimal data bases
put forward by the committee at a recent workshop on Challenging Issues in
Stroke Data Bank Research [20]. The Ten criteria for an optimal SDB used
for clinical research are:
1. Diagnostic criteria
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2. First ever strokes
3. High rate of CT investigations
4. Detailed autopsies whenever possible
5. Prospective data whenever possible
6. Pilot phase and interrator studies
7. Consistent screening procedures to identify
patients enrolled and consistent time frame of examinations
8. Collection of a large spectrum of clinical and investigative data
9. Follow up investigations
10. Baseline report
2.4 Uses of stroke data banks and the issue of population based
versus hospital based registries.
Because of the diversity of clinical syndromes and causes of stroke, stroke
registries are currently regarded as the best tools to improve our knowledge
concerning cerebrovascular diseases [21]. The various types of stroke
registries in existence include
1. hospital based studies
2. single centre studies
3. hospital based multicentre studies
4. hospital based community studies
5. community studies.
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SDB's are powerful tools for clinical research especially when designed
prospectively to answer specific questions in mind. Brainin (22] regarded the
place of stroke registries as being intermediate between case series studies and
epidemiological studies. The relative strengths of SDB's in general include;
1. Deciphering similar patterns in related items of information
2. Deciphering similar patterns in unrelated items of information
3. Looking for trends in the data collected
4. Generation of research hypotheses, theories and analogies
5. Testing of current and new hypotheses on aetiological and clinical issues in
stroke such as acute treatments and interventions.
An advantage that epidemiological or population/community based studies
have over hospital based studies are the ability to address incidence and
prevalence of disease. In practice such studies are rare and not practical in
large metropolitan centres.
2.5 Clinical and cost factors
For several reasons, stroke data banks are important from a clinical and cost
containment point of view. Stroke causes are heterogeneous and vary between
races, regions and countries - hence the need for local data. Dedicated stroke
units which typically arise from a stroke data bank project, improve outcome
and reduce hospital stay.
Stroke data banks and trials do not give adequate attention to the incidence of
higher cortical function deficits. The true extent of a neurological deficit must
be known to ascertain treatment and monitor rehabilitation. Meaningful stroke
measurement at the present time may well have been misguided and this may
be an important factor in the almost universal stroke treatment failures thus
far [23]. We may well be measuring the wrong thing wrt improvement and
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outcome when applying the standard stroke scales. It appears more important
to weight or emphasise higher cortical function deficits in the acute stroke
setting to enable ascertainment of true improvement [23]. Thus far only two
stroke scales have achieved this objective - the CNS and NIH scale [23].
2.6 The concepts of impairment, disability and handicap and their
measurements.
Perhaps one of the most important functions of a stroke registry is the
measure of human suffering, handicap and cost.





This allows for decreasing objectivity but increasing relevance. This part of
the DSDB was designed to incorporate popular validated scales to measure
each of these components. The scales used included the CNS (impairment),
Barthel (disability) and Rankin (handicap) scales.
The International classification of disease (ICD) is the official basis for
morbidity and mortality of the World Health Organisation (WHO). This
classification is mainly based on aetiology which is the primary axis. The
model may be depicted as
Aetiology (microorganism, external cause, genetic defect)
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pathology - manifestation (syndrome, symptom, disease).
The International Classification of Impairments, Disabilities and Handicaps
(ICIDH) is a more sophisticated model that allows for definition by aetiology,





The application of these principles to the DSDB may be presented as follows:
Disease (categorisation of stroke subtype and aetiology DSDB and
ICD classifications)
I mpairment (analysis of neurological manifestations - CNS)
Disability (measure of ADL and IADL activities - Barthel)
Handicap (assessment of changes/losses in social roles - Rankin)
2.7 Overview of neurological scales and rationale for inclusion in
DSDB
Many different scales are in existence and were designed to measure outcome
in trials, treatment responses and rehabilitation. Neurorehabilitation
1 0
recognises that premorbid status is rarely quantified and the negative
connotations of "handicap scales" should rather be replaced by the more
positive terms of activities of daily living and instrumental activities of daily
living. Overall, measurement of disability and handicap may be categorised
into:
I. Activities of daily living (ADL)
2. Instrumental or extended activities of daily living (IADL)
3. Outcome scales mainly used in medical trials
4. Global health [11
The reason for measuring ADL is that these best measure the basic skills
necessary for personal independence. A review of which of the various ADL
scales best suited the purposes of the present study suggested the Barthel Index
for ADL and Rankin Scale for global health. Due consideration was given to a
reliable, valid and above all simple to perform evaluation and the ability to
ascertain telephonically for follow up purposes. The telephonic assessment
validity has been done in well designed studies for only few of these studies
including the Barthel index of ADL scale [1] and Rankin scale much more
recently [2]. The choice of the Barthel index of ADL was made after review













Measuring ADL is essential to guide clinical management especially where
various treatments are being used or evaluated, in the initial stages of stroke,
the identification of the most important disabilities and making follow up
more precise and scientific. Communication between researchers and different
centres is facilitated if the same measurement tools are being used. In the
current economic climate of rationalisation of medical care, the scored
disability assessment will be most important to securing remuneration for
rehabilitation services and other supportive services required.
The choice of the Barthel index of ADL is supported in the review by Wade
and Collin [3] who proposed that this scale should be the preferred measure of
physical disability because it contains all 10 ADL activities, has been used in
research studies more than any other scale and has been used to evaluate a
wider range of conditions. Gresham et al showed that the Barthel was superior
to the Katz ADL Index and the Kenny Self Care evaluation [4]. The aspects
looked at were sensitivity to change, completeness of the scale, amenability to
statistical evaluation and greater familiarity amongst clinicians because of
widespread use. Self report and obtaining the information from nursing staff
or care givers was shown also to be quick (less than 5 minutes) and reliable
[5]. Reliability and sensitivity studies on the Barthel index were reported and
found to be adequate [6-9]. Collin argued for the acceptance of the Barthel
scale as the standard index of disability [1].
No scale is perfect and knowledge of the limitations is as important as its
advantages so as not to overlook possible meaningful clinical deficits or
recovery. The Barthel index suffers from inability to measure communication,
cognition and motivation. In the event of requiring testing for such
parameters, scales designed to measure these specifically need to be
implemented.
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The Modified Rankin Scale
The modified form of which (includes death) appears below:
Grade Description
0 No symptoms at all
1 No significant disability despite symptoms; able to carry out all
usual duties and activities
2 Moderate disability; requiring some help, but able to walk
without assistance
3 Moderately severe disability; requiring some help, but able to
walk without assistance
4 Moderately severe disability; unable to walk without assistance
and unable to attend to own bodily needs without assistance
5
	
	 Severe disability; bedridden, incontinent and requiring constant
nursing care and attention.
6 Death
The Freanchay Activities Index is the best tool to assess return to "normal
living" - the only scale that does this [11]. This was not used in the DSDB.
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2.8 Cognitive issues
2.8.1 The challenge of cognitive assessment
Overview and inherent constraints - a brief synopsis of problem areas in 
testing cognition as noted by prominent researchers in the field 11-7]. 
Traditional cognitive assessment is organised according to discrete mental
faculties such as apraxias, amnesias, aphasias. These may reflect abstractions
on the part of the clinician rather than correlate with neural organisation [2].
With higher mental function assessment it is important to note the most
elementary cognitive disturbance before proceeding with the entire screening
or more complex neuropsychological assessment. The tiers of assessment
appear in the left column. The right hand column delineates their individual
limitations on further cognitive testing [1];
Cognitive domain: If impaired limits: 
consciousness all other cognitive testing
attention interaction and tasks
language communication
memory tests/past relevant history
frontal system syndromes interaction eg abulia
Viewed in another way, each mental task basically has the following
components:
input channel (consciousness, attention language)
intermediary processing stage (language, memory, frontal systems)
an output channel (language).
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Because of the network theory of the brain [2], very similar behavioural
deficits may occur due to widely different brain lesions. For example
hemispatial neglect may arise with frontal, parietal or thalamic lesions. More
precise localisation requires evaluation of neighbourhood signs which
accompany the behavioural deficit.
Our available repertoire of mental tests allows us to test only those faculties
that are easily testable, such as memory, language and praxis. There are no
tests for a wide variety of other equally important human functions such as
lateral thinking ability, reasoning, perseverance and judgement [2]
To gain a reasonable overview of mentation, the choice of tests must be
individualised and flexible and degrees of difficulty need to be used according
to the individual's level of ability.
The requirement of flexibility in cognitive testing is not limited to the level of
difficulty. A person may present with complaints for which no specific tests
exist let alone a medical description. An example is a report of patients with
brainstem stroke either having strange dreams or sudden of lack of dreams.
The history given by the patient may differ considerably from that given by
family members. Often the latter is more accurate and revealing.
The particular difficulty the person has also must be related to the deficits in
daily living.
Such problems in cognitive testing are challenging, and daunting. As Mesulam
has put it so aptly;
LL 
the task should be approached with the spirit of an explorer, the cautious
flair of a detective and the training of a neuroscientist" 121
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Flexibility and improvisation are essential.
2.8.2 Important points about cognitive testing
A particularly succinct review of the currently perceived problems with
cognitive testing is quoted from Orrin Devinsky [1].
"The mental status examination has an undeservedly bad reputation and should
never be omitted from the neurological examination".
During neurological assessment, it is as inappropriate to omit the mental status
examination as it is to ignore the muscle strength or reflexes. It should be the
first component of the neurological examination as it is critical to the
interpretation of other findings.
"The neurologists law - localise the lesion - also applies to mental fimction".
Findings from the mental status examination must be synthesised with each
other and with findings from the neurological and general medical
examinations.
"The observation and history of the patient's behaviour are the most important
aspects of mental evaluation".
There are several reasons why behavioural problems are easily overlooked:
1. Most people tend to minimise problems, especially behavioural ones
2. Some patients are not fully aware of their problem
3. The duration of patient contact for most physicians is limited
4. Behavioural problems are often intermittent or situation dependent [1]
"Mental status examination is systematic and hierarchical".
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It is essential to recognise this in cognitive testing as certain functions are
critically dependent on the integrity of others. For example, if comprehension
is impaired as with Wernicke's aphasias, praxis testing cannot proceed and one
cannot test memory before attention.
The following is regarded as the strict test order for mental status
examination:






"Neuropsychological testing is an elaboration of the mental status
examination"
- Bedside mental status testing is limited by time, environment, qualitative
analysis and materials. Neuropsychological evaluation permits a more
complete and quantitative assessment of cognitive functions. However
neuropsychological testing does not replace bedside screening of mental status"
[1].
Note: In the hyperacute setting cognitive evaluation must proceed as accurately
and with as much thoroughness as the situation allows. An emergency standby
neuropsychologist is neither necessary, nor does the anxious, frightened or
alarmed patient make a good candidate for concentrating on
neuropsychological testing when emergency treatment and urgent
investigations must take priority. What cannot be accomplished in the form of
cognitive testing within approximately 15-20 minutes during the acute
admission must wait for a more opportune time when the patient's condition
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has stabilised and the patient is in a better frame of mind to concentrate on the
neuropsychological testing which is demanding even for normal individuals.
There is no practical battery of neuropsychological tests that will be applicable
to all patients. Neuropsychologists often use a battery of tests but supplemental
tests will often be required to delineate a deficit fully. In the acute stroke
setting, indications for neuropsychological testing include the assessment of the
extent and degree of cognitive deficit and determining areas of preserved
functioning which then become important for rehabilitation.
"Positive symptoms reflect activity of preserved, but often dysfunctional
nervous tissue"
- Positive symptoms are abnormal superimposed behaviours that presumably
reflect overactivity of neural function"
"Diaschisis is dysfunction in cerebral areas remote from the destructive
lesion".
Subcortical lesions are able to disrupt function at remote sites. Interruption of
fibres passing from the brainstem to the diencephalon and cerebral cortex can
cause coma and depress cerebral blood flow and oxygen consumption. Failure
to activate specific cognitive areas may be the explanation for specific
language and other cognitive deficits consequent to thalamic lesions.
The concept of diaschisis may be important not only to explain behavioural
deficits observed in clinical neurology but may provide insights into the
mechanism of functional recovery and ultimately therapy [8,9]. Future
neurological therapy may focus on brain regions that are structurally intact
but functionally impaired and restorative neurology may be able to reverse the
process of diaschisis.
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"Subcortical lesions can produce cortical deficits"
The neurobehavioural relationship between higher and lower centres is not a
one-way street. The anatomy of the cortex and subcortical areas are
intricately interwoven. Cortical and subcortical areas that are richly
interconnected are associated with strikingly similar clinical findings when
either one is damaged" [1].
Examples included
Language
Mutism - cingulate, medial forebrain bundle, diencephalon
Dysarthria - pyramidal and extrapyramidal tracts, cerebellum
Aphasia - subcortical white matter, striatum, thalamus
Short term memory
Hippocampus, fornix, basal forebrain
modified from [1]
2.8.3 Reasons for adopting a clinical (bedside) cognitive screening
test
As the method of testing was important, a number of experts from different
backgrounds in the field were consulted. These included behavioural
neurologists, neuropsychologists and biological psychiatrists [1-12].
1. There is no standardised cognitive test applicable to stroke. Lezak describes
specific batteries for Multiple Sclerosis, Parkinsons, Epilepsy and others [10].
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2. Stroke is now classified as a medical emergency and treated as such
(American Heart Association Stroke Council). There is no time within the first
few hours or even days in many patients to conduct neuropsychological
testing.
3. A screening battery has the advantage of screening for a wide range of
cognitive impairments without becoming too specific and also without
standardisation and test scores. This is the value of well conducted predefined
clinical tests and they have an important function in this respect. Once the
clinical situation has stabilised, the patient feels more comfortable and the
family has calmed down better cooporation is usually possible. The testing
therefore is done in at least 2 stages and sometimes in several stages. During
this time period the emergence of new deficits and disappearance of others
may occur, such as Global aphasia to Broca's to dysnomia. The process is
dynamic and a more flexible and easily administered battery of cognitive
testing has its value. Also, the clinician who sees the patient on a daily basis is
best suited to do this testing but is in most instances not the most qualified to
do so. By having clear, concise, definitions for the various cognitive deficits,
the elicitation of the many and interesting deficits will be better appreciated.
Neuropsychologists are not generally found in the emergency room and
generally operate and do best on an elective appointment basis. Although there
may be merit in involving a neuropsychologist more acutely in stroke, as
indeed was done for the Transient Global Amnesia (TGA) patients, this is not
practical and requires resources and finances that are scarce especially in
developing countries.
Both Lezak [10] and Luria [11] advocate flexible, (double dissociation)
qualitative as opposed to quantitative testing. A similar conclusion was also
drawn in Watts Runge's PhD thesis [12]. Both have their value.
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2.8.4 Cognition - what is human intelligence and what are we
measuring.
The dominant view of human intelligence from a psychological point of view
was of a unidimensional or monolithic capacity. It is now viewed as a diamond
ie multifaceted array of distinct capacities [13]. There is however no universal
agreement on how to conceptualise, measure or clinically evaluate these
differing entities. Howard Gardner [14, 15] proposed that intelligence can be








Each is conceptualised as a basic unit of intelligence that is not further
divisible. These are regarded as the fundamental building blocks of human
intelligence which in turn is dependent on the integrated action of these
multiple discreet information processing components. Gardner's schema has
been noted to be very compatible with the behavioural neurological approach
(aphasias, amnesias, apraxias, agnosias etc). The cognitive approach allows for
a more fine grained assessment. In addition the clinical disorders of human
intelligence can be understood in terms of which facets of intelligence are
impaired and which underlying information processing modules are affected
[14,15].
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2.8.5 Disorders of intelligence and disorders of the forces which
modulate intelligence.







Only consciousness and attention are assessed by the Cognitive Screening Test
used in the DSDB. The lack of assessment of personality, motivation and
emotion is a potential criticism of the DSDB screening battery, although it
should be recognised that they are complex and difficult to assess at the
bedside.
2.8.6 Disorders of forces which modulate intelligence
This concept allows us to readily understand the difference (from a cognitive
neurological point of view) between dementia and encephalopathy;
- cognitive disorders occurring with normal level of consciousness and
attention are called demential
-cognitive disorders occurring in the context of a minor or subtle
decline in the level of consciousness and attention are termed
encephalopathy.
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2.9 Using the syndrome of stroke as a means for studying
cognitive disorders
As Orrin Devinsky has remarked, stroke has been one of the great teachers of
behavioural neurology. Most of the classical neurobehavioural syndromes
such as aphasia, apraxia, alexia without agraphia, cortical blindness, left sided
neglect, anosognosia and peduncular hallucinosis were originally described in
patients with stroke. Tumours, infectious diseases, demyelinating diseases and
trauma diffusely injure the brain and are often associated with increased
intracranial pressure, oedema and compression of surrounding structures.
Stroke produces more circumscribed and " purer" lesions. Four or five days
after a stroke is a good time in general for assessment because the oedema and
compression in some acute strokes has then subsided [1].
The DSDB was designed with this knowledge in mind and the cognitive testing
done in the acute and subacute phase within the first week. Before conclusions
about a stroke related cognitive disturbance can be drawn a cautionary note by
Devinsky is appropriate here;
"Alterations in behaviour suggest brain dysfunction. Diseases that affect the
brain in a multifocal or diffuse manner (vascular, infectious, inflammatory,
neoplastic) produce unusual clinical pictures. A common diagnostic pitfall is
the assumption that emotional, bizarre and atypical cognitive disorders are
psychiatric in nature especially when exaggeration or emotional overlay is
superimposed on organic features" [ I
A good example of just how precise the clinico radiological association in
stroke syndromes can be is given by the example of left anterior choroidal





without aphasia is present clinically.
2.10 There are several major problems with cognitive testing that
necessitate discussion:
2.10.1 Rationale of clinical bedside testing as opposed to standardised mental
test schedules. Qualitative versus quantitative testing.
2.10.2 Theoretical considerations of qualitative versus quantitative assessment.
2.10.1 Rationale of clinical bedside testing as opposed to
standardised mental test schedules. Qualitative versus quantitative
testing.
Many mental test schedules have been devised ranging in complexity, ease of
use and time taken to administer them. Many require specialised test items and
training in their administration and are for this reason alone not suited to the
practising clinician handling medical emergency patients such as those with
stroke.
Three of the more commonly used tests include the Mini Mental State
Examination, The Information Memory Concentration Test and the ten item
Hodkinson Mental Test [31. Although having normative data and good
interrator reliability there are several major criticisms and shortcomings if
applied to the stroke population.
1. These tests tend to sample cognitive areas of attention, concentration,
memory, language and visuospatial abilities and a low score may be due to one
area of cognitive dysfunction or several. Two entirely different disorders may
have the same score.
2. The profile of performance in these tests is not taken into consideration -
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only the overall score. A low score may reflect a severe deficit in one domain
only or a mild impairment across all the domains evaluated.
3. All schedules were developed for the quantification of cognitive impairment
in elderly patients with dementia or delirium and not the more circumscribed
impairments of stroke patients.
4. These standardised tests are particularly insensitive to circumscribed
cognitive deficits such as amnesia, aphasia, visuospatial, right hemisphere or
frontal lobe syndromes [3].
2.10.2 Theoretical considerations of qualitative versus quantitative
assessment.
As argued by Watts in her thesis 112] and Lezak [10], both techniques are
required for effective assessment.
The psychometric evaluation reflects a persons performance on specific tests
relative to age adjusted, educational and other representative criteria.
Psychometric tests therefore focus on a person's performance. Such a model
is inadequate for neuropsychological evaluations for several reasons [12];
1. It has been observed in neurology and neuropsychology that the descriptive
approach has led to the accurate identification of many of the syndromes
recognised today (Gerstmann's, alexia without agraphia) and the development
of theories [17].
2. Tests and procedures which involve averaging and comparisons of group
performances are bound to miss patients with specific and unique deficits.
Descriptions such as alexia without agraphia have contributed to an
understanding of brain behaviour relationships [18].
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3. The clinical method, as opposed to the psychometric method has the ability
to pick up new and unusual syndromes and in the apt words of Anastasi; "is
best suited to the processing of rare and idiosyncratic events whose frequency
is too low to permit the development of statistical strategies" [19].
4. Every brain injured person is unique and so is the premorbid personality
characteristics, reaction to the brain behaviour disturbance, capacity for
adaptation and recovery. These factors impact assessment and evaluation [101.
Such views have led authors such as Watts to comment that the use of the
psychometrics seems limited to defining whether or not brain damage is
present or not [121.
The theme of much of American neuropsychology traditionally has been based
on the application of quantitative standardised tests [10,20-251.
Walsh in particular has recommended the application of more flexible,
informal batteries of tests [24,251.
The single case study method is a feature of the Lurian approach to
neuropsychological assessment and such an approach may in fact be traced
back to Hippocrates and was particularly popular in the nineteenth century
when many of the neuropsychological syndromes were identified [18,26,271.
In turn, the problem of generalising from the results of a specific case study
were highlighted [28,29]. An important aspect of the Lurian approach to
neuropsychological assessment is the interpretation of data using syndrome
analysis and double dissociation (that all functional systems which involve a
disturbed factor will be disrupted whilst those which do not include this
factor will remain intact) of function. Syndrome analysis necessitates a
detailed qualitative analysis of the symptoms and signs in accordance with this
principle of double dissociation [11,12].
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3.0 AIM
1. Establishment of an indigenous stroke data bank using contemporary
neuroinvestigative modalities to determine stroke mechanism as precisely as
possible.
2. To determine in this population, the frequency and extent of cognitive
disorders in the acute and subacute stroke period, using a battery of
predefined higher cortical function tests applied to all patients.
3. Collation of a comprehensive array of epidemiological, clinical,




The DSDB was a prospective, observational, hospital based study with
collection of acute care and follow-up clinical and laboratory data on patients
with stroke. The study was designed to facilitate research on the
characteristics, clinical course and outcome of patients with acute stroke and
with particular emphasis on cognitive impairment in the acute and subacute
phase. Each patient with acute stroke was examined by the author and all
patients underwent initial and subsequent computerised tomographic brain
(CT) scanning or magnetic resonance imaging brain (MRI) scanning or both.
Information was collected on each patient concerning the details of medical,
neurological and social history, general and neurological examinations,
cognitive examination, laboratory studies, final diagnosis or diagnoses and
complications.
4.2 Stroke protocols
Since patients often have several risk factors and more than one possible cause
of stroke (eg atrial fibrillation and carotid artery stenosis), ending the work
up at the first positive test may not be the optimal approach. Until various
algorithms are compared however, stroke diagnostic plans needed to be
individualised. This has recently been supported in a review by Adams [1].
1. Recommended minimum work up
2. Additional work up in selected patients.
3. Rarely used tests but listed as options
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The latter two tiers were used as appropriate - tailored to each individual
patient's conundrum of clinical details. Hence a 3 tier investigative protocol
was used, incorporating a basic minimum workup, tests often used and tests
seldom used.
4.2.1 The minimum workup included (1st tier):








erythrocyte sedimentation rate (ESR)
serum glucose
International Normalised Ratio (INR)
partial thromboplastin time (PTT)
Neuroimaging
computerised tomography (CT) or
magnetic resonance imaging (MRI) brain scan or




Higher cortical function deficit (HCFD) bedside screening test 
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4.2.2 Additional work up when appropriate (the 2nd tier)
included:
Sonographic studies 
transcranial Doppler (TCD) of the intracranial large arteries
duplex Doppler (DD) sonography of the cervicocephalic vessels (common,
internal and external carotids, proximal vertebral (origin or V1) and
extracranial (V2) vertebral arteries
transcranial Doppler studies of the distal internal carotid arteries
transcranial Doppler of the distal vertebral arteries (V3 and V4) intracranial
segments
Transcranial Doppler with 10 ml aerated saline injection in antecubital vein
for the detection of right to left shunt (patent foramen ovale, pulmonary
shunts)
Angiography noninvasive and invasive 
MR angiography
Spiral computerised tomography angiography

















Cerebrospinal fluid analysis (CSF) 
4.2.3. A category of seldom required tests (the third tier) for the
following:
Fasting plasma homocysteine levels for homocystinuria (heterozygotes)
Coagulation defects - factor VIII, IX, V, afibrinogenaemia
Haemoglobinopathies (Sickle Cell disease, haemoglobin SC)
Lactate levels - mitochondrial cytopathies (MELAS)
Brain biopsy
4.3 Diagnostic classification
The databank was designed according to the four levels of illness in the World
Health Organisation model of impairment, disability and handicap (WHO
ICIDH) [2] model:
pathology (organ or organ system)
impairment (symptoms and signs)
disability ( functional limitations - interaction between the organism and
environment)
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handicap (social consequences of disease) [3].
Several scales were employed in this registry to accommodate these
measurements in an objective and quantifiable manner. In addition it
facilitated accurate comparison within the registry, with other data banks and
stroke trials. These included six classification systems each measuring
differing but important aspects of disease;
1. A neurological deficit scale
Canadian Neurological Scale [4] (CNS)
2. A clinical stroke scale
Oxfordshire Community Stroke Project Scale [5] (OCSP)
3. A disability scale
Barthel Index (61 (BI)
4. A handicap scale
Rankin [7] ( R)
5. An aetiopathogenetic scale
Trial of Org 10172 in acute stroke [8] (TOAST)
6. The International Classification of Diseases Neurology [9] (ICD-9)
Many scales in use represent simplified versions of a neurological examination
focussed more on diagnostic and localisation information rather than
functional deficits and prognostic data. Most scales in use have not been
validated, are difficult to use and are in some ways inappropriate for the acute
stroke patients. The CNS was used because of the following points as outlined
by Cote' et al [10]:
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detection of clinical noteworthy differences in the neurologic status
testing, of relevant modalities most commonly affected in acute stroke
and having possible prognostic value
ease of use and interpretation by observers with different medical
training
brevity and practicality of its use in the acute stroke period. In
addition to the above points, the CNS paid particular attention to the
three basic types of validity; content, criterion and construct validity.
The scales were chosen because of their validity according to the following
principles for evaluation of clinimetric scales;
Content validity - the extent to which the scale includes all relevant
dimensions of what is being measured
Criterion validity - whether a scale can be used to estimate the current clinical
status (concurrent validity) or predict the future health status (predictive
value) of the acute stroke patient
Construct validation - the behaviour of the scale compared with an index
which measures a different type of deficit (discriminant validity) and its
responsiveness in identifying, change in the neurologic status of stroke patients
(convergent validity) [10].
The combination of scales is of great advantage and the CNS and Barthel are
amongst the best scales for stroke currently in use. However a glaring deficit
with all scales is the paucity of cognitive function testing in stroke patients
[12].
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432 Other haemorrhage for example subdural haemorrhage
433 Occlusion or stenosis of precerebral arteries
434 Occlusion or stenosis of cerebral arteries
434.1 Embolism of the cerebral arteries
435 Transient ischaemic attacks
436 Stroke - ill defined
437.0 Stroke - other cerebral atheromatous
437.6 Cerebral venous thrombosis
437.4 Vasculitis
437.1 Binswangers
437.5 Moya Moya Syndrome
437.7 Transient Global Amnesia
362.34 Amaurosis Fugax
4.4 Clinical stroke diagnosis
Oxfordshire Community stroke Project grading for ischaemic infarction into
1. Total anterior circulation infarct (TAC)
2. Partial anterior circulation infarct (PAC)
3. Lacunar infarct (LAC)
4. Posterior circulation infarct (POC)
Clinical diagnosis of intracerebral haemorrhage
5. Intracerebral haemorrhage
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4.5 Clinicoinvestigative aetiopathogenetic diagnosis according to
the modified TOAST (expanded) classification:
1. Cardioembolism
2. Large vessel disease
3. Small vessel disease
4. Other
In the "other" category were included probable or presumed causes of
stroke after the investigative protocol failed to determine any cause of
stroke. The "other" category included strokes in association with or












4.6 The Barthel index of activities of daily living
This choice was made after review of the literature indicated that there were









8. Going to the toilet
9. Wheelchair skills
10. Continence
4.7 The Rankin Scale
This scale incorporated a simple 6 item scale;
0 No symptoms at all
1 No significant disability despite symptoms; able to carry out all
usual duties and activities
2 Moderate disability; requiring some help, but able to walk
without assistance
3 Moderately to severe disability; requiring some help, but able to
walk without assistance
4 Moderately severe disability; unable to walk without assistance
and unable to attend to own bodily needs without assistance
5
	
	 Severe disability; bedridden, incontinent and requiring constant
nursing care and attention.
6 Death
4.8 Cognitive Testing
Cognitive Testing - Timing
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Was deemed to be important so as not to miss the true extent of neurological
deficit as this is not reflected adequately in the current neurological scales. A
higher cortical function deficit (HCFD) screening examination was applied to
all alert patients in the DSDB in the first two weeks of presentation.
Only alert patients were tested cognitively within the first week of
presentation. There is no ideal time as initially oedema, diaschisis, and
metabolic abnormalities may confuse the clinical picture. A trade off however
is unavoidable as some patients have only fleeting or very transient deficits
that last hours or days.
Cognitive Testing - Indication for neuropsychological testing. 
1. In patients whose deficit was subtle
2. In patients whose brain imaging revealed an appropriate stroke but who on
bedside cognitive testing were normal.
3. Where the screening examination suggests but does not decisively delineate
a syndrome.
Note that this was in accordance with the recently published recommendations
from the report of the Therapeutics and Technology Assessment
Subcommittee of the American Academy of Neurology that appeared
subsequent to the design of the DSDB. This provided Class II evidence and an
A grade recommendation for the use of neuropsychological testing in specific
neurological disorders including stroke subject to certain stipulated guidelines
[12]
Neuropsychological test battery employed included:
Clinical interviews
Trail Making Test [13,14]
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Symbol Digit Modalities Test [13,151
South African Wechsler Adult Intelligence Screen (Digit Span, Block Designs,
Object Assembly) [16]
Rey Complex Figure Test [13]
Wechsler Memory Scale [17]
Rey Auditory Verbal Learning Test (RAVLT) [13]
Verbal Fluency Tests (FAS) (adapted from Benton and Hamsher 1976 and
cited in Lezak in 1995) [13]
Category Naming (adapted from Newcombe 1969,cited in Lezak in 1995)1131
Wisconsin Card Sorting Test (WCST) [18]
Luria's Neuropsychological Investigation (South African adaptation) [19,201
including preliminary conversation, motor functions (optic - spatial
organisation), writing (letter), reading (text) and arithmetic skills.
The neuropsychological assessment procedure incorporated both a qualitative
and quantitative data analysis, the latter according to the norms indicated
above. Qualitative analysis proceeded according to a process of hypothetico
deduction and was based on the principal of syndrome analysis and double
dissociation as per Luria [21].
The rationale of the cognitive testing in this study was that simple bed side
higher cortical function testing and not in depth neuropsychological evaluation
must remain the mainstay of assessment as these patients are often critically ill,
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exhausted and anxious and the latter testing is inappropriate at such times. In
addition time constraints do not permit lengthy testing and with the advent of
acute stroke therapy an evaluation of HCFD must be made rapidly but as
accurately as possible. Neuropsychological testing was regarded as an
elaboration of the bedside cognitive assessment in this study.
4.9 Single Photon Emission Computed Tomography (SPECT) brain
scanning
Performed in patients with discrepancy of clinical signs and anatomical brain
scan despite appropriate timing of CT or MRI brain scanning. Twenty
Millicuries 99m Technetium - HMPAO 99 is administered intravenously.
Ceretec with Technetium produces a lipophilic complex which crosses the
blood brain barrier and is retained in the brain, allowing assessment of
regional cerebral blood flow. Imaging commenced 2-3 minutes after the
injection of the tracer. The patient is positioned as comfortably as possible
with the room slightly darkened and encouraged to be as relaxed as possible.
Scans are obtained for 20 seconds, with regular 6 degree rotation of the
camera head around the patient, completing a 360 degree rotation with
approximately 60 images obtained. This required cooperation from the patient
for a period of about 30-40 minutes. A medium to high resolution collimator
was used on the gamma camera. Reconstruction was performed with
positioning of the patient in the orbitomeatal line, in the transverse, coronal
and saggital planes. Transaxial slices were contiguous, 16 in number and 3.3
mm thick. Three dimensional reconstruction was also performed. Images were
interpreted on the computer screen comparing right and left regions of
interest. This was done both visually in a qualitative manner by a radiologist
blinded to the anatomical scan and semi quantitatively, the latter adapted from
methods by Podreka et al [22] and Steinling et al [23]. The transaxial slice with
the largest perfusion defect was identified and a circular region of interest
traced over that area. These circular regions of interest (ROI) were also
obtained for six areas of the gray matter. These included the cerebellum,
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thalami, basal nuclei, frontal, parieto occipital and temporal regions. These
areas and their mirror images on the homologous region of the other
hemisphere were stored on a template and adjusted for surface area when
required for a particular scan. The ROI radioactive counts from homologous
regions of both hemispheres were taken to compare side to side perfusion
differences and expressed as an asymmetry index. An asymmetry index
percentage (AI) was calculated according to the formula A-B4A+B/21 x 100
where A and B represent right and left sides. AI comparison was done with 5
age matched controls (on a case by case basis) and matched on education but
not social class. Follow up scans were not routinely performed.
4.10 Final diagnosis
A final diagnosis was made with the benefit of all available clinical and
investigative data by the same cerebrovascular neurologist. For a diagnosis to
be made within the frame work of the extended TOAST classification, the
diagnosis needed to be one of exclusion in which all clinically indicated tests
according to the hierarchical protocol were negative save for the factor in
question. Comorbidity was also documented. It is acknowledged that some
would be definite diagnoses, some probable and some possible by this method.











Age breakdown into 10 year intervals
Date of birth
Handedness
Number and dates of visitations
Referral source



























































































Reflex status and tone
Normal

















Truncal level (brainstem strokes)
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Digit


















































Brain scan topographic lesions - brain anatomical scanning (CT and MRI)
Brain anatomical structures and vascular territories of the brain were
diagnosed according to the anatomical plates with CT and MRI correlates of
Kretschmann with permission for the supratentorial territories. For the
brainstem and cerebellar territories this was according to the templates of and



































































































Normative values were taken from the three regional laboratories used in the
study; Bouwer and Partners, Pillay MacIntosh and Partners, department of




















Tissue plasminogen activator (t-PA)
Surgical
Carotid endarterectomies (CEA)







































Frequencies and percentages were calculated for categorical data while means
and standard deviations were calculated for continuous data. For skewed




Significance of associations between categorical variables were assessed using
Chi square or Fisher's Exact Test for 2x2 tables with small cell sizes.
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Sensitivity and 95% confidence intervals were calculated for HCFD using
neuropsychological testing as the Gold standard.
The CNS score was compared to the Rankin score using a Spearman
correlation coefficient. CNS was also categorised as mild (11.5-9.5), moderate
(9.0-5.5) or severe (5.0-0). This was compared to the Rankin score graded as
independent (0-1), dependent (2-3) and severely affected (4-5). The Kappa
statistic was calculated to assess the agreement between these two parameters.
Risk factors related to HCFD
Chi square or Fisher's Exact Test was applied for assessing the univariate
associations between an abnormal HCFD and the various recorded risk factors.
In addition, the Odds ration and 95% confidence intervals were reported for
these associations.
Risk factors with a p-value of <0.200 on univariate analysis were subsequently
entered into a Multivariate Logistic Regression model to determine which of
the variables independently associated with an abnormal HCFD. A Maximum
Likelihood estimation procedure was applied. A stepwise backward technique
was used to eliminate the non significant risk factors with a p-value to stay of
<0.05.
4.12 Data Bank Software and design
The software used was Filemaker Pro 3.0 (Apple Macintosh and Windows
95). The following were unique features exploited with this software.
4.12.1 Multimodality digitised storage
New information needs to be incorporated easily and the various investigations
and imaging data are not usually part of the databank. The DSDB design
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enabled digitised storage of:
- text (clinical notes, final diagnoses, follow up notes)
- i mages (brain MRI, CT, SPECT, Doppler, angiographic images)
- sound (aphasia progress monitoring, Doppler embolic sounds)
4.12.2 Multiple database layouts
In addition five different layouts of the databank were designed, the switching
from one layout to another easily executed with one "mouse click". These
included:
- layout 1: comprehensive clinical admission, progress, follow up notes
- layout 2: official report to referring doctor or institution
- layout 3: stroke data bank of 50 fields each with 2-76 variables
- layout 4: patient name lists
- layout 5: stroke data bank fields with neuroimaging in selected patients
- layout 6: optional - any combination of fields possible
These special features of the data bank allowed for easy and rapid access to the
rough notes, official report to colleagues, patient lists and the prospective
input to predetermined fields and variables. The latter is done by means of a
check list with variables entered with a "point and click" operation from a
computer mouse or touch pad. This expedites data entry and accuracy.
4.12.3 Flexibility with database fields, back up storage and
portability of databank.
Additions and reordering of database fields is simple and necessary as new
classifications and information becomes available. Data is exported to a
statistical package for statistical calculations. Such a data base can be entirely
independent from conventional file storage systems and with the aid of
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external hard drives. The external drives used were Iomega Zip drive (100
mb discs) and Jaz drives (1000 mb) can be easily transported. The method
described saves time and money and obviates delays in obtaining conventional
patient charts and radiographic images.
The Modular principle of the Durban Stroke Data Bank
Because certain core features are important and to allow for comparison with
other stroke data bank these are always collected. It allows for additional items
to be gathered. Also the theme is from general to specific or from areas of
high sensitivity (HCFD screening examination) to high specificity
(neuropsychological testing).
4.13 Statistical software
Epi Info (Centres for Disease Control package).
Available at; http//:www.cdc.gov/EPO/EPI/EPI.HTML
4.14 Exclusions
Patients presenting with transient ischaemic attacks were excluded provided
they had a normal brain scan. This population as whole were not included as
the differential is wide and includes partial seizures, classic, complicated and




5.1 Stroke Data Bank Results
5.2 Cognitive Results
5.1. Stroke Data Bank Results
5.1.1 Descriptive statistical analysis
5.1.1.1 Demographics








































Figure 1. Age Analysis of patients in 10 year increments.
Age distribution
1-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Age in years










Figure 3. Box and whisker plot of black versus white age group
analysis
Black White
100% maximum 87 90
75% quartile 54 71
50% median 41.5 64
25% quartile 34 52













Age analysis (years). Three basic groups were categorised.
Paediatric 0-14 years
Young 15-49 years













Right handed 982 (98.2%)
Left handed 13 (1.3%)
Ambidextrous 5 (0.5%)
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5.1.1.2 Timing of the initial examination and initiation of
investigations
Acute period: This was performed within
0-6 hours in 84 (8.4%)
7-12 hours in 55 (5.5%)
13-24 hours in 88 (8.8%)
25-48 hours in 74 (7.4%).
Subacute period: The examination was performed within
3-7 days in 137 (13.7%)
1-4 weeks in 182 (18.2%)
1 to 3 months in 109 (10.9%).
Delayed: the examination was performed within
3-6 months in 36 (3.6%)
7-12 months in 21 (2.1%).
In 84 (8.4%) patients the initial examination and investigations were
preformed longer than one year after initial onset of symptoms or the timing
or date was uncertain.
5.1.1.3 Symptoms
Although 23 different symptoms were prospectively sought at time of stroke
presentation, in 150 patients, some of their symptoms did not fit into one of
the categories. Within the category named other, examples of these
nonclassifiable symptoms of relatively sudden onset included; subdued
behaviour, relatively sudden onset of depression lacking, blunting of emotion,
i mpaired insight into condition, sudden onset of impaired bladder control (not
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incontinence but for example micturating in the bedroom), slowed up in work
environment (unable to manage well known software programmes), slowness
of thinking and talking in general, sensation of a thick and swollen tongue and
hearing strange sounds (auditory illusions). In 15 (1.5%) patients this was the
only symptom.
Table 1. Prospectively defined symptoms. Frequency.




















* Other with no other concomitant symptoms 15/150 (10%)
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5.1.1.4 Risk factors - modifiable
These were divided into proven and as yet unproven risk factors. Non
modifiable such as age, race, sex and hereditary factors were not analysed
apart from within the demographics section.







Transient ischaemic attack 53
Hyperlipidaemia 47
Carotid stenosis 251
Probable but unproven risk factors
Lipoprotein (a) 195
Infection within the last month 43
Gout 33








Hemiparesis was the most common presentation in 309 (30.9%), followed by
tongue weakness in 57 (5.7%), dysphagia in 38 (3.8%) and monoparetic
presentations in 35 (3.5%). Unusual patterns such as triparesis and isolated
digital weakness were encountered and typically associated with diagnostic
delay. In most patients the degree of (Medical Research Council grading)




Right sided weakness 169










Grading (MRC). At time of initial examination and included only the weak








Sensory impairment type was most commonly a hypoesthesia (24.8%) or
86.7% of total instances of sensory deficit types. Sensory impairment
topography was most commonly in a hemi distribution (20.6%) with a
fragmentation of the deficit involving the face only in 23 (2.3%), distal arm in
21 (2.1%). The leg was less often involved with the distal leg only occurring
in 15 (1.5%) and the whole leg in 7 (0.7%) being infrequently encountered
and not always volunteered by the patient Interestingly a hand digit alone in 9
(0.9%) was about as commonly involved as the entire leg. Although rare, the
DSDB has demonstrated as have other data banks (Lausanne) that stroke may
mimic a peripheral nerve sensory pattern (digital only in 9 patients) or
myelopathic pattern (truncal level in 2 patients with brainstem stroke).
















Visual neurological deficits such as homonymous heminanopias,
quadrantanopias, sectoranopias (n=80; 8%) and various ophthalmoplegias





INO and Ophthalmoplegias 38
5.1.1.6 Initial clinical stroke classification (Oxfordshire
Community Stroke Project Classification) and intracerebral
haemorrhage.
The most numerous group of stroke patients were in the category of partial
anterior circulation infarct numbering 447, followed by posterior circulation
infarct numbering 258, followed by total anterior circulation infarct with 185
and the smallest group was the lacunar infarct group with 82. The
intracerebral haemorrhage and haemorrhagic infarct group numbered 48.






Figure 4. Clinical Stroke Subtypes - Oxfordshire Community
Stroke Project Classification (OCSP)
Legend to clinical types of infarcts as per OCSP
TAC: Total anterior circulation




5.1.1.7 Anatomical brain scans
All 1000 patients had an anatomical brain scan. Either a CT (n=698) or MRI
(n=426) brain scan or both 124 (12.4%) were done in all patients. The
distribution of lesions consistent with strokes were 411 in the right
hemisphere, 426 in the left hemisphere and 296 subcortical. Multiple strokes
were seen in 189 people.
The arterial distribution frequencies included 259 in the middle cerebral
artery cortical territory, 87 in the brainstem arteries, 61 in the cerebellar
cortices, 25 in the anterior cerebral cortical artery territory, 52 in the
posterior cerebral cortical territory, 37 in watershed distribution, 2 anterior
choroidal and 5 in the venous system.





















The frequencies of abnormalities is listed in Table 3. All patients had 1st tier
investigations hence the number of abnormalities is a fraction of 1000. For the
2nd and 3rd tier investigations the number is listed as a fraction of the total
number of investigations done within that category.
Laboratory findings listed in Table 3 were notable for the high rate of
complete blood count (haemoglobin, mean cell volume, haematocrit, white cell
count and differential count, platelets) abnormality in 99 patients compared to
the relatively few abnormalities for INR (8;0.8%), PTT (7;0. 7%) and ESR
(35; 3.5%). There were 143 instances of blood count abnormalities including
haemoglobin (high in 17, low in 25), MCV (high in 31, low in 8), white cell
count (high in 32, low in 3), platelets (high in 7, low in 3), haematocrit (high
in 10, low in 2) and MCHC (high in one, low in 3). With respect to the 43
patients reporting an infection in the month prior to their stroke, only 15 of
these (32 overall) had raised white cell counts.
Lipogram abnormalities were notable for the relatively high rate of elevated
Lipoprotein (a) fractions recorded (195 or 19.5%). Interestingly 345 (34.5%)
of patients had either a lipogram abnormality or Lipo(a) abnormality, 168
(16.8%) had both and 150 had a lipogram abnormality without raised Lipo(a).
These levels were measured with relatively high reference values that have
recently been lowered so in fact may represent a slight underestimate.
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Prothrombotic factors such as protein S, C, antithrombin III and
anticardiolipin antibodies were not tested in all patients. Together they were
thought to be aetiologically causative in only 21 cases.
In 5 patients with clinical and angiographically demonstrated vasculitis there
was a clinical indication for brain biopsy of which 2 were negative. The three
positive biopsy proven cases were ascribed to temporal arteritis in one,
systemic lupus erythematosis (SLE) in one and isolated angiitis in one.
Table 3: Brain scan, laboratory, Doppler sonographic and cardiac
investigations - frequency of abnormalities
First tier investigative findings












Complete blood count abnormality
Elevated Lipoprotein (a)
Lipogram abnormality
Lipogram and Lipoprotein (a) abnormality 168









Duplex Doppler 325/629 51.6
Transcranial Doppler 268/575 46.6
Cardiac
Cardiac echo transthoracic 131
Cardiac echo transoesophageal 21









Anti thrombin III 3
Fibrinogen 5





Testing for patent foramen ovate was carried out in 16 patients, 7 of which
were positive. In 2 patients high intensity transient signals (HITS) were
detected over a middle/anterior cerebral artery bifurcation in the setting of
prosthetic heart valve and atrial fibrillation in one patient and preocclusive
stenosis due to fibromuscular dysplasia in one patient. (See figures)
Cardiac
Significant cardiac abnormalities were present in 122 patients (with 162
cardiac abnormalities) and accounted for a relatively smaller number (12.2%)
in comparison to other young stroke data banks 11-231. High risk and medium
risk causes as noted in Table 4 were all diagnosed with the help of
echocardiography (131 transthoracic and 21 transoesophageal). Patent
foramen ovale as the most likely factor associated with stroke occurred in 7
patients (age range; 25-47 years and mean age; 35.8 years) and accounted for
25% of the cardiac causes in the young stroke population. In one patient this
was associated with an atrial septal aneurysm. All patients were diagnosed with
transcranial Doppler and the injection of agitated aerated saline in an
antecubital vein and all patients had an echocardiogram. However since only 4
patients had TEE the true incidence of other frequently occurring
abnormalities such as atrial septal aneurysms cannot be commented on. Other
predisposing factors for blood clot formation in the context of PFO included;
Valsalva manoeuvre (vomiting, asthma attack) 2
Atrial septal aneurysm 1
Prothrombotic state (anticardiolipin positivity)
Congenital heart disease (Ebstein's anomaly)
Concurrent infection (influenza) 1
Significant emotional/personal stress
In the dysrhythmia group, atrial fibrillation accounted for 32 (43%).
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Table 4. Cardiac abnormalities
High risk cardiac source
Ischaemic heart disease 62
Atrial fibrillation with dilated left atrium 1
Mechanical prosthetic valve and atrial fibrillation 1
Rheumatic mitral stenosis, atrial fibrillation, dilated left atrium
Left ventricular thrombus 1
Dilated cardiomyopathy wth left ventricular clot 1
Atrial myxoma 1
Infective endocarditis 1
Congenital heart disease - Eisenmenger's complex, infective endocarditis  1
Congenital heart disease - Ebsteins anomaly 1
Congenital heart disease - Atrial septal defect - perioperative repair stroke I
Medium risk cardiac source
Dysrhythmia 73
Patent foramen ovale 7
Mitral valve prolapse 6
Dyskinetic or hypokinetic left ventricular segment 3
Atrial septal aneurysm and patent foramen ovale 1
Mitral annular calcification 1
Total 162
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5.1.1.9 Aetiologies - TOAST categories and 'Other' subgroups.
Within the slightly modified TOAST aetiological classification, the most
numerous groups with similar frequencies included; large vessel disease 264
(26.4%), small vessel disease 262 (26.2%) and other 253 (25.3%). Cardiac
causes were relatively less frequent, numbering 122 (12.2%) and in 99 (9.9%)
the cause of stroke was classified as unknown and not associated with a
recognised cerebrovascular risk factor in isolation.
In the subcategories of the 'Other' group the conditions diagnosed were







In the miscellaneous group the most frequently diagnosed conditions were;
- cerebral haemorrhage
- dolichoectasia with artery to artery embolism or thrombosis
- transient global amnesia (abnormal SPECT,normal MRI scans)








































Subgroup analyses: Frequencies of abnormalities included;
Prothrombotic group 58
Definite - laboratory determined
Anti cardiol ipi n antibody 10
Elevated fibrinogen 5
Protein S deficiency 5
Protein C deficiency 3
Antithrombin III deficiency 3
Plasmin system defect 1
Probable prothrombotic mechanisms. Recognised predisposing causes for
hypercoagulable state. Other causes of stroke excluded(probable causes)








Four patients had 2 prothrombotic causes.
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Vasculitides 	41
Biopsies were performed in 5 patients (2 negative). Angiograms were
performed in 20 patients. In 18 patients the diagnosis was made on the basis of
laboratory evidence together with a known cause of vasculitis with other
possible causes of stroke excluded. In the latter group the diagnosis of









Giant cell arteritis 1
Kawasaki disease vasculitis 1











Diagnosis was based on a typical clinical history of neck pain,
either angiographic evidence (n=14) or duplex Doppler evidence
(n=14).
Spontaneous carotid dissection 7
Blunt cervical trauma 5
Spontaneous vertebral dissection 4
Fibromuscular dysplasia/dissection 2
Temporally related to chiropractic manipulation 1
Spontaneous basilar artery with subarachnoid haemorrhage 1
Migraine 9
Metabolic stroke (hyperhomocysteinaemia) 4
Moya Moya syndrome 1




Other - Miscellaneous category
The following most likely causes were identified after a diagnosis of exclusion
(possible causes):
Cerebral haemorrhage 47
Dolichoectasia with artery to artery embolism or thrombosis 28
Transient global amnesia (abnormal SPECT,normal MRI scans) 14
Cerebral venous thrombosis 5
Cerebral aneurysm with distal territorial embolism 3
Sleep apnoea syndrome 2
Anaesthetic complication, cardiac arrest, hypoxic encephalopathy 2
Stroke in association with brain tumours 2
Chemotherapy complicated by stroke 2
Stroke in association with cerebral trauma 2
Eclampsia and stroke 1
Arterial redundancy of a persistent hypoglossal artery 1
Arterial redundancy of a persistent trigeminal artery 1
Carotid coils, kinks and loops (arterial redundancy) 1
Gunshot to the neck with carotid artery with thrombosis 1
Brainstem AVM haemorrhagic infarct, polycystic kidneys 1
Post operative stroke during cervical spondylotic surgery 1
Migril abuse related cerebral haemorrhage 1
Latrodectism (spicier bite ) haemorrhage 1
Low serum folate level 1
Surgical clip placed over middle cerebral artery 1
Basilar artery fenestration 1
Stroke in association with electrocution 1
Stroke due to vasospasm after aneurysmal clipping in SAH 1
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Haemorrhage
The relatively small number of haemorrhagic infarcts and intracerebral
haemorrhages (n=47) were due to established and pre existing hypertension in
only 25 patients (53.1%). In 15 patients without a history of hypertension
other associated conditions known to cause cerebral haemorrhage are listed in
Table. These causes were thought to be probable. In 7 patients the diagnosis of
the intracerebral bleed could not be established.
Probable causes of cerebral haemorrhage (n=15)
Cardiac valvular disease or atrial fibrillation 2
Arteriovenous malformation 1
Infective endocarditis (mycotic aneurysm) 1
Cerebral amyloidosis 1
Alcoholic liver disease 1
Trauma - assault 1
Trauma - motor vehicle accident 1
Brainstem AVM haemorrhagic infarct, polycystic kidneys 1
Migril abuse related cerebral haemorrhage 1
Latrodectism (spider bite ) haemorrhage 1
Aneurysmal bleed 1
Takayasu's arteritis with Moya Moya 1
















Frontal lobe syndrome 3
Lateral medullary syndrome 1
ii) Isolated symptom (1 or 2 of the following)












i) Brain parenchymal imaging and angiography (MRA, catheter angiography,
spiral CT)
Arterial territories n %
Basilar artery 32 (100)
Vertebral artery 2 (6)
Anterior circulation - carotid 1 (3)
Anterior circulation - middle cerebral arteries 1 (3)
Aortic arch with "Shaggy aorta syndrome" 1 (3)
Brain parenchymal imaging abnormalities (CT and MRI)
Posterior circulation infarcts 27 (100)
Multiple 18/26 (69)
Ventriculomegaly 4/31 (13)
Sonography - Transcranial Doppler
Low velocity and increased pulsitility 18/25 (72%)
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5.1.1.10 Causes of stroke in black patients
These differed markedly to the White and Indian population group and to the
DSDB as a whole. Contrary to the usual atherogenic subgroups of large and
small vessel disease being the most numerous, in black patients the "Other"
group and those with causes unknown were the most populous. Within this
group HIV vasculopathy was the most common cause of the vasculitides
accounting for 13 % of all black strokes.
Other 39
Unknown 20
Small vessel disease 17
Cardioembolic 12
Large vessel disease 12







Analysis of the largest subfraction - vasculitides
HIV associated vasculitis 13
Takayasu's arteritis 3




5.1.1.11 The young stroke population (8 - 49 years)




Small vessel disease 33 (13.4%)
cardiac 29 (11.8%)
Large vessel disease 22 (8.9%)
Other - expanded categories were classified into definite, probable and
possible causes. The most frequently diagnosed conditions (and as a percentage
of the group other) were;
- vasculitides 29 (25.4%)
- prothrombotic states 26 (22.8%)
- dissection 13 (11.4%)
- migraine 9 (7.8%)
- cerebral venous thrombosis 4 (3.5%)
Two important treatable conditions were common in young stroke patients;






arterial redundancy - coils, loops and kinks
hypoplasia and agenesis
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accounted for 76/245 (31%) causes and probable causes in the young stroke
population.
2. Patent foramen ovale 
This condition accounted for 7 of the 29 cardioembolic causes.
Aetiologies - racial differences 
Differences were most obvious within the large 'Other' group which contained
39/100(39%) blacks and 193/781 (24.7%) whites. The majority of strokes in
blacks studied in this limited sample were infection related (HIV, TB,
Takayasu's, Syphilis, Neurocysticercosis) vasculitides (n=19; 19%)
Severity of stroke (as assessed by CNS, Barthel and Rankin scales).
Assessment for neurological deficit (by CNS scale), revealed that 47% were
normal and a further 40% had a mean score of 9.4. When the Barthel Index
was computed, 4% had a normal Barthel index on admission and a further
65% scored 16-19. Measurement by Rankin score, 87% had a score of 0-3, ie
ambulant. There was moderate agreement between the CNS and Rankin scales
(kappa = 0.58)
5.1.1.12 Cerebral Perfusion Index - early prognostication
Single photon emission computed tomography scanning was performed as per
protocol in 104 patients of which 78 (75%) studies were abnormal (graded as
hypoperfusion, hyperperfusion, absent, mixed). These were also used to
calculate the cerebral perfusion index (CPI) together with transcranial
Doppler values in acute stroke patients.
Overall in the DSDB, The CPI was performed in 44 patients in the acute phase
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of stroke (within 48 hours of onset of the ictus). Because of the possibility of
other neurodegenerative disease only the young patients were considered for
analysis. The Rankin scale mean value of these patients showed a significant
difference (ANOVA) between the poor and medium, poor and good, but not
between good and medium categories.
Table 5. Cerebral perfusion index in the acute phase of stroke in
the young stroke patient.
CPI n Mean Rankin score (48h)
Good 15-20 5 1.6 (SD 0.6)
Medium 6-12 25 1.8 (SD 0.9)
Poor 1-5 2 3.5 (SD 0.7)
ANOVA p = 0.029
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5.1.1.13 Complications
Eight specific categories of complications were specifically sought according
to predefined criteria. Overall, complications as prospectively sought and
recorded over a 4 month follow up period occurred in 347 patients. In order







Post carotid endarterectomy stroke 5
Brachialgia 2
Died 53
Sleep apnoea syndrome (post stroke) 4
84
5.1.1.14 Follow up










> 2 years 50
Patients that died during the follow up period numbered: 53/824 (6.4%).
Range 1 week to 5 years.
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5.1.1.15 Treatment








Tissue Plasminogen Activator 1
Carotid endarterectomy 140
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5.1.2 Stroke Data Bank - computational analytical statistics
5.1.2.1 Table 6. Clinical subtype on admission (OCSP) vs final
aetiopathogenetic classification (TOAST) for ischaemic stroke
patients
Card Large Small Other Unk Total
TAC 40 19 38 45 21 163
PAC 49 124 147 86 37 443
LAC 9 41 23 8 1 82
POC 22 78 52 75 31 258
946
Chi square test (p=0.001) showed a significant difference in the overall
distribution between the clinical scale (OCSP) and the final aetiopathogenetic
scale (TOAST).
Pairwise comparisons: comparing different combinations of OCSP
categories with relation to TOAST:
TAC vs PAC p=0.001
TAC vs LAC p=0.001
TAC vs POC p=0.001
PAC vs LAC p=0.003
PAC vs POC p=0.001
LAC vs POC p=0.001
Legend: (OCSP and TOAST scales - see appendix)
TAC - total anterior circulation
PAC - partial anterior circulation
LAC - lacunar
POC - posterior circulation



























>49 497 223 Chi square value: p=0.001
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5.1.2.3 Table 8. Neurological admission deficit versus disability -
CNS vs Rankin scales
Rankin Score CNS Score
11.5-9.5 9.5-5.5 5.0-0
0-1 454 13 0 467
2-3 227 110 8 345
4-5 15 81 78 174
696 204 86
Kappa = 0.543. There is moderate agreement between CNS and Rankin scores.
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5.1.3 Stroke Data Bank: Treatable stroke mechanisms
Noteworthy case reports of stroke mechanisms elucidated by the
protocol of neurodiagnostics.
1. Luetic cerebral vasculitis (LW).
Clinical: A 59 year old white man with multiple minor strokes, frontal lobe
syndrome and subcortical impairment.
Serology: Positive syphilis serology WR and FTA in the blood and CSF.
Anatomical brain scan: MRI brain scan revealed multiple hyperintense lesions
in the subcortical regions and leukoaraiosis.
Doppler sonography: Cervicocephalic vessels normal.
Cardiological tests: Normal.
Angiography: Catheter angiography revealed multiple vessel narrowing in the
anterior and posterior circulation.
Interpretation: Syphilis angiitis.
Figure 6. Cerebral Luetic Vasculitis. Catheter angiogram showing
irregularity of the basilar artery and posterior cerebral arteries.
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2. Haemodynamic hemispheric hypoperfusion with haemodynamic
transient ischaemic attacks and failing medical therapy - a case for
EC/IC bypass? (WR)
Clinical: A 56 year old white man with positive symptoms of left limb shaking
TIA's and right altitudinal type amaurosis fugax since an episode of nonfatal
strangulation.
Sonography: Duplex Doppler sonography revealed an occluded right internal
carotid artery and transcranial Doppler showed preserved and normal flow of
the right middle cerebral artery that ceased entirely with digital occlusion of
the right common carotid or right external carotid.
Anatomical brain scan: MRI brain scan showed punctate hyperintense lesions
in the high cortical region typical of watershed infarcts.
Functional brain scan: SPECT brain scanning revealed marked underperfusion
of the right hemisphere which was exacerbated by intravenous Acetazolamide
suggesting exhausted cerebrovascular reserve.
Cardiological tests: Normal
Angiography: Catheter and MR angiography revealed pial collateralisation of
the left middle cerebral artery territory by the left posterior cerebral artery
territory. Both posterior communicating arteries were absent.
Collateralisation was also seen through the left ophthalmic artery from the left
maxillary artery confirmed by angiography and transcranial Doppler.
Interpretation: Haemodynamic transient ischaemic attacks and established
infarcts failing medical therapy. He would satisfy current criteria for
extracranial/intracranial bypass surgery [1,2].




















Figure 7a. MRI brain scan showing typical watershed infarcts (arrows)
consequent to right internal carotid occlusion. This patient had no
posterior communicating arteries.
Figure 7b. SPECT scan with Diamox (upper half images) and without
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Figure 7c. Magnetic resonance angiogram showing asymmetric right
posterior cerebral artery flow indicative of the contribution of the right
posterior cerebral artery to pial collateralisation. This patient had
bilaterally absent posterior communicating arteries - the most important
source of cerebrovascular collateralisation.
Figure 7 d. Catheter angiogram demonstrating collateralisation via the
external carotid artery, maxillary artery, ophthalmic and reconstitution
of middle cerebral artery blood flow.
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3. Congenital artery abnormality and arterial redundancy -
persistent hypoglossal artery and stroke
Clinical: A 48 year old white woman reported a sudden onset of bilateral
visual impairment lasting several minutes, followed by intermittent shaking on
both sides of her body lasting about 2 hours. Turning her head to the left for
more than 1-2 minutes invariably provoked dizziness.
Anatomical brain scan: The magnetic resonance (MRI) brain scan was normal.
Doppler sonography: Transcranial Doppler sonography including dynamic
studies with head rotation and flexion was normal. Specifically basilar artery
velocity was unchanged with head rotation to the right and left for 2 minutes.
Cardiological tests: Normal
Angiography: Catheter and MR angiography showed an abnormal signal void
due to a carotid basilar anastomosis which was confirmed on time of flight
magnetic resonance (MR) angiography as a very dilated tortuous hypoglossal
artery with an aplastic right vertebral and hypoplastic left vertebral artery.
Selective angiography confirmed the MR angiogram findings.
Functional brain scan: The SPEC f brain scan showed left hemisphere
hypoperfusion to visual inspection and semiquantitative analysis. The
asymmetry index was calculated as 22%, significantly different to the normal
controls. The cerebral vasomotor response was tested with intravenous
Diamox without any further abnormalities noted on the SPEC!' scan.
Interpretation: A persistent primitive hypoglossal artery was the sole
identifiable stroke risk factor for a patient presenting with positional,
posterior circulation ischaemic episodes. Redundancy of the primitive
hypoglossal artery was the postulated mechanism of cerebral ischaemia on a
haemodynamic basis.
Figure 8. MR angiogram of the cervicocephalic vessels showing the
hypoglossal artery connecting to the basilar artery (arrow)
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4. Comorbidity in stroke - which is the relevant mechanism?
Clinical: A 49 year old white woman presented with symptoms and signs of
posterior circulation stroke. She had rheumatic fever, a mitral valve
replacement and had triple atherogenic risk factors.
Anatomical brain scan: The CT brain scan showed a superior cerebellar
infarct and the MRI minor subcortical infarcts bilaterally.
Doppler sonography: Duplex Doppler of the carotid arteries showed bilateral
significant carotid stenosis. Transcranial sonography revealed multiple high
intensity transient signals (HITS) interpreted as emboli. These occurred in
both middle cerebral arteries and the basilar artery.
Functional brain scan: SPECT showed biparieto occipital hypoperfusion.
Cardiological tests: Prosthetic mitral valve, atrial fibrillation.
Comment: It was most likely that the HITS were cardiogenic emboli as they
































Figure 9. Terminal intracranial internal carotid artery Doppler wave
form. High intensity transient signal with all the criteria of an embolus.
These occurred with a frequency of several per minute in a patient with
atrial fibrillation and mitral valve prosthesis.
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5. Patent foramen ovale and stroke. The role of other contributing
factors.
Clinical: A 29 year old professional sky diver and scuba diver presented with
sudden onset imbalance, dsyarthria and diplopia immediately after extensive
aerial acrobatics during which he became violently ill and vomited copiously.
Anatomical brain scan: The MM scan showed a right posterior inferior
cerebellar and superior cerebellar branch infarction as well as a right
frontoparietal infarct.
Angiography: Catheter four vessel angiography was normal.
Doppler Sonography: Transcranial Doppler with contrast injection showed
multiple air embolic signals in the middle cerebral artery.
Cardiological tests: Transoesophageal cardiac echocardiography: In addition to
confirming a patent foramen ovale, an atrial septal aneurysm was diagnosed.
Comment: Forceful valsalva manoeuvre (plus other factors?) was required in
addition to the patent foramen ovale to cause the stroke. In addition the atrial
septal aneurysm could have serves as a nidus for clot.
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Figure 10 a. Injection of 10 ml of agitated saline and simultaneous
recording of the middle cerebral artery Doppler waveform. Multiple air
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Figure 10 b. This patient also had an atrial septal aneurysm (arrow) in
addition to the patent foramen ovale - seen on transoesphageal
echocardiography.
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6. Basilar artery fenestration causing posterior circulation
ischaemia and stroke - an obscure cause.
Clinical: A 71 year old white man suffered progressively more debilitating
attacks of dizziness, diplopia, imbalance and incoordination over a 7 year
period with several daily attacks present at time of presentation.
Anatomical brain scan: The MRI brain scan revealed no parenchymal lesion.
Functional brain scan: The SPECT brain scan revealed bi occipito parietal
hypoperfusion.
Doppler sonography: Cervical and intracranial sonography was normal.
Cardiac echocardiography: Normal.
Angiography: MR angiography revealed basilar artery fenestration.
Comment: Basilar artery fenestration with recurrent artery to artery emboli
was the postulated mechanism of stroke/ischaemia. No other causes of stroke
were identified and his symptoms improved dramatically with antiaggregant
therapy - a combination of Aspirin and Persantin.
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Figure 11 a. Above. Magnetic resonance angiogram of the vertebrobasilar
arteries. A dilatation of the mid basilar artery with an intravascular
hypointense signal (arrow).
Figure 11 b Below. Transaxial magnetic resonance angiogram revealing
the biconcave appearance of the basilar artery typical of a fenestration
(arrow).
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7. Significant carotid stenosis but with symptoms referable to the
posterior circulation. Transcranial Doppler detection of relevant
intracranial stenosis.
A 76 year old hypertensive man reported sudden onset visual blurring and
visual illusions.
Anatomical brain scan: The MRI brain scan revealed a right parieto occipital
infarct.
Doppler sonography: Duplex Doppler revealed a >80% stenosis of the right
internal carotid origin. Transcranial Doppler revealed features consistent with
a severe stenosis (circumscribed velocity increase; mean of 116 and peaking at
144 cm/sec) of the right P2 segment of the posterior cerebral artery.
Angiography: The right posterior cerebral artery stenosis was confirmed by
noninvasive MR angiography.
Cardiological tests: Normal
Comment: These findings demonstrated the value of transcranial Doppler in
detecting intracranial stenoses that are responsible for the symptoms. He



















Figure 12 a. above. Magnetic resonance angiogram showing a right
posterior cerebral artery stenosis (arrow).
Figure 12 b. below. Accompanying high velocity (mean 200 cm/sec)
transcranial Doppler signal with features of turbulence.
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8. Multimodality magnetic resonance imaging in the rapid
aetiological diagnosis of stroke subtype. A patient in whom
hyperacute administration of intravenous tissue plasminogen
activator was indicated.
Clinical: A 61 year old white man presented with sudden onset right
hemiparesis with speech impairment within 90 minutes of onset. His NIH
stroke scale score was 10.
Anatomical brain scanning: MRI brain scan was normal.
Diffusion MRI: This revealed a clear hyperintensity of the left parietal region.
Cardiological tests. Normal
Doppler sonography: Normal
Management: Intravenous tissue plasminogen activator was administered.
Comment: Multimodality magnetic resonance imaging allows rapid work up
of the brain parenchyma, large and small intracranial vasculature,
cervicocephalic vessels. This assists in rapidly making an aetiological stroke































Figure 13. Magnetic resonance diffusion scan. The subcortical
hyperintense signal indicates ischaemia or infarction in the acute phase
(done 4 hours post ictus). The MRI scan was normal at this time and
subsequently revealed a hyperintense T2 signal in the same area -
indicative of an infarct.
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9. The complementary role of transcranial Doppler and magnetic
resonance angiography in non invasively establishing stroke
mechanism. A case of bilateral intracranial vertebral artery
stenoses.
Clinical: A 61year old diabetic, hypertensive, white man developed sudden
onset vertigo, nausea, diplopia and imbalance. These recurred on a daily basis
and incapacitating episodes had occurred for several months.
Anatomical brain scan: The MRI brain scan revealed an occipital lobe infarct,
multiple cerebellar infarcts and a right thalamic infarct. The basilar artery
was dolichoectatic.
Doppler Sonography: The carotid duplex Doppler was normal. The
transcranial Doppler study of the posterior circulation showed marked
turbulence in the basilar artery at about 85-90 cm depth with mean velocities
of 145 cm/sec.
Cardiological tests: electrocardiography and echocardiography normal.
Angiography: MR angiography confirmed the stenoses but this was seen to
involve the terminal V4 vertebrals on both sides.
Management: Warfarinization but not antiaggregant therapy completely
abolished the episodes.
Comment: The combination of transcranial Doppler sonography and magnetic
resonance angiography proved to be excellent complementary methods in
detecting an unusual cause of posterior circulation stroke - bilateral vertebral
artery stenoses. This allowed specific effective therapy with Warfarin to be
Given with conviction and with excellent results.
Figure 14. Magnetic resonance angiography. Bilateral terminal
intracranial (V4) vertebral artery stenoses (arrows).
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10. Intracranial collateralisation in a patient with Takaysu's
arteritis.
Clinical: A 14 y black female reported intermittent dizzy spells and seizural
episodes for 6 months. Neurologically she was normal.
Anatomical brain scan: The MRI brain scan revealed a small left parieto
occipital infarct.
Duplex Doppler: Small calibre left common carotid artery (CCA) with no
flow seen in the left internal carotid (ICA) artery. The right CCA and ICA
and vertebrals were normal. Transcranial Doppler sonography revealed
bilaterally increased velocities in the anterior and posterior circulations.
Angiography: Catheter arch angiography and magnetic resonance
angiography: Absent left internal carotid artery and Willisian collateralisation
from the basilar artery through the left posterior communicating artery to the
anterior circle of Willis.
Cardiological tests: Normal
Management: Revascularization for Takayasu's arteritis.
Comment: Good demonstration of pathophysiology - Willisian collaterals
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Figure 15. Magnetic resonance angiogram revealing the posterior to
anterior circulation collateralisation from the basilar artery, through the
left posterior communicating artery to the left middle cerebral artery
(arrow). This patient had an occlusion of the left internal carotid artery
due to Takayasu's arteritis.
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11. Stroke mechanism. Carotid redundancy - kinks, coils and
loops.
Clinical: A 77 year old hypertensive white woman presented with amaurosis
fugax.
Anatomical brain scan: The CT brain scan showed a left subcortical corona
radiata infarct.
Doppler sonography: 60-80% left carotid stenosis.
Cardiological tests: Normal
Angiography: The spiral CT of the carotids revealed a left ICA kink with the
angle close to 70 degrees. At the bulb there was about 50% stenosis with a
large irregular plaque that was calcified just proximal to the bifurcation. The
plaque extended to involve the bulb.
Management. Revascularization and carotid endarterectomy.
Comment: Carotid kinks have been associated with ischaemia and infarction
without concomitant atheroma and are regarded as a stroke mechanism (31.
Figure 16. Spiral computed tomography angiogram. An approximately
70% kink in the internal carotid artery (arrow).
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12. Cerebral vasculitis diagnosed by magnetic resonance
angiography
Clinical. A 35 year old Indian woman presented with a mild frontal lobe
syndrome and paraparesis. The erythrocyte sedimentation rate was 72,
haemoglobin 8.2, antinuclear factor positive and haematuria present.
Anatomical brain scan: The MRI brain scan revealed multiple small
subcortical infarcts
Cardiological tests: Normal
Doppler sonography: Cervical vessels normal.
Angiograpy: Medium sized vessel irregularity suggestive of vasculitis
Management: Steroids
Comment: A high quality magnetic resonance angiography may suffice to
diagnosis medium vessel cerebral angiitis and obviate the need for invasive
catheter angiography.
Figure 17. Magnetic resonance angiography. Irregularity of both
proximal middle cerebral arteries consistant with angiitis (arrow).
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13. Diffusion weighted imaging in assisting differentiation of
ischaemia and infarction in eclampsia.
Clinical: An 18 year old black woman presented with eclampsia and
simultanagnosia.
Anatomical imaging: The MRI brain scan revealed hyperintense lesions
posteriorly in both parieto occipital regions. These persisted on the T2 images
at follow up one week later.
Diffusion weighted MR imaging: This revealed extensive anterior and
posterior watershed ischaemialinfarction. These resolved one week later.
Cardiological tests: Normal
Management: Magnesium sulphate. Caesarean section.
Comment: Diffusion weighted imaging allows a better pathophysiological
appreciation of the extensive watershed type distribution of lesions in
eclampsia and assists in differentiating ischaemia from infarction.
Figure 18. Magnetic resonance diffusion weighted scan in a patient with













14. Frontal lobe syndrome due to isolated left thalamic infarct.
A 48 year old hypertensive white woman awoke with right sided numbness
and found to have a frontal lobe syndrome on neuropyschological testing.
Anatomical brain scan: The MRI brain scan revealed a left paramedian
thalamic infarct.
Functional brain scanning: The SPECT showed bifrontal hypoperfusion, left
more than right as well as left thalamic hypoperfusion.
Doppler sonography: Normal.
Cardiac evaluation and echocardiography: Normal.
Neuropsychological testing: Frontal lobe syndrome.
Comment: In this relatively young woman the sudden onset of a frontal
systems syndrome was correlated with SPECT brain scanning demonstration
of frontal hypoperfusion - hypometabolism due to diaschisis?
Figure 19 a. Computerised tomography scan of a paramedian thalamic
infarct (arrow) with accompanying SPECT scan revealing bifrontal
asymmetric hypoperfusion.
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15. Frontal systems syndrome due to caudate nucleus infarction
and frontal hypoperfusion on SPECT brain scan.
Clinical: A 39 year old hypertensive white man awoke with headache and
abnormal behaviour with apathy and abulia noted on clinical testing.
Doppler sonography: The duplex and transcranial Doppler studies were
normal.
Anatomical brain scanning: The MRI scan revealed signals consistent with left
caudate nucleus infarction.
Functional brain scanning: The SPECT brain scan revealed extensive left
frontal hypoperfusion.
Cardiological evaluation: Normal
Angiography: Catheter angiography was normal.
Neuropsychological testing: Marked left frontal lobe neuropsychological
deficits.
Comment: The frontal systems syndrome due to the caudate nucleus infarction
was best correlated with the SPECT functional scan.





Figure 20 a. MRI brain scan of a caudate nucleus infarct (arrow).
Clinically a frontal lobe syndrome was evident.
Figure 20 b. SPECT scan showed frontal hypoperfusion (arrows).
104
16. Frontal lobe syndrome due to isolated pontine infarction and
SPECT brain scan correlation.
Clinical: A 77 year old white woman with mild hypertension and
hyperlipidaemia developed sudden dizziness, imbalance, mild right sided long
tract signs, ataxia and behavioural abnormality in that she felt and was
observed to be "odd". She had previously been healthy in all respects and had
not suffered from neurodegenerative disease or depression. Her behavioural
changed had occurred suddenly.
Doppler sonography: Minimal atherosclerotic disease in the cervical and
intracranial vessels.
Anatomical brain scan: The MRI scan showed a left pontine infarct without
other cerebral lesions. The basilar artery appeared dolichoectatic.
Functional brain scan: The SPECT showed bifrontal hypoperfusion.
Cardiological evaluation: Normal.
Neuropsychological testing: Frontal lobe syndrome.
Comment: The isolated pontine infarct, probably caused by the dolichoectatic
basilar artery was associated with a frontal system syndrome correlated with
the SPECA hypoperfusion.
Figure 21a. Isolated pontine infarct presenting with a frontal system
syndrome.




17. Hyperintense T2 signal on MRI brain scanning - pyramidal
tract degeneration
Clinical. A 40 year old black woman presented with right sided hemiparesis
and expressive dysphasia.
Doppler sonography: Duplex Doppler of the carotid and vertebral arteries was
normal.
Anatomical brain scan: The MRI brain scan showed a marked hyperintensity
of the deep left middle cerebral artery territory consistent with a large deep
MCA infarct and occlusion of the left middle cerebral artery stem. In addition
there were hyperintense signals in the left internal capsule, cerebral peduncle,
pons and medulla.
Cardiological evaluation: Normal.
Comment: The hyperintense signals in the internal capsule, cerebral peduncle
and brainstem were consistant with Wallerian degeneration of the pyramidal
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Figure 22. Left middle cerebral artery infarct and associated
hyperintense signal in the brainstem, cerebral peduncle and subcortical
area - pyramidal tract degeneration.
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18. The value of MR spectroscopy in differentiating stroke from
tumour in a patient with coexistence of stroke and brain tumour
Clinical: A 59 year old white man reported poor short term memory,
intermittent visual hallucinations, loss of taste and smell and episodes of blank
stares interpreted as partial seizures.
Doppler sonography: The duplex and transcranial Doppler studies were
normal. Testing revealed dysmnesia, dyscalculia, dysnomia and
quadrantanopia.
Anatomical brain scanning: The MRI and CT showed a right medial occipital
infarct and a left parieto temporal lesion.
Functional brain scanning: Magnetic resonance spectroscopy confirmed a
right occipital lobe infarct but a high choline and lactate peak and low NAA
indicative of a tumour [6] in the left parieto temporal lobe.
Cardiological evaluation: Normal
Angiography: MR angiogram was normal.
Brain Biopsy: Grade 2 astrocytoma of the left parietotemporal region.
Comment: The MRS was decisive in resolving the difficulty in differentiating
the left parietotemporo occipital lesion clinically and radiologically from a


























Figure 23 a. Magnetic resonance spectroscopy. Typical brain tumour
signal of relatively high Choline, high Lactate and low NAA.
Figure 23 b. MRI scan of right occipital infarct and left temporal lesion.
CH
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5.2 Cognitive testing results
5.2.1 Descriptive Statistics
1. Overview 
One or more HCFD were present in 607 (60.7%) of the patients with 746
instances of higher cortical functions deficits. Patients who were not alert
were excluded. This included drowsy patients (n=25), patients in light coma






































Visual illusions, hallucinations and palinopsias 4
Balint's syndrome 3
Gerstmann's syndrome 2




Cognitive impairment in absence of elementary neurological deficits such as 
weakness, sensory disturbance or visual impairment. 
HCFD abnormal without weakness 193
HC111) abnormal without sensation disturbance 279
HCFD abnormal without visual field defects 566
HCFD abnormal without any of the above 137/608 (22.5%)
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5.2.2 Computational Statistics - cognitive issues
5.2.2.1 Higher cortical function screening test sensitivity and
specificity (compared to the gold standard - neuropsychological
testing)
Table 9. Neuropsychological testing was performed in 76 patients




Abnormal 61 0 61
Normal 15 0 15
76 0
Sensitivity:  61/76 = 80.2% (95% CI: 72-88%)
Specificity 
Evaluated in 20 normal individuals of whom all had normal HCFD results
Specificity: 20/20 = 100%
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5.2.2.2 Table 10. Risk factors for higher cortical function deficits:
univariate and multivariate associations.
Risk factor n % abn. of HCFD p value OR (95% CI)
Sex
553 62.21male


















no 574 62.89 0.269 0.86(0.67;1.12)
Cardiac *
175 66.86yes
no 813 60.27 0.104 1.33(0.94;1.88)
Diabetes
yes 102 58.82
no 886 61.74 0.567 0.88(0.58;1.34)
TIA
53 62.26yes
no 935 61.39 0.899 1.03(0.59;1.84)
Previous stroke *
62 72.58yes
no 926 60.69 0.063 1.71(0.97;3.04)
Hyperlipidaemia
47 55.32yes
no 941 61.74 0.377 0.76(0.43;1.38)
Drug abuse
3 66.67yes
no 985 61.42 0.85 1.25(0.11;13.9)
Hypercoagulable
10 50.00yes
no 978 61.55 0.455 0.62(0.18;2.17)
Migraine
40 52.50yes
no 948 61.81 0.236 0.68(0.36;1.29)
Overweight *
32 81.25yes




no 969 61.40 0.876 1.07(0.42;2.76)
Alcohol
80 66.25yes
no 908 61.01 0.356 1.25(0.77;2.03)
Smoking
263 59.70yes
no 725 62.07 0.498 0.90(0.68;1.21)
Oral contraceptive *
yes 16 43.75
no 972 61.73 0.143 0.48(0.18;1.31)
Gout *
33 48.48yes
no 955 61.88 0.120 0.58(0.29;1.16)
Sleep apnoea
4 75.0yes
no 984 61.38 0.577 1.89(0.19;18.2)
COAD
27 66.67yes
no 961 61.29 0.571 1.26(0.56;2.84)
Cervical manip.**
4 0yes
no 984 61.69 0.022 0.07(0.004;1.28)
Neck trauma **
12 91.67yes
no 976 61.07 0.035 7.01(1.20;40.9)
Infection (<1m) *
43 90.70yes




no 971 61.26 0.468 0.70(0.27;1.84)
Vasculitis
7 85.71yes
no 979 61.26 0.260 3.79(0.46;31.6)
Autoimmune
9 77.78yes
no 979 61.29 0.495 2.21(0.45;10.7)
Collagen Vasc.Dis.
1 100.0yes
no 987 61.40 0.428 1.89(0.08;46.4)
Neurocysticercosis
2 50.0yes
no 986 61.46 0.739 0.63(0.04;10.06)
Tuberculosis
8 75.0yes
no 980 61.3 0.429 1.89(0.38;9.42)
HIV *
13 92.31positive
negative 975 61.03 0.021 7.66(1.35;43.4)
DVT *
11 81.82yes
no 977 61.21 0.163 2.85(0.61;13.27)
Note:
1. The approximated LOGIT approach has been used to estimate the 95%
confidence intervals for the Odds Ratio.
2. * Denotes the parameters entered into the multivariate analysis




Risk factors with a p value smaller than 0.2 on univariate analysis were
entered into the multivariate model. Multivariate Logistic Regression was used
to determine which of the risk factors contributed independently to an
abnormal HCFD. A backward elimination technique was applied and variables
with a p value of <0.05 remained in the model.
5.2.2.3 Table 11. Results of Multivariate Logistic Regression.
Risk factor Parameter estimate (B) p-value OR (95% C.I)
Intercept 6.529 0.0001
Age 0.126 0.0138 1.134 (1.026;1.254)
Race -0.339 0.0138 0.713 (0.544;0.933)
Overweight 1.214 0.0147 3.367 (1.271;8.928)
Infection (recent) 1.747 0.001 5.747 (2.02;16.39)
Hence:
Log (p/1-p)=6.529+0.126 age -0.339 race+1.214 overweight+1.747 infection
Age: 1=0-49; 2=50-59; 3=60=60; 4=70-70; 5=>80
Race: 1= black; 2 = white; 3 = Indian; 4 = mixed race
Overweight: 1 = yes; 2 = no
Infection: 1 = yes; 2 = no
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Examples of the above equation:
A black man aged 62 years who is overweight and has had a recent infection.
p=exp(6.529+0.126(3)-0.339(1)+1.214(1)+1.747(1)/1+exp(6.529+0.126(3)-
0.339(1)+1.214(1)+1.747(1)
= exp (9.529)/1+exp (9.529)
= 0.99
A person with the above factors therefore has a high probability of having a
cognitive impairment at time of stroke.
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5.2.2.4 Table 12. Overall incidence of HCFD in younger (<49y)
and older (>49y) patients with stroke
Age Abnormal Normal Total
<49 142 103 245
>49 446 266 712
Total 588 369 957
p-value 0.194 (not significant)
1 1 8
5.2.2.5 Table 13. Incidence of HCFD subgroups in younger (<49










A .cznosi as 0.573
Miscellaneous 0.396
Note: * denotes significance level of <0.05
1 1 9
5.2.2.6 Table 14. Frontal lobe syndromes - cerebral lesion site as
determined by functional brain scanning.
Supratentorial
cortical lesions (n=23;25% ; 95 % CI: 16.2;33.8%)
subcortical lesions (n=32;35% ; 95% CI: 27.1;46.9%)
Multiple lesions (n=21;23% ; 95% CI: 14.4;31.6%)
Lesions unclassifiable (n=4;4%)





The frequency for the cortical and subcortical groups was significantly
different (Binomial Test).
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5.2.2.7 Table 15. Frontal lobe syndromes in young and old patients
Young (15-49 years) 41/246 (16.7%)
Old (50-100 years) 51/754 (6.7%)
Chi square p value <0.0001
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6.0 DISCUSSION
6.1 Stroke Data Bank Issues
6.2 Cognitive Issues
6.1 Stroke Data Bank Issues
6.1.1 Symptoms
Both the complexity of the brain as well as the heterogeneous causes of stroke
intuitively suggest an array of presentations of stroke syndromes. The
publicity campaign by the National Stroke Association lists six major








Although these accounted for the majority of presentations in the DSDB
(n=1388 symptoms, total symptoms 1963; 70.7;%), a much larger number of
prospectively defined and evaluated symptom categories (n=23) within the
DSDB still did not account for all presentations. In 150 (15%) patients a
further undefined symptom was present and in 15 (10% or 0.15% overall). In
these patients the "undefined" symptom was the sole manifestation of stroke.
Without resorting to an unwieldy and impractical list of stroke presentations,
it behoves us to remember that the presentation of stroke may be unusual. As
acute stroke treatment is already a reality, with time windows measured in
hours, an imprecise diagnosis may result in critical time delays and failure of
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effective therapy. A likely explanation for these 'other symptoms is stroke
presenting with a frontal lobe type presentation that defies simple description.
This hypothesis is supported by the frequency of frontal systems syndrome
within the data bank of 92 patients (9.2%) as will be seen under discussion of
cognitive impairment.
6.1.2 Risk factors
Risk factors in stroke may be divided into modifiable and unmodifiable ones.
The latter include age, race, sex and hereditary factors and will not be
discussed further. The modifiable risk factors include those considered
definite by the literature and those that are probable but awaiting
confirmation. Since the original design of the DSDB protocol in 1992 several
of the latter factors such as; recent infection [2-71, sleep apnoea [8-18],
homocystinaemia [16-19] and lipoprotein (a) [20-24] have achieved
independent risk factor status. The contribution of the DSDB in the risk factor
analysis is two fold. In confirming the importance of recent infection in stroke
in a population in whom Tuberculosis, HIV, Neurocysticercosis and Bilharzia
are endemic. Secondly the analysis of recent significant and personal stress
revealed that this was an important factor in this population.
6.1.3 Signs
Elementary neurological signs that are traditionally and classically associated
with stroke are one sided weakness, numbness and vision impairment singly or
in various combinations. When present these immediately suggest a
cerebrovascular accident and obviate further diagnostic difficulty. Overall,
574 (57.4%) patients had some form of weakness, 484 (48.4%) had some
form of sensory impairment and 80 (8.%) a visual deficit. No more than half
the time can one rely on elementary neurological deficits to assist
diagnostically. Similar findings were reported in the NINCDS Stroke Data
Bank Study [25].
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6.1.4 The importance of determining stroke mechanism
One of the most important functions of stroke data banks is to determine
aetiopathogenesis as this determines treatment. Earlier studies relied heavily
on risk factors and clinical syndromes to determine stroke subtypes. With the
widespread use of computerised tomography scanning in the 1970's and 1980's
the differentiation of haemorrhagic stroke and bland infarction became
accurate in vivo 126-311. Current neurodiagnostics allow a more precise
diagnosis of stroke subtype and in many instances a mechanism is deduced.
The study by Sacco et al [321, using a more rigorous diagnostic scheme in the
NINDS Stroke Data Bank study, revealed a relatively high frequency of cases
falling into the diagnostic category of Infarct of Unknown Cause (IUC), with a
relatively lesser number falling into the traditional subtypes.
In addition to ascertainment of degree of neurological deficit of which
cognitive impairment is a part, it is of vital importance to determine stroke
mechanism. With the current popularity and emphasis on clinical trials for
secondary prevention of stroke, the more precisely a mechanism of stroke can
be determined, the more likely an accurate outcome of the drug study. The
index patients described in the results section attest to this.
A plausible explanation for the many successful animal as opposed to human
drug and treatment failures in stroke thus far, have suffered from one or both
of these aspects. These are either imprecise neurological deficit appraisal or
lumping widely differing stroke mechanisms.
A further dimension that deserves mention is the degree of likelihood of the
determined mechanism. A hierarchical system was used in the DSDB whereby
diagnostic causes such as cardioembolic, vasculitis or prothrombotic states
were graded into high risk or low risk causes or definite, probable and
possible causes. Such as system as well as carefully itemising those patients in
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whom comorbidity is present (eg atrial fibrillation and significant carotid
stenosis) allows for more precise and in some retrospective reclassification.
6.1.5 Subtypes of ischaemic stroke. Clinical (OCSP) versus
aetiological classification (TOAST)
The OCSP scale allows a rapid bedside identification of stroke subtypes -
hence its appeal. As can be seen from Table 6 there was a significant
difference in the overall distribution between the clinically determined type of
stroke and the stroke type after investigations. No study at the time of writing
has reported this save for an abstract [331. As an example, lacunar syndromes
are traditionally correlated with small vessel cerebrovascular disease. The
conclusions of these authors were similar to the DSDB in that they showed
only half of their clinically diagnosed lacunar syndromes had small vessel
disease. The DSDB results showed that only 28% of patients diagnosed as
lacunar syndrome had small vessel disease with a large proportion (50%)
being due to large vessel disease for example.
These results suggest that a complete diagnostic work up is indicated in all
patients with ischaemic stroke no matter the clinical presentation.
6.1.6 Black stroke issues
Given the above considerations and reservations, the causes of stroke in black
people in Southern Africa deserves comment. HIV associated vasculopathy
emerged as the most common cause of stroke in blacks after unknown causes
and small vessel disease. HIV associated vasculopathy was a more common
cause of stroke than cardioembolism and large vessel disease. There is to date
a paucity of research into causes of black strokes in Southern Africa. In
comparison to other stroke studies of black people in Southern Africa [34-37],
the causes differed in several respects. Firstly, the fact that the DSDB took
place during an HIV epidemic which is still increasing, is a likely explanation
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for the high rate of HIV associated strokes. Secondly the high incidence of
cerebral haemorrhage (25 -32%) reported in the 3 [34-36] other studies in
black South Africans was not seen in the DSDB (11 %) bearing in mind that all
studies were hospital based referrals and not truly population based. All
studies had a similar break down of aetiological entities to the TOAST
classification. The largest group comprised of "other" (39%) causes most
notably vasculitides, prothrombotic states, infection and numerous less
frequent entities in the miscellaneous group. The improved neurodiagnostics
that were employed in the DSDB allowed more precise identification of stroke
mechanism and the shift from one category to another.
As stroke is currently the second highest cause of death due to chronic diseases
of lifestyle in South Africa [38], outstripped only by coronary artery disease,
intervention at primary, secondary and tertiary levels are urgent.
6.1.7 Vasculitis
Human Immundeficiency Virus (HIV) and Takayasu's arteritis were the two
most common entities. The diagnosis was made as per definition; angiographic
or biopsy evidence with positive serology and the absence of other possible
competing causes of stroke. The diagnosis was presumptive if no angiogram
was performed or the angiogram was normal and no other possi hie
explanation of the stroke.
Earlier pathologic studies of infarction in HIV positive patients were ascribed
to marantic endocarditis, disseminated intravascular coagulation or hypoxia
[1]. More recently it has been appreciated that the causes of infarction in these
patients are protean and may be due to other infections (cytomegalo virus,
varicella zoster virus, tuberculosis, cryptococcosis, syphilis and
toxoplasmosis). Other possible causes include those of associated drug abuse
(often cocaine but depending on the population) which may be associated with
infective endocarditis, vasoconstriction, platelet aggregations, emboli of
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foreign material [2,3]. Even more recently there have been reports alluding to
the likelihood of a primary HIV vasculitis [4,51. Autopsy reports cited the
frequency of stroke in AIDS patients at a relatively high 19-34% [6,7] and
clinical frequency reports vary from 0.5 to 7% [8,9]. The emergence of a HIV
associated vasculopathy or vasculitis is therefore a likely entity.
The endemic proportions of HIV positivity in the black population is reflected
in this study by a 13% prevalence rate. No HIV patient in this series abused
any drugs but concomitant seropositivity with Toxoplasmosis (2) and syphilis
(2), Cryptococcus (1) and Tuberculosis (1) was documented. In view of the
ethical aspects of performing brain biopsies in HIV positive patients and the
competing causes of a vasculitis in half of the HIV patients in the DSDB the
diagnosis must remain generic ie HIV associated vasculopathy/vasculitis as true
causality cannot be ascertained.
6.1.8 Dissection
In other stroke data banks this has been purported to be the most common
cause of stroke in the young. In the Lausanne Stroke Data Bank dissection of
the cervicephalic vessels and mitral valve prolapse together accounted for
51% of causes in the young stroke patients WO years) [1]. A wide variation
exists, with the study by Carolei et al [21 of 333 patients with cerebral
ischaemia only quoting one patient with dissection as the mooted cause of
stroke. A more recent hospital based study by Adams et al quoted a figure of
16.8% in 119 young stroke patients [3]. In a unique study of young stroke
patients, all of whom had catheter angiography, dissection accounted for 10%
of the causes of stroke 14]. Indeed, it was a relatively common cause of stroke
in the young in the DSDB, accounting for 5.3% (n=13 of 245) in the young
stroke population and 2% (n=20 of 1000) of all strokes.The literature on
arterial dissection typically cites numerous causes [5-171 with about 15% being
due to fibromuscular dysplasia and spontaneous in approximately 10 % 118-
25]. In the DSDB both common and uncommon causes were identified.
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Spontaneous dissection in the carotid (n=7) and vertebral arteries (n=4), blunt
neck trauma (n=5) and fibromuscular dysplasia (n=2) accounted for the more
common causes with one due to chiropractic manipulation and one presenting
with a subarachnoid bleed secondary to intracranial dissection of the basilar
artery. These figures are similar to those reported in the literature which
consists only of case series. Reliable noninvasive detection and monitoring of
dissection is well reported in the literature [26-33]. In the DSDB, reliable
detection was possible with duplex Doppler and/or magnetic resonance
angiography in all patients, with catheter angiography being required in 12.
6.1.9 Prothrombotic states
The causal association of venous and arterial stroke with abnormalities of the
coagulation cascade, fibrinolysis and their various control mechanisms is well
described [1-7]. Stroke in itself may cause changes in the acute and subacute
phase so that measurement during this period is not necessarily indicative of
an association [81. The disorders that are most important include;
Protein C deficiency - congenital and acquired
Protein S deficiency - congenital and acquired
Antithrombin III deficiency - congenital and acquired
Plasminogen deficiency - congenital
Lupus anticoagulant
Anticardiol i pin antibody
All of these were identified within the DSDB with 27/58 (47%) patients
having a measurable defect. These were mostly due to anticardiolipin
antibodies (10/27; 37%). The remaining 31 patients had a described
association with a prothrombotic medical condition such as malignancy,
ulcerative colitis, polycythaemia, pregnancy, oral contraceptives, connective
tissue disease and and hepatic failure. Recent work has demonstrated that all
these so called prothrombotic states may produce an acquired deficiency of
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protein S, protein C and antithrombin III [9]. Anaemia with a raised ESR,
identified as the likely mechanism in 9 patients has been described as a
probable cause of stroke with the exact mechanism uncertain [10-12]. In at
least half the cases a definite explanation of the cause of stroke was possible
and in the other half only a possible, but likely, causative association could be
proposed. In 13/58 (22%) of the prothrombotic cases there was comorbidity
with competing causes such as atrial fibrillation, patent foramen ovate,
hypertension, smoking and diabetes.
6.1.10 Young stroke population results
Overview of previous studies of theyoung stroke population and reasons for 
the methodology.
The main areas of focus were aetiology, racial differences, stroke severity and
prognostication as these are most pertinent in the young population, in this
multiethnic young stroke population.
The young stroke patient poses a particularly important diagnostic challenge in
view of the varied documented aetiopathogenesis and likelihood of recurrent
events. Notwithstanding the clinical urgency of the problem, the available data
are discordant with respect to aetiology, therapeutic, rehabilitative and
prognostic considerations. There is considerable heterogeneity in the
multitude of causes as reported by different investigators as well as variation
between races, regions and countries 11-23]. Differing diagnostic protocols,
diagnostic armamentarium and variability in the criteria for the probable
causes of stroke applied by different investigators make the data currently
available non uniform. The predominance of retrospective series and paucity
of prospective studies [1,3, 24-26] with the unavoidable fact that information
has been collected, often, over a decade or more, with inherent nonuniform
testing is a further problem associated with most studies reported at the time
of writing. Few studies have employed clinimetric and pathogenetic scales to
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allow uniformity of clinical reporting. Many studies included in their series
cerebral ischaemia or transient ischaemic events [3,12,16,17,19,21,27,26,29]
with (other than those employing SPECT or PET acutely) no hard copy
neuroimaging signature of stroke. This is problematic in view of the number
of conditions that may masquerade as stroke or ischaemia in young people
(tumour, epilepsy, migraine, infective and inflammatory cerebral lesions).
Many studies have concentrated on determining incidence in a specific
population such as that in Florence Italy with a 9.0 per 100 000 for males and
8.7 per 100 000 for females [30]. This may be compared with the study from
Saudi Arabia where over a 10 year period 25% of all strokes occurred in the
age group 15-45 with an approximately equal frequency of cerebral infarction
and intracranial haemorrhage in this population 131 I. Such studies are
important as different parts of the world have markedly different incidences
of young strokes, subtypes and different causes. Several studies from the
United States such as one from San Francisco where the most common cause
of stroke in people under the age of 35 was drug abuse, have highlighted the
importance of drug abuse as a cause of young stroke [32]. A Finnish study
reported alcohol intoxication as the cause of stroke in 40% [33], a study from
the Oxford community reported a traumatic aetiology in 22% [34], a Parisian
study considered the oral contraceptive pill causative in 43% [35] of strokes in
young women and an Indian study found meningovascular syphilis to be the
cause in 15% and cerebral venous thrombosis to be the cause in 20% of their
young strokes [36,371.
Finally, a disturbing approximate one third of strokes remained unexplained
in the series published to date [4,6,7,8,13,16].
To help address some of these issues, the findings of the Durban Stroke Data
Bank (DSDB) is presented as one of the largest prospectively defined young
stroke population, with first ever stroke, all proven by neuroimaging using
contemporary diagnostic methods available in large centres in the years 1992-
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1997. In view of the short time frame of recruitment, a high rate of modern
neuroinvestigative modalities was a possible.
Finally young stroke series reported to date have been largely retrospective,
included cerebral ischaemia (transient ischaemic attacks) and have lacked
clinical standardisation made possible by clinimetric scales. The present study
adds to the experience noted by others that causes of stroke in the young are
many. However, being the first young stroke study to be reported out of South
Africa, obvious differences are apparent.
A major difference was noted in the frequency of the aetiopathogenetic
groups. Four (large vessel, small vessel, other and unknown) of the 5
different aetiological categories differed significantly when compared to the
older stroke population. Only cardiogenic causes showed no significant
difference between the younger and older stroke patients. Small and large
vessel disease reflect atherosclerotic disease in its various forms and were
more common in the older patients as might be expected. The 'other' group
was the largest group within the young stroke population and more young
patients than older ones had strokes of unknown causes.
The TOAST 'other' group which accounted for about half of all the
aetiologies emphasises the varied causes and consequently necessitated a
comprehensive work up. Overall, the presence of prothrombotic factors,
vasculitides of infective origin and dissection were the most common definite
or presumed causes in young patients. Non atherosclerotic vasculopathies
accounted for 76/245 (31 %) of definite and probable causes in the young
stroke population. This underscores the importance of angiography, whether
catheter, spiral CT or MR angiography with the noninvasive methods often
sufficing.
Patent foramen ovale accounted for 7/29 (24%) of the young potential cardiac
causes stressing the importance of testing for this condition in young stroke
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patients. All represent treatable or potentially treatable entities or avoidable by
public health education with obvious personal health and socioeconomic
benefits.
Ethnic differences are important to note for many reasons, probably the most
notable being the added insight into pathophysiology. Black - white differences
are different to ones noted in North American studies [38,39] of stroke in
general and even other Southern African studies done more than 10 years
previously [40-42]. No doubt investigative advances and the increasing burden
of infective causes such as HIV, TB and Syphilis all of which are on the
increase are part of the explanation. As the database is ongoing, with
increasing numbers of black patients entering the study a clearer picture may
emerge. Sociopolitical constraints were the reasons for the relatively low
number of black patients enrolled early within a tertiary care facility and
having as part of their stroke investigation a brain scan. This is despite the fact
that black people account for over 80% of the South African population.
The majority of stroke patients had favourable CNS, Barthel and Rankin
scores. Yet a large proportion (54%) had cognitive impairment.
Interpretations may be that the majority of patients with stroke, depending on
the population sampled and selection bias may have a relatively mild stroke
with good recovery and opportunity for effective secondary prevention
provided a correct aetiological diagnosis is made. Also the fact that more than
half the patients have a neurocognitive deficit implies that this is an important
manifestation of neurological deficit that deserves better quantification than
current scales allow. This has obvious importance for measuring treatment
responses to new drugs and interventions.
The cerebral perfusion index (CPI) proposed by Alexandrov et al [43] appears
to be a reliable and valid test for prognosticating in the acute phase of stroke
as demonstrated in this relatively small sample of 32 young patients.
Alexandrov correlated the CPI with the Canadian Neurological Scale. In the
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DSDB it was correlated with the Rankin scale which may be more accurate in
terms of overall physical and social disability (handicap).
The young stroke cohort analysis expands the database of stroke in young
people in that causes display inter and intraregional variation, may often be
relatively mild but with cognitive deficits, the true clinical importance and
extent of which remains uncertain. Intensive investigation influences the mode
of therapy.
6.1.11 Cardioembolic stroke
The finding of a potential cardiac source of embolism is insufficient grounds
for implicating the heart for certain. Rather, stratification into high (cardiac
thrombus, valvular vegetations, prosthetic heart valve), medium (atrial
fibrillation, cardiomyopathy, aortic or mitral valve stenosis, left ventricular
aneurysm) and low (mitral valve prolapse, mitral annulus calcification, septal
aneurysm, patent foramen ovale) risk sources is required and the
documentation of the presence or absence of concomitant stroke risk factors is
necessary. In the DSDB, cardioembolism was diagnosed if a high or medium
risk cardiac source was present and no other possible stroke cause was
concurrently present. This included the presence of large or small vessel
disease diagnosed by sonographic, angiographic or brain scan imaging
modalities. Despite the identification of newer cardioembolic risk entities such
as patent foramen ovale, atrial septal aneurysms, mitral valve strands and
atrial smoke, the true frequency of cardioembolic stroke remains unknown.
Stroke registries have reported an incidence of 15-20% Pt Three prospective
stroke registries; the Giessen, Klosterneuburg and Berlin studies, looked
specifically at cardioembolism and revealed that most patients can be identified
by history, clinical examination, conventional ECG and appropriate use of
echocardiography. These studies differed greatly in the use of
echocardiography and transoesophageal echocardiography (TEE). Whereas
only 24% of the 1048 patients in the Klosterneuberg stroke data bank had an
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echocardiography, over 90% of the 516 patients in the Berlin (n=266) and
Giessen (n=250) registries performed echocardiography which were mainly
TEE. [21. A potential cardiac source was found in 62% of Giessen SDB, but
with stratification of cardiac sources of stroke into high risk (8.4%), medium
risk (23.3%) and low risk (30.4%) a more realistic picture emerges. In
addition, 71.4% of patients with high risk source and 82.8% of patients with a
medium risk source already had some evidence of a cardiac disorder by
medical history, clinical examination or routine electrocardiography and
57.9% of all low risk sources were first identified by echocardiography.
About 25-30 % of patients in stroke registries may have competing causes of
stroke making it difficult to assign a definite cause [3]. In the Giessen SDB
62% of patients had a detectable cardiac source of embolism and only 25.9%
of the Klosterneuburg SDB patients were ascribed a final diagnosis of
cardioembolism. However when applying the criteria outlined the final
diagnosis of cardioembolism was remarkably similar ie 16.8% in the Giessen
SDB and 16.2% in the Klosterneuburg SDB [11.
In summary, the application of routine echocardiography, both TTE and TEE
identifies an increasing number of minor cardioembolic risk entities and the
likelihood of not identifying significant cardioembolic risk factors is low if
echocardiography is performed appropriately according to a tailor made
protocol.
6.1.12 Patent foramen ovale (PFO)
The presence of a right to left shunt in the setting of a prothrombotic state
may account for a number of stroke patients where no cause is found despite
extensive diagnostic work up. Studies performed to date consistently report a
higher prevalence of PFO in young stroke patients and stroke of unknown
origin [1-3]. PFO also occurs in 10-30% of normal controls [1,2,4-7]. Both
transcranial Doppler with agitated saline injected in the antecubital vein and
transoesophageal echocardiography are approximately equally accurate in the
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detection of PFO [8,9]. However TCD with bubble contrast may be more
accurate in the detection of small PFO's and in the detection of pulmonary
arteriovenous shunts [9]. According to the definition proposed by Meister et al
for paradoxical embolism to be causative a venous thrombosis needs to coexist
at the time of stroke [10]. It has been established that a deep venous thrombosis
is rarely found in patients with stroke ascribed to a patent foramen ovale [7].
Because the clinical significance of PFO in stroke causation remains to be
demonstrated, a search for other significant associated factors such as PFO
size, atrial septal aneurysm or more proximal venous thrombosis may answer
some of these questions [9].
In the DSDB two groups of stroke patients were systematically tested for the
presence of a right to left shunt. Young patients who presented with a stroke
of unknown cause or patients where the deficit occurred during a valsalva
manoeuvre were specifically investigated with transcranial bubble contrast to
determine the presence of a right to left shunt. Seven patients were identified,
all of them young and all with some other potential risk factor for developing
stroke in the setting of a patent foramen ovale (atrial septal aneurysm,
congenital heart disease, valsalva manoeuvre, anticardiolipin antibody, recent
infection). Clearly some other factor needs to be present in addition to the
PFO to explain some strokes. Formation of clot within an atrial septal
aneurysm, valsalva manoeuvres and prothrombotic states are some
possibilities. The illustrative patient with PFO from the DSDB who suffered a
stroke during a bout of severe nausea and vomiting implies that for PFO to
cause stroke requires an interplay of factors. The diagnosis and type of PFO
[11,12] is important in helping to understand the pathophysiology and in
guiding treatment which may consist of antiaggregant treatment in some, or
more usually anti coagulation. More recently transcutaneous closure has
become an option [12].
6.1.13 Dolichoectasia
Elongation and tortuosity (dolichoectasia) of the basal intracranial vessels is
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known to cause cerebral ischaemia and infarction, compressive cranial
neuropathies, hydrocephalus and a variety of brainstem symptoms [1,2].
Megadolichoectatic basilar artery syndromes have been the most extensively
studied by autopsy, angiography, CT and MRI. No distinct clinical syndrome
is recognised, probably leading to under diagnosis [1]. The reported incidence
is 0.06 - 5.8% but varying criteria have been applied [3,4]. The radiological
dolichoectasia criteria used were; ectasia >4.5 mm diameter and the basilar
artery lying lateral to the margin of the clivus in the cerebellopontine angle or
above the level of the suprasellar cistern [5,6]. Newer imaging procedures can
facilitate non invasive diagnosis. The entity has not been subject to prospective
analysis [1]. The prospective Durban Stroke Data Bank specifically included
this as a predefined entity and the results to date are presented.
This study represents one of the largest series and one of few prospectively
evaluated consecutive case series within a large data bank series of
dolichoectasia of the cerebral arteries. This has allowed delineation of the
frequencies of different stroke syndromes associated with this disorder as well
as follow up ie posterior circulation stroke and or isolated symptoms such as
facial paresis ("Bell's palsy"), facial neuralgia and hemifacial spasm. The
diagnosis can easily be made in most cases within the first tier (CT brain or
MRI brain scanning) of the investigative protocol without resorting to invasive
studies. This is an important clinical point as the majority of these patients
present with posterior circulation ischaemia or stroke, a syndrome in which
invasive angiography is associated with a significant morbidity and mortality.
In this series all patients were identified by CT or MRI brain scanning. MRA
was done in 6, catheter angiography in 3 and spiral CT in 1. Angiography in
these 10 patients was used to better delineate the ectatic arteries and confirm
the diagnosis, the latter often necessitated by the presence of comorbidity.
Transcranial Doppler sonography has a specific wave form associated with
this syndrome and in agreement with Rautenberg et al [1], in this study it was
found to be a useful adjunctive test in cases where there may be some doubt as
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to the presence of dolichoectasia.
In agreement with the other larger series on this topic, the three main modes
of clinical presentation were ischaemia, cranial nerve compression and mass
effect. The most common presentation was ischaemic (85%). In the ischaemic
group the vast majority presented with posterior circulation strokes (63%).
Patients with posterior circulation ischaemia or infarction should be evaluated
for the presence of dolichoectasia, as this can be done noninvasively and
secondary preventative treatment is an option with Class III evidence of
benefit from Warfarin or Aspirin (see appendix). As most patients in this
series were relatively mildly disabled (CNS mean score of 10.7), the
opportunity to avoid further strokes by identification of the correct stroke
mechanism becomes all the more important. This does not detract from the
rare possibility of dissection of the basilar with poor outcome as was seen in
one patient.
With respect to the postulated biological mechanism as proposed by Hegedues,
Sahibeck et al and Schwartz et al [1,7,8], the increase in vessel diameter results
in reduced blood flow velocity and there may be a plug of inversion or even
zero flow near the vessel wall (transcranial Doppler evidence) [1]. Ring
shaped layering of thrombus formation occurs with a small patent lumen.
Thrombus may occlude the origin of small penetrating vessels of 200-800
micrometers in diameter and give rise to thrombotic occlusion and lacunar
infarction in the setting of large vessel (dolichoectatic) rather than small vessel
disease. Embolism to more distal vascular territories is also thought to occur
from the layered thrombus in the dilated arteries. Both represent different
causes of cerebral infarction due to large artery disease mostly in the context
of long standing hypertension, which is more typically associated with small
vessel disease.
In conclusion, dolichoectasia as a stroke mechanism can be diagnosed
noninvasively with established brain parenchymal scanning and with greater
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accuracy with newer imaging modalities such as MRA and TCD. It should be
suspected in patients presenting with posterior circulation ischaemia or stroke
syndrome, particularly if hypertensive and associated with one or more of the
symptoms listed. The diagnosis is important as it usually necessitates
additional specific therapy such as anti coagulation with Warfarin and in some
antiaggregant therapy with Aspirin, Dipyridamole, Ticlopidine or
Clopidogrel.
6.1.14 Infection related stroke
The temporal association of infection with stroke has recently been found to
be an independent risk factor when occurring within the preceeding month
[1]. This is particularly so for bacterial infections. Both chronic infections
(Chlamydia pneumonia, Helicobacter pylori, Cytomegalo virus, chronic
bronchitic patients) and acute infections have been shown to be a risk factor.
Mechanisms whereby infection may cause stroke include [2-6];
- dehydration and hyperviscosity
- leucocyte and platelet aggregation
- cytokines and TNF alpha
- coagulation factors such as fibrinogen, protein S and C [7,8].
Black patients for example, who had a stroke of unknown cause and had recent
infection - also showed large artery occlusions. This supports the theory that
haemostatic and inflammatory pathways mutually interact with each other.
The scope of the DSDB did not encompass the measurement of acute phase
reactants and cytokines. The frequency of infection as a presumptive cause of
stroke in the DSDB merits further research especially as it pertains to black
patients in whom TB and HIV are endemic in Southern Africa.
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6.1.15 Impairment, disability and handicap and their
measurements.
Notwithstanding the popularity of the Barthel Index, experience with the
Barthel Index in the DSDB was disappointing as cultural factors detracted
from its applicability. The Barthel Index was not a good scale for
measurement in the majority of black patients. Because of poor socioeconomic
disposition, items such as stairs, wheelchair skills, combing hair and bathing
were not as relevant in other populations. As a result it could only be reported
as normal and abnormal and a score was inappropriate. To the contrary, the
Rankin Scale was found very user friendly and easy to administer to all
population groups. Its relative simplicity and application by non medical
personnel are major advantages. The large number of near normal, for
example scoring 1 (n=443 or 44.3%) which means symptoms but no signs,
argue for a more accurate measurement however.The Freanchay Activities
Index is the best tool to assess return to "normal living" - the only scale that
does this. This was not used in the DSDB but should be a consideration for
future data banks.
As can be seen from Table 8, there was moderate agreement (Kappa = 0.543)
between the three categories of the CNS scale measuring neurological deficit
and the Rankin scale which measures disability and handicap. This issue has
not been addressed in large stroke data banks. The Kappa value gives support
to the reliability and validity of these two relatively simple stroke measures.
6.1.16 Complications after stroke
The risks for patients with stroke fall into two major complication categories.
1. Those related to the direct consequences of the brain damage and which
occur within the first few days
2. Those occurring over the following weeks are due to potentially
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preventable problems such as infection, venous thromboembolism and cardiac
disease.
Because of this it has been suggested that the effectiveness of acute stroke units
in reducing morbidity and mortality may be due to improvements in the
prevention, identification and treatment of secondary complications. The
present study is prospective whereas the largest study to date on multiple post
stroke complications complications by Davenport [1] was retrospective. There
were only five other studies addressing this issue [2-6].
The complications and their definitions as described by Davenport are:
1. Falls - any documented fall regardless of cause
2. Pressure sores - skin break or necrosis from prolonged inactivity
3. Urinary tract infection - Clinical and laboratory confirmation
4. Chest infection - clinical and radiographic characteristics
5. Depression - by direct questioning or volunteered and deemed significant
enough to require therapy
6. Confusion - altered cognition lasting more than 48 hours, no easily
recognised higher function disorder and interfering with nursing care and the
rehabilitative process.
7. Painful shoulder - sufficiently severe to require medication
8. Seizures - Focal or generalised seizures occurring after the onset of stroke
9. Pyrexial illness - temperature >37.5 for more than 48 hours without other
identifiable cause
10. DVT - clinical diagnosis or positive imaging
11. Pulmonary embolism - clinical or positive imaging
12. Miscellaneous - any medical or surgical complication attributable to the
stroke eg GIT haemorrhage, musculoskeletal pain, cardiac complications etc
In the DSDB the following complications were prospectively sought and
defined within the protocol: behavioural abnormalities, seizures, depression,
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recurrent stroke, pneumonia, progressing stroke, post carotid endarterectomy
stroke, brachialgia and death from any cause. In addition patients were
specifically questioned and if appropriate tested for symptoms of sleep apnoea.
In the DSDB falls and urinary tract infections were not recorded as
complications as their reliable detection was considered problematical. Pyrexia
was not recorded as a complication in view of the wide variety of possible
causes other than stroke related infection. Cardiac abnormalities also were not
recorded as routine ECG monitoring was not performed. Pressure sores,
DVT's and pulmonary embolism were not encountered. The reliability of
these statistics may be questioned as such complications may present to other
medical specialities.
The frequency of seizures (DSDB 5.3%, Davenport et al 4%) depression
(DSDB 4.4%, Davenport et al 5%) were similar. Areas in which the DSDB
complication list differed to Davenport's study included the incidence of
pneumonia and brachialgia. An item not documented by any other multiple
post stroke complication study was sleep apnoea syndrome in association with
stroke. Four patients were identified in the DSDB with clinical and
polysomnographic verification. In two patients this antedated the stroke and in
two appeared to occur only after the stroke. The study by Dyken et al [7]
suggested an increased incidence of obstructive sleep apnoea in stroke patients
and the work by Palomake et al and Mohensin et al [8-10] supports snoring
and sleep apnoea as an independent risk factor for sleep related brain
infarction. Proposed potential mechanisms include cardiac dysrhythmias,
haemodynamic disturbances, increased levels of catecholamines, disturbances
of cerebral blood flow and episodes of hypoxaemia [11]. Few studies have
used polysomnography to look at the association between obstructive sleep
apnoea and stroke [10,12-14]. The small numbers identified within the DSDB
do not allow any conclusions to be drawn other than that the association may
exist and that modern portable polysomnographic devices (eg SLEEPIT)
facilitate its measurement.
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6.2 Discussion: Cognitive Issues. Contributions of the DSDB to
cognitive neurology
6.2.1. General - high frequency of cognitive dysfunction during
early evaluation and wide spectrum of deficits
6.2.2. Subcortical and subtentorial stroke and cognitive
impairment - frontal system syndrome impairment.
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6.2.1. General - early evaluation and wide spectrum of deficits
As recently as 1990, in an editorial in the Journal "Stroke", Finlayson
remarked that a review of the recent stroke rehabilitation literature would
lead one to think that stroke was a disorder of the tongue, arm and leg. A
strong warning was sounded regarding the relative neglect of cognitive factors
in the management and rehabilitation of stroke patients [1]. A literature review
of the previous studies on cognition and stroke revealed that all have one or
more of the following shortcomings;
1. The period of evaluation was typically months to years after the stroke
2. Only a limited or selected range cognitive deficits were measured
3. Only quantitative measurements were used and not complemented by
qualitative assessment
4. Numbers were generally small [2-15].
These studies were limited in that they focussed on areas such as language,
memory, orientation, attention and visuospatial abnormalities, cognitive
domains that are relatively easily tested and for which quantitative normative
data are available. The wider spectrum of cognitive impairment and specific
stroke syndromes were ignored. The frequency of the cognitive impairment in
these studies ranged from 21% to 56% [2-15]. The study most comparable to
the DSDB was that of Wade et al [12] which had a similar number of patients
(n=976), used predominantly bedside mental tests and evaluated 535 patients
during the first week. This was also the only population based study. Although
only selected cognitive aspects were tested (non verbal reasoning, copying,
level of consciousness, orientation with the Hodkinson Mental Scale),
interestingly the frequency of cognitive impairment (56%) was similar to the
61% determined in the DSDB. The NINCDS stroke data bank provided pre
defined higher functions but specific bedside testing was not given [16]. In
addition the DSDB makes provision for the evaluation of a more
comprehensive list of cognitive disturbances. Finally, the DSDB has
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undertaken a comparison of the higher cognitive function screening tests used
in the DSDB in the most mildly affected patients with standard
neuropsychological testing, currently the gold standard.
Analysis of the subgroups as a function of age (younger versus older stroke
patients) revealed that overall there was no significant difference in the
frequency of HCFD. However younger patients had significantly higher
frequency of frontal systems syndromes and amnesias. No information was
found in the literature on these cognitive aspects in the young stroke
population.
Calculations with univariate and multivariate regression analyses concluded
that 6 of the prospectively defined risk factors were predictive of developing a
HCFD in the stroke setting: age, male gender, black race, overweight, recent
infection, cervical manipulation and cervical trauma. The latter two were not
considered for the model because of small numbers. This is novel information
for the local population and assists with identifying high risk subgroups who
would benefit from diagnostic and therapeutic intervention.
6.2.2. Subcortical and subtentorial stroke and cognitive
impairment - frontal system syndrome impairment. Current state
of knowledge and brief overview
The prefrontal granular cortex enlarges dramatically in phylogenetic
evolution W. It has no obvious role in sensory and motor function and has








Executive function is the usual term applied by investigators to this
conundrum of human qualities but the neural basis remains enigmatic. In other
parts of the brain, it has been demonstrated that metabolic activity is task
dependent. In the frontal lobes one may see activation without regard to the
nature of the task [2]. Preferential prefrontal increased metabolic activity is
however seen with performance of attentional tasks and reasoning tests but not
during their subsequent execution [3-5].
Prefrontal granular cortex has extensive cortico-cortical connections to
sensory and paralimbic association cortex. These connections enable it to
monitor information flow at all levels of processing and may account for the
task independent pattern of metabolic activation [6,7]
As succinctly described by Mesulam, in this manner the frontal lobes are in a
position to activate a given network, inhibit another, influence network
combinations and perhaps allow internal readouts in a way that disengages the
information processing from the response stage. The highest level of internal
representation (of networks rather than of sensory data or motor programs)
would provide an arena for the various networks to play out different
scenarios, the most successful of which would dominate the landscape of
neural activity [2].
The computational basis of the executive function would then be twofold
- a high density of connections with other networks
- a relative isolation from direct participation in elementary perception and
movement.
Even sizable prefrontal lesions could thus cause little disruption of routine
behaviour except under circumstances that place a premium on disengaging
customary stimulus response linkages and on executing complex internetwork
coordinations.
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The major neural connections for the head of the caudate nucleus and the
dorsomedial thalamic nucleus come from the prefrontal granular cortex. In
accordance with the network theory the frontal lobe syndrome can be seen in
patients with lesions not only of in the frontal cortex but also in the caudate
nucleus and in the dorsomedial nucleus [6,7]. The Frontal lobe syndrome is
also seen in disease processes affecting the brain more diffusely such as
multifocal white matter disease and metabolic encephalopathies. The
emergence of the frontal lobe syndrome is hardly surprising in view of the
physiological role of the frontal lobe in integrating networks for combined
action. Multifocal partial lesions - none individually severe enough to disrupt
specific cognitive domains (language, memory) collectively undermine the
internetwork coordination. Clinical experience suggests that subcortical lesions
and toxic metabolic encephalopathies are more frequently encountered causes
of the frontal lobe syndrome than lesions which involve the prefrontal cortex
directly [2].
The frontal lobes in disease states. The frontal subcortical circuits
These are one of the principal cerebral organisational networks and pivotal to
brain behaviour relationship. Frontal subcortical circuits are regarded as
effector mechanisms allowing an organism to act in response to environmental
challenges. Five frontal subcortical circuits are identified;
I. Motor circuit from the supplementary motor cortex - motor function
2. Oculomotor circuit from the frontal eye fields - eye movement
3. Dorsolateral prefrontal - executive cognitive functions
4. Lateral orbital - aspects of personality
5. Anterior cingulate - motivation
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Common to all is the following circuitry:
Frontal cortex - striatum - globus pallidus - substantia nigra - thalamus -
frontal cortex [8].
The dorsolateral prefrontal subcortical circuit allows the organisation of
information to facilitate a response. The anterior cingulate subcortical system
is required for motivated behaviour and the orbitofrontal circuits allows the
integration of limbic and emotional information into behavioural responses.
Impaired executive functions, apathy and impulsivity are hallmarks of frontal
subcortical circuit dysfunction. Obsessive compulsive disorders occur when
the orbitofrontal subcortical structures are affected. The circuits are composed
of neurotransmitter systems, receptors subtypes and second messengers. Such
systems lend themselves to pharmacological manipulation. As the
chemoarchitecture of the circuits becomes known, so will opportunities to
construct "a pharmacoanatomy that will guide circuit specific intervention"
[8].
6.2.3 DSDB contributions to frontal systems syndromes
Three contributions were noteworthy;
1. Frontal lobe syndromes are frequent in subcortical stroke and not
significantly different in frequency from cortical frontal stroke.
2. Isolated brain stem stroke and cognitive impairment (mainly frontal) with
corroborating data from neuropsychological testing and SPECT brain
scanning.
3. Isolated cerebellar stroke and cognitive findings (mainly frontal) with
corroborating data from neuropsychological testing and SPECT brain
scanning.
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6.2.4 Frontal lobe syndromes in stroke - relation to lesion site.
Detection of frontal lobe damage is notoriously difficult especially if only
standard neurological examination is used including cursory higher function
evaluation. Standardised, quantifiable schedules were all developed to assess
dementia in elderly subjects. Such tests are particularly insensitive to
circumscribed cognitive disorders that occur with stroke. Frontal lobe
syndrome patients are commonly scored as normal by these tests. They may
escape detection even with the use of standardised and validated behavioural
psychometric evaluation such as the Wechsler Adult Intelligence Scale.
Changes may often only be discerned with reference to the person's previous
behaviour, personality and social interaction.
As Mesulam had proposed; "multifocal partial lesions - none individually
severe enough to disrupt specific cognitive domains (language, memory)
collectively undermine the internetwork coordination. Clinical experience
suggests that subcortical lesions and toxic metabolic encephalopathies are more
frequently encountered causes of the frontal lobe syndrome than lesions which
involve the prefrontal cortex directly" [2].
This finding was confirmed by the DSDB and in addition identified frontal
system syndromes from lesions other than subcortical and cortical. These
included infratentorial lesions in the brainstem and cerebellum in whom no
other identifiable cause was found for the frontal system syndrome.
Ninety two patients with frontal lobe syndromes as delineated by a HCFD
screening test were present in the DSDB, of which 36(40%) had formal
neuropsychological testing confirmatory for frontal lobe syndromes in all
patients. Nineteen patients had SPECT scans or which 17(89%) were
abnormal. Frontal hypoperfusion was seen in all 17 (100%) of the SPECT
scans and frontal lobe lesions were seen on anatomical imaging (CT or MRI)
in only 44 (48%). The degree of agreement for frontal lesion detection
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between anatomical and functional imaging was poor.
The present study cannot be regarded as a true reflection of the frequency of
frontal lobe syndromes in stroke because of limited assessment time by the
screening battery, non routine neuropsychological testing in stroke patients
and our current oversimplified appreciation of these diverse disorders.
However the proportion of 9.2% detected by the screening test suggests that
these syndromes comprise an important neurological/neuropsychological
deficit. This is important for cerebrovascular neurologists with the advent of
new treatments. Popular stroke scales currently used to assess treatment
outcome do not provide for measurement of these important syndromes.
Although difficult to evaluate and quantify, they often remain as stroke
sequelae and as the most significant cause of impairment and handicap.
SPECT scanning may be the most appropriate paraclinical investigation to
help verify and monitor such deficits. Just as the standard neurological
examination needs to be complemented by neuropsychological testing (bedside
or psychometric), anatomical imaging (CT and MRI) and functional (SPECT)
complement each other. The latter is especially relevant in the stroke setting
where a strategic subcortical infarct may manifest as a frontal lobe syndrome
through remote deactivation and consequently hypoperfusion and
hypofunction - presumably by a diaschisis phenomenon. This was first shown
by Tatemichi et al leading to the concept of strategic infarct (vascular)
dementia [9].
The DSDB experience with frontal systems syndrome has allowed the
following deductions;
1. Subcortical strokes are the most common cause of frontal systems
syndromes
2. Subtentorial strokes, either isolated brainstem or cerebellar may cause a
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frontal system syndrome
3. SPECT scanning was more sensitive to frontal lobe dysfunction detected
neuropsychologically than anatomical scanning.
The DSDB findings pertaining to frontal lobe syndromes support the network
theory of brain functioning [2]. The DSDB findings also support Mesulam's
premise that the most common causes of frontal lobe syndromes are multifocal
and subcortical processes [10].
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7.0 CONCLUSIONS
Novel findings have emerged from the Durban Stroke Data Bank. These may
be summarised as:
1. Cognitive disturbance is present in the majority of all types of stroke. This
necessitates a reliable appraisal of this form of neurological deficit in all
stroke patients in order to measure the true extent of deficit and monitor
treatment and rehabilitation. This has important consequences for acute
treatment trials that depend on changes in quantifiable deficit.
2. At times cognitive disturbance may be the sole presentation of stroke,
unaccompanied by long tract signs. Therefore inadequate HCFD assessment
may miss the deficit altogether.
3. Subcortical stroke is commonly associated with cognitive impairment -
usually of a frontal system impairment. Such deficits are best correlated with
functional brain scanning and not anatomical brain scanning. This is consistent
with the network theory of brain functioning.
4. Risk factors for developing cognitive impairment in the indigenous stroke
population included increasing age, black race, overweight body habitus and
recent infection. This is an important message for the local population as the
latter two are amenable to preventative measures.
5. In the young stroke population, although causes of stroke were numerous.
prothrombotic states, infection associated strokes and dissection were the most
numerous. All are amenable to primary preventative measures and treatable in
the acute phase of stroke.
6. The Durban Stroke Data Bank showed that at least two dozen symptoms in
stroke are important. In some instances, the diagnosis of stroke may be missed
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altogether if a wide array of symptoms are not entertained on presentation.
7. There were important black white differences in stroke with black people
being younger and an increasing rate of HIV associated stroke being
documented.
8. Clinical and aetiological post investigative classification is useful in the
management of stroke patients with significant differences found in all
subgroups. This guides early, emergent stroke investigations and management.
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8.0 CONCLUDING REMARKS
The DSDB was an ambitious project to record a comprehensive list of known
cognitive disorders in the acute and subacute stroke period, although it may be
argued that during this period, cognitive disorders are most likely to change
and alter. Cognitive disorders are also inherently difficult to measure and no
other study has attempted to measure both a wide range cognitive disorders in
the acute and subacute setting. Stroke is now classified as a medical
emergency, carrying with it a window of treatment opportunity with acute
treatment options available in selected patients (intravenous Tissue
Plasminogen Activator) - the precise extent of deficit matters. The emphasis
was on bedside clinical tests which are the only ones appropriate in the acute
and emergency setting. Although quantitative tests too are important and
desirable, they do not cover the wide range of known cognitive disturbances
and therefore may miss a neurological (neuropsychological) deficit. No ideal
gold standard exists for comparing cognitive deficit measurement scales as
these too may detect abnormalities in otherwise 'normal' people.
In the words of Orrin Devinsky " Behavioural (or cognitive) neurology has
recently emerged as an important discipline for studying how the brain
subserves cognition, emotion and consciousness. Behavioural neurology
straddles the boundaries of numerous more established disciplines - extending
from the most fundamental explorations of molecular biology to the broadest
questions of philosophy. Yet our knowledge is still remarkably limited. We
test what we have tests for, focus on those behaviours we have some
knowledge of and ignore those deficits we have not been taught to recognise.
Some of the most critical behavioural problems that accompany stroke and
dementia - personality change, irritability, loss of will power, impulsiveness -
remain poorly defined, their therapy ignored" [1].
Every scientific work endeavours to push the frontiers of knowledge a little
further. This thesis has attempted to better the understanding of the range and
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import of cognitive impairment as it pertains to stroke. It is my hope that the
DSDB with its specific emphasis on cognitive disorders will catalyse more
research into these pinnacle aspects of humanity.
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9.0 THE FUTURE
What of the future of stroke data banks? In the author's opinion so called
Second Generation Expert (or Intelligent) Systems hold great promise for the
facilitation of digitisation of data and streamlining decision making in specific
disease states such as stroke. These systems are in the embryonic stage of
development elsewhere [2,3] and work is in progress in their incorporation
into the DSDB II. Such systems involve the patient to a greater degree in the
management of his condition. These systems utilise the information technology
now available by electronic means and open the way for telemedicine and
telediagnostics and management. The relatively low cost input in terms of
computer hardware, software, Internet access and E mail facilities yield
tremendous savings in doctors consultations, time and money. A recently
launched database design available on the Internet called Powermed
(http//:www.powermed.com) has some of these features. It is Filemaker Pro





"A rapidly developing focal or global loss of cerebral function with symptoms
leading to death or lasting >24 hours with no apparent cause other than
vascular". For this study brain imaging with CT, MRI or SPECT scanning had
to reveal changes consistent with a stroke. In addition the concept of cerebral
infarct with transient symptoms (CITS) was included but only with
appropriate imaging definition by CT, MRI or SPECT scanning.
Demographic factors
Race grouped as black (negroid), white (of europoid extraction), Asian Indian,
mixed race and other.
Handedness
Handedness - defined as the person's reported hand preference for writing,
using domestic implements, such as a telephone, key, knife and toothbrush. If




Arterial blood pressure in a rested person free of stimulant agents of  160
systolic and 95 diastolic at least twice before stroke or antihypertensive
treatment prior to stroke.
2. Diabetes Mellitus
Fasting blood sugar level above 6.0 mmol/L, random above 8.0 mmol/L or
positive glucose tolerance test (GTT).
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3. Byperlipidaemia
A cholesterol value of more than 6.5 mmol/L fasting or 8.0 mmol/L random
blood cholesterol. The normal triglyceride range was 0.28-1.69 mmol/L.
4. Lipoprotein (a)
In excess of 350 IU/L
5. Smoking
Daily cigarette smoking of 5 or more cigarettes per day over the last month or
longer. If not daily then more than 20 cigarettes per week.
6. Alcohol excess
Daily or near daily alcohol intake of 4 or more units of alcohol per day over
the last month or longer. One unit was considered to be one standard 340 ml
can of beer, one glass of wine or one tot of spirits.
7. Migraine
History of migraine with or without aura according to the International
Headache Classification Committee. In brief the definition for migraine with
aura; one or more fully reversible aura symptoms indicating focal cerebral
cortical or brainstem dysfunction , lasting less than 60 minutes with headache
following within 60 minutes with clinical and investigative findings ruling out
organic disease. For migraine without aura; at least 5 attacks of a headache
lasting 4-72 hours associated with possible features of nausea, vomiting,
photophonophobia, unilateral pulsating quality of moderte to severe inentitiy
with clinicoinvestigative finding ruling out organic disease aura. IHS criteria
were also used for ophthalmoplegic migraine, retinal migraine, childhood
periodic syndromes, complications of migraine and atypical migraine Ill.
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8. Gout
Attacks diagnosed by medical doctor with a laboratory diagnosed elevation of
uric acid level (>0.48 mmol/L) or on maintenance antigout medication.
9. Cardiac disease
Ischaemic heart disease, dysrhythmias, impulse conduction disorders,
valvulopathies, mitral valve prolapse, infective endocarditis, hypertensive
heart disease. Required the diagnosis to be made by a medical doctor with the
minimum investigations including electrocardiograph and chest radiograph.
Cardiac disease was further categorized into medium and high risk causes
usually with the help of a cardiologist and echocardiography.
High risk cardiac source 
Mechanical prosthetic valve, mitral stenosis with atrial fibrillation, atrial
fibrillation other than lone atrial fibrillation, left atrial appendage with
thrombus, sick sinus syndrome, recent myocardial infarction (<4 weeks), left
ventricular thrombus, dilated cardiomyopathy, akinetic left ventricular
segment, atrial myxoma, infective endocarditis.
Medium risk cardiac source 
Mitral valve prolapse, mitral annulus calcification, mitral stenosis without
atrial fibrillation, left atrial turbulence (smoke), atrial septal aneurysm, patent
foramen ovale, atrial flutter, lone atrial fibrillation, bioprosthetic cardiac
valve, nonbacterial thrombotic endocarditis, congestive cardiac failure,
hypokinetic left ventricular segment, myocardial infarction (>4 weeks, < 6
months)
10. Transient ischaemic attack
A focal neurological defect of sudden onset occurring in a cerebrovascular
territory distribution and recovering without sequelae in less than 24 hours.
Specific attention was paid to exclude mass lesions, partial seizures,
migrainous events, hyperventilation, drug effects and labyrinthine disturbance.
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11. Intermittant claudication
Calf pain on walking with documented vascular disease by a vascular surgeon
or physician and/or substantiated by supporting Doppler evidence.
12. Family history of stroke or previous stroke
A history of stroke as diagnosed by a medical doctor with supportive cerebral
neuroimaging.
13. Overweight
More than 20 percent over the ideal weight for age and height. May be a
personal history or a clinical estimate.
14. Hypercoagulable state
Laboratory evidence of a prothrombotic disorder such as antithrombin III,
protein S, protein C, anticardiolipin antibody or plasmin system defect. A
probable diagnosis was made if a well defined predisposing cause was present
such as pregnancy, dehydration, infection without other causes for stroke
found after investigation.
15. Drug or substance abuse
Habitual use of known, illicit, habit forming drugs such as Cocaine,
Amphetamines, Lysergic acid and Marijuana.
16. Oral contraceptive use
Use of oral contraceptives during the last month or more.
17. Sleep apnoea/significant snoring
Sleep apnoea as diagnosed by abnormal apnoea index by polysomnography.
Snoring occurring nightly or often.
18. Chronic obstructive airways disease
Diagnosed by a pulmonologist or physician with supporting clinical and
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radiographic evidence
19. Cervical trauma or neck manipulation
Any blunt or incision trauma or neck manipulation resulting in neck pain in
the last month.
20. Recent Infection
Clinical symptoms or signs with laboratory or radiographic evidence of
infection such as urinary, chest, upper respiratory or gastrointestinal within
the last month.
21. Chronic Infection (HIV, Lues, Tuberculosis,
Neurocysticercosis, Schistosomiasis)
Clinical symptoms and signs with documented laboratory or radiographic
evidence.
22. Chronic systemic disease (collagen vascular, autoimmune,
vasculitides)
Clinical symptoms and signs with documented laboratory or radiographic
evidence.
23. Cancer
Clinical symptoms and signs with documented laboratory or radiographic
evidence.
24. Personal emotion/stress
Subjective appraisal of a severe emotional or stressful situation within the last
month - such as loss of spouse or significant family member, diagnosed life




1. Neurological deficit scale Canadian Neurological Scale
2. Clinical stroke scale Oxfordshire Community Stroke Project Scale
3. Aetiopathogenetic
	
	 Trial of Org 10172 in Acute Stroke Treatment
scale (TOAST)
4. Disability Scale Barthel
5. Handicap scale Rankin
6. ICD-9 Neurology
7. Harvard Cooperative Stroke Registry (items for haemorrhagic stroke only)
Patients selected for interventional trials
8. NIH - used for trial purposes only
9. Scandinavian Stroke Scale - used for trial purposes only
10. Unified Neurological Scale - used for trial purposes only.
Neuroimaging
Computerised tomography diagnosis of stroke: hypodensity corresponding to
clinical manifestations or when the CT is normal in the setting of a clinically
definite stroke. Magnetic resonance imaging diagnosis of stroke: hypointensity
on T1 or hyperintensity on T2 weighted imaging in a recognised arterial brain
territory.
Stenosis on angiogram
Lumen diameter reduced by at least 50% preferably on two dimensional
imaging
Duplex Doppler definitions
Stenoses were graded into categories according to peak velocity ratios
reported as percentage stenosis of the distal common and proximal internal
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carotid artery of <40, 40-60, 60-80, 80-99 and occlusion. Plaque appearance
was graded into echodense, echolucent, complex and calcified
Criteria for the Classification of Carotid Stenosis by Means of
Pulsed Wave Doppler Sonography with 4 - 5 MHz probe (Modified
from Zwiebel et al) [2]
Diameter Peak Systolic End Diastolic
Stenosis Frequency Velocity Frequency Velocity Systolic Ratio
(%) (kHz) (cm/s) (kHz) (cm/s) (ICA/CCA)
40-60 >4.0 >120 <1.3 <40 <1.8
61-80 >4.0 >120 >1.3 >40 >1.8
80-90 >8.0 >240 >3.3 >100 >3.7
TCD definitions
Significant TCD abnormality was defined as:
i) evidence of ipsilateral carotid HITS
ii) middle cerebral artery stenosis
iii) carotid siphon stenosis
iv) other large basal cerebral vessel stenosis (posterior cerebral, basilar)
v) occlusion of a basal cerebral vessel
vi) markedly reduced ipsilateral middle cerebral artery velocity (side to side
difference greater than 50%) and abnormal pulsitility downstream to the
carotid stenosis. TCD sonography included monitoring for high intensity
transient signals (HITS) or emboli from either carotid artery or more
proximal source such as the heart or aorta. "Bubble TCD" incorporating
injection of 10 ml of agitated, aerated saline for diagnosis of PFO was done
where clinically indicated.
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TCD evidence for collateralization
Collateralization through the anterior part of the circle of Willis if ACA flow
ipsilateral to the carotid occlusion was reversed. This usually occurred in
conjunction with the acceleration through the contralateral ACA. Through the
external carotid artery if the ophthalmic artery flow was reversed and through
the basilar artery if the ratio of the ipsilateral to contralateral velocity in the
PCA exceeded 50%. [3]
Ultrasound criteria for microembolus detection
I. Characteristic harmonic sound
2. Unidirectional signals within the advancing velocity spectrum, visible on
the screen
3. Short duration <0.15 seconds for systolic signals and <0.3 seconds for
diastolic signals
4. Random occurrence within the cardiac cycle
5. Intensity > 3dB or more above the background doppler blood velocity
spectrum. [4]
SPECT brain scanning
Interpreted by cartographic analysis and counts compared with cerebellum.
Divided into normal, high counts, low counts, mixed and absent.
Cerebral perfusion index (CPI). Derived from TCD and SPECT

















Higher cortical function deficits
Aphasias
As tested by ascertaining spontaneous speech, comprehension, naming,
repetition, reading and writing using selected items from the Boston Aphasia
Diagnostic Examination. Eight subcategories were defined namely; Broca's,
Wernicke's, global, conduction. anomic, transcortical motor, transcortical
sensory and semantic aphasia.
Neglect syndromes
Disregard in a field of vision, without total loss of vision in a field as tested by
presentation of double simultaneous stimuli for visual neglect, unilateral
extinction of bilateral simultaneous auditory stimuli for auditory neglect and
consistent inability to perceive one of two simultaneous tactile stimuli for
tactile neglect. Three categories were defined; visual, auditory and tactile
neglect.
Apraxias
Impaired execution of previously learned movements not explainable by
weakness, neuropathy, dystonia or other movement disorders. In
constructional cases, inability to copy drawings or block designs. Failure to
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accurately carry out previously learned skilled motor acts in response to
examiner's command (usually applies to limb commands e.g. throw a ball, stir
a cup of tea, show me how you brush your teeth).
Anosognosia
Failure on confrontation inquiry to acknowledge obvious disease of the
nervous system.
Agnosias
Inability to recognise objects or pictures of objects presented visually despite
preserved vision (can trace or copy or master objects) and normal object
naming by other modalities.
Alexias
Acquired inability to read with preserved writing and no significant aphasia or
acquired inability to read and write despite normal use of and comprehension
of spoken language.
Aprosodias
Poor comprehension of affective components of speech as expressed by
prosody or inability to inject affect in speech by altering the prosody of
speech.
Frontal lobe syndromes
Relatively sudden onset of disinhibition, apathy or abulia with respect to pre -
stroke behaviour. Poor abstraction as evidenced by impaired proverb




Isolated , finger agnosia, dysgraphia, dyscalculia and right/left disorientation
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Angular Gyrus syndrome
Anomia, alexia, agraphia, R/L disorientation, finger agnosia, constructional
apraxia, occasionally mild fluent aphasia and right visual field defects
Visual hallucinations 
These are subjective experiences - elicited direct questioning. such as simple
(photopsias, phosphenes, scintillations), complex (such as aware of unreal
people, objects or scenes around you)
Visual Illusions 
Illusions may be restricted to areas with partial visual loss or affect the entire
visual field. The image may be altered in size (micropsia or macropsia), shape
(dysmorphopsia or metamorphopsia), position (teleopsia), number (polyopia),
colour or movement.
Palinopsia
The persistence or recurrence of visual images after the excitatory stimulus
has been removed.
Prosopagnosia
A visual agnosia hallmarked by an inability to recognize previously known
human faces (the retrograde effect) and the inability to learn new ones (the
anterograde effect).
Simultanagnosia
Tested with the Cookie Theft Picture. The inability to perceive the visual field
as a whole also called piecemeal vision. However able to describe minute
details that require normal visual acuity. Unable to see more than one or two
objects at one time.
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Balint's Syndrome
The triad of Simultanagnosia (piecemeal vision), visual ataxia (deficit of visual
reaching) and optic ataxia (deficit of visual scanning). Simultanagnosia is the
central feature.
Achromatopsia
An acquired disorder of loss of colour perception in part or all of the visual
field. The colour loss may vary in degree - shades of grey and black, washed
out or bleached. Often accompanied by alexia and quadrantanopia.
Cortical blindness 
Distinguished from other forms of blindness in that the pupillary light reflex
is present. Such patients are usually unaware of their blindness - Anton's
syndrome. These patients act as if their vision intact - walk into walls and
bump into furniture and do not take precautions that ocular blind people take.
Complications
Behavioural abnormality.
Significant (interfering with social, work or family interaction) change in
character, apathy, inability to cope with work or home circumstances as
reported by family members or neuropsychological impairment as diagnosed
by a neuropsychologist
Depression
As per DSM III criteria for depression [6]
Seizures
Appropriate history by medical, paramedical or family witnesses of tonic or




A second neurological deficit that clinically and with brain scan supporting
evidence suported a stroke within the first month of the initial stroke.
Pneumonia
Clinical, palpatory or auscultatory signs of chest infection with supporting
chest radiographic findings within the first month of the stroke.
Pulmonary embolus
Clinical, palpatory or auscultatory signs of chest infection with supporting
chest radiographic and radio isotope findings and within the first month of the
stroke.
Brachialgia
Ipsilateral shoulder pain and restricted movement with signs of mild,
moderate or severe reflex sympathetic dystrophy.
Deep venous thrombosis.
Calf pain and tenderness with a positive Homan's sign within the first month
of stroke.
Miscellaneous items
Volume of infarction 
Formula:
Volume = (A x MF)(B x MF) x SN x ST / 2
A - Tranverse diameter
B - Longitudinal diameter
MF - magnification factor
SN - number of slices
ST - slice thickness
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ICH volume measurement
Formula for and ellipsoid = 4/3 (Pi)(axbxc) which can be simplified to
abc/0.52 or abc/2.
Use centimeter scale and round off to nearest half centimeter. The number of
1 cm slices on which the haemorrhage could be seen was recorded and if just
visible given 1/2 a point for example. The result is in cm 3 and usual ranges
are <30, 30-60 and >60 cm. [7]
Modified Harvard Cooperative Stroke Registry Definitions of
infarct subtype - used for definition of haemorrhagic stroke only
Intracerebral haemorrhage
Gradual onset over minutes to days or sudden onset of focal neurological
deficit accompanied by signs of increased intracranial pressure such as
vomiting, diminished consciousness and hypertension. Typically no TIA or
signs of large vessel disease. The CT and MRI reveal a focal mass of high
intensity.
Subarachnoid haemorrhage
Sudden onset of headache usually accompanied by vomiting, syncope with
later recovery of consciousness , subhyloid haemorrhages on fundoscopy. The
CT reveals changes consistant with blood in the subarachnoid space.
Angiography frequently reveals an aneurysm or arteriovenous malformation
in the cerebral arterial system.
Large artery thrombosis
Gradual stepwise or stuttering stroke occuring over less than one week, often
with TIA. Evidence of large vessel occlusive disease such as a bruit, angina
pectoris or myocardial infarction, peripheral vascular disease. CT/MRI shows
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bland infarction, angiography or Doppler reveal evidence of major
intracranial (ACA, MCA, PCA, basilar) or cervicocephalic (carotid, vertebral
or subclavian) occlusion or stenosis.
Lacunes
Abrupt or gradual onset of deficit compatible with a recognized lacunar
syndrome ie pure motor hemparesis, pure sensory stroke, dysarthria clumsy
hand syndrome or crural ataxia. Absence of headache, diminshed alertness or
vomiting. CT/MRI shows small deep infarct. Angiography and Doppler
studies normal.
Embolism
Sudden stepwise or fluctuating onset within 24 hours of a focal neurological
deficit usually without TIA's in the same vascular territory. A cardiac source
such as atrial fibrillation, myocardial infarction, valvular heart or bacterial
endocarditis or systemic embolism, prior stroke or TIA in a different vascular
territory. CT reveals low density or hyperintensity on MRI involving arterial
territory. May be haemorrhagic infarct [8].
TOAST classification
Large artery atherthrombosis
Cerebral cortical, brainstem or cerebellar impairment with supportive
evidence by duplex Doppler or angiography of a stenosis greater than 50% in
an extra or intracranial artery. Supporting findings include previous TIA in
the same vascular territory, intermittant claudication or diminished peripheral
pulses. Cortical, cerebellar or brainstem lesions greater than 1.5 cm in
diameter are supportive of potential large artery atherosclerotic origin.
Cardioembolism
Cortical, cerebellar or brainstem lesions greater than 1.5 cm in diameter in a
patient with at least one either high or medium risk cardiac source of
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embolism. Potential large artery sources of embolism should be eliminated.
Small artery disease (lacunae)
One of the traditional lacunar syndromes in association with a normal brain
scan or one revealing a brainstems or subcortical hemisphere lesion with a
diameter of less than 1.5 cm. Potential cardiac sources should be absent and
large artery stenoses should not be greater than 50% of an ipsilateral artery.
Acute stroke other determined aetiology
Rarer causes of stroke such as nonatherosclerotic vasculopathies,
hypercoagulable states, haematologic disorders. The CT or MRI scan shows
features of an acute stroke and diagnostic studies such as blood tests,
angiography reveal one of these unusual causes of stroke. Cardiac sources of
embolism and large artery atherosclerosis should be excluded by other
appropriate studies
Stroke undetermined aetiology
In certain cases the cause of stroke cannot be determined with any degree of
certainty. Some patients will have no likely aetiology despite an extensive
evaluation. In others, no cause can be found but the evaluation was cursory.
This category also includes patients with two or more causes of stroke so that
the physician is unable to make a final diangosis eg atrial fibrillation and and




Ectasia = >4.5 mm diam
Basilar artery lies lateral to the margin of the clivus in the cerebellopontine
angle or above the level of the suprasellar cistern [9,10]
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High risk cardiac source
Mechanical prosthetic valve
Mitral stenosis with atrial fibrillation
Atrial fibrillation other than lone atrial fibrillation
Left atrial appendage with thrombus
Sick sinus syndrome
Recent myocardial infarction (<4 weeks)
Left ventricular thrombus
Dilated cardiomyopathy
Akinetic left ventricular segment
Atrial myxoma
Infective endocarditis
Medium risk cardiac source
Mitral valve prolapse
Mitral annulus calcification
Mitral stenosis without atrial fibrillation








Hypokinetic left ventricular segment
Myocardial infarction (>4 weeks, < 6months) [11]
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Handedness
Inquiry from the patient as to which hand is used for writing, combing hair,
picking up a telephone or brushing teeth. If required corroborating evidence
is gleaned from the spouse or family members. (This is the method used in the
Austin Stroke Data Bank from G. Donnan)
The Oxfordshire Community Stroke Project Study - definitions for
subtypes of cerebral infarction.
Total anterior circulation infarcts (TACI)
These were defined as acute stroke with the combination of new higher
cerebral dysfunction (for example, dysphasia, dyscalculia, visuospatial
disorder); homonymous visual field deficit; and ipsilateral motor and/or
sensory deficit of at least two areas of the face, arm, and leg. If the conscious
level was impaired and formal testing of higher cerebral function or visual
fields was not possible, a deficit was assumed to be present.
Partial anterior circulation infarcts (PACI)
These were defined as only two of the three components of the TACI, with
higher cerebral dysfunction alone, or with a motor/sensory deficit more
restricted than those classified as LACI (for example, confined to the limb, or
to face and hand, but not to the whole arm).
Lacunar infarcts (LACI)
These were defined as an acute onset of one of the five major recognised
lacunar syndromes: pure motor stroke, pure sensory stroke, ataxic
hemiparesis, dysarthria-clumsy hand syndrome, or sensory-motor stroke.
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Posterior circulation infarcts (POCI)
These were defined as acute onset of focal neurological deficit that included
any of the following: ipsilateral cranial nerve palsy with contralateral motor
and/or sensory deficit; bilateral motor and/or sensory deficit; disorder of
conjugate eye movement; cerebellar dysfunction without ispilateral long-tract
deficit (for example, ataxic hemiparesis); or isolated homonymous visual field
deficit.
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Appendix 2. Higher cortical function screening test manual.
Bedside screening test
Scored for every category
Subtyping of individual categories
Hierarchial

























Days of the week in reverse





1. Conversational (spontaneous) speech. Ask the patient what the major presenting
problem is, how it started and associated symptoms. (History of main complaint). Number
of words per minute eg Wernicke's up to 200 per minute and Broca's typically 10-12 per
minute. Record on Sound edit DSDB.
2. Auditory Comprehension
Close your eyes
Stick out your tongue
3. Naming. Name a pen watch, key, three colours (eg grey, brown, orange)
4. Repetition: 'No ifs, ands or buts'.
5. Reading: The quick brown fox jumped over the lazy dog's tail.
6. Writing: In one sentence explain your occupation. Must make sense and contain a
subject and verb.
Characterise aphasias according to table.



















I mmediate memory (anterograde)
digit span (examiner's 7 digit telephone number forward and back)
three words three shapes test (pen, watch, key and shapes triangle
with circle inside, mushroom and Greek cross.
Recent memory (retrograde). Make population/race/individual specific
one important local event in last month
3 items (words) at 5 minutes
Remote memory (retrograde). Make population/race/individual specific
dates of 2 important famous events several years to decades ago (eg school attended,
WW1 +2)
Transient global
Witnessed sudden onset anterograde and retrograde memory loss with repetitive
questioning without other neurological symptoms.
Amnesia present and subtype
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3. Anosognosia and neglect syndromes
Anosognosia definition: Denial of disease usually of the left side of the body with varying
grades of severity identifiable
Denial of the existence of one side (anosognosia)
Denial of hemiplegia or hemiparesis (anosognosia)
Gross underestimation of the severity of the hemiparesis (anosodiaphoria)
Neglect syndromes
a) Sensory neglect
Presentation of bilateral simultaneous stimuli for visual, auditory and tactile faculties.
b) Visual neglect - bilateral hand movements or two 10 mm red spheres one in each visual
field.
c) Auditory neglect- two tuning forks or clicking watches held next to either ear and
assess
for appreciation of both sounds.
d) Tactile neglect - bilateral simultaneous pin pricks on similar parts of the extremities
and assess whether both are appreciated or only one.
e) Motor Neglect tests
1. Bisect this line
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4. Apraxia
Use one command only for each category. If uncertain use the others.
a) Ideomotor apraxia
May involve buccofacial, limb or truncal (axial) musculature.
Buccofacial idemotor apraxia
Blow out a match
Drink with a straw
Stick out your tongue
Cough
Sniff
Puff out your cheeks
Lick your lips
(At the same time look for incomplete, unrelated or opposite motor acts).
Limb apraxia
May involve upper or lower limb and may be unilateral. Test both sides.
Brush teeth
Stir tea
Use a screwdriver, saw, hammer
Wave goodbye
Beckon come here
Truncal apraxia (Whole body)
How does a boxer stand
How does a golfer stand
How does a soldier march
Stand up turn around twice and sit down
Optional: Severity of ideomotor apraxia may be graded:
Mild - failure to perform on verbal commands
Moderate - failure to imitate behaviour
Severe - failure to imitate or perform with an actual object
b) Ideational apraxia
Ideational apraxia is a sequencing disorder in the conceptual organization of complex
actions (agnosia of usage). In conctrast to ideomotor apraxia, each separate component
of a sequence can be successfully performed. Test with the multiple object test: 
1. Prepare a letter for mailing - give paper, envelope. Fold the paper in half twice to fit in
envelope and seal.
OR
2. Drink a glass of water - jug with cap and a glass is presented.
Look for; clumsiness, omissions, mislocations, misuse and sequence errors
c) Callosal and Sympathetic apraxia
Unable to perform motor acts (as in ideomotor apraxia) in response to commands with their
left arm or leg although they execute the commands quite well with right sided limbs.
d) Limb kinetic dyspraxia
Focal clumsiness in performance of fine motor acts - unilateral or confined to one limb
only. Test both hands by rapidly touching each finger with the thumb forward and back,
once.
e) Dressing Apraxia
Inability to put on a shirt, gown or pyjama top despite normal attention, strength and
coordination.
Apraxia present and subtype
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5. Alexias
a) Posterior Alexia (Alexia without agraphia)
Acute loss of ability to read despite full retention of ability to write. Use point 5 of aphasia
testing. The patient can however recognize words spelled out aloud, written on the palm or
words that can be palpated.
b) Central Alexia (Alexia with agraphia)
Inability to recognize words spelled out aloud, written in the palm, or palpable words. In
addition inability to write - refer to point 6 of aphasia testing.
c) Anterior Alexia (Third alexia)
Alexia in association with Broca's and transcortical motor aphasia.
Definition of Paralexia (Deep dyslexia)
Substitutions in reading aloud ie synonym sustitutions that is called Semantic paralexia.
Here aircraft may be read as plane and dog as hound. Paralexia (Deep dyslexia).
Adjectives may also be turned into nouns and an inability to read nonsense words.
Use the table to help categorise:





































Test: Name a pen, tie, paper, book, file.
Using only vision only (and not aided by touch or hearing), the person is able to identify
and describe the shape, size, contour, edges and position of an object . Agnosic patients
can describe the features and shape of an object but fail to recognize it and cannot state
what the object is or is used for. Patients with object agnosia are unable to state what it is
and what you do with it.
Tactile agnosia
Using only touch only (and not aided by vision or hearing), the person is able to identify
and describe the shape, size, contour, edges and position of an object. Agnosic patients
can describe the features and shape of an object but fail to recognize it and cannot state
what the object is or is used for. Patients with object agnosia are unable to state what it is
and what you do with it.
Auditory agnosia
The person is unable to respond to verbal (speech) and nonverbal (environmental) sounds
as tested by written requests and answers despite having relatively normal end organ
hearing capabilities.
Prosopagnosia
Test: Faces of Mandela, De Klerk and Buthelezi. Ask about recognizing family, friends
and relatives by sight. Inability to recognize familiar faces visually but can recognize by
auditory and tactile means. A visual agnosia hallmarked by an inability to recognize
perviously known human faces (the retrograde effect) and the inability to learn new ones
(the anterograde effect).
Simultanagnosia
Testing: Cookie Theft Picture
The inability to perceive the visual field as a whole also called piecemeal vision. Patients
appear blind at first glance, unable to detect new stimuli approaching them, bump into
walls, don't see cars pass in front of them and make inaccurate movements when
reaching for objects. However they are able to describe minute details that require normal
visual acuity. Unable to see more than one or two objects at one time.
Agnosia present and subtype
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7. Constructional apraxia/Visuospatial
a) Copy two dimensional figures
- daisy
- greek cross
b) Copy 3 dimensional figures
- copy a cube or five pointed star




Infarctions in the right inferior middle cerebral artery are difficult to detect clinically.
Although sensorimotor, neglect phenomena and speech deficits may be present they are
usually minimal and transient and associated agitational confusional states frequent.
Aprosodic speech has been shown to be a specific marker for this relatively "silent" area
of the brain [Darby].
Testing
1. Spontaneous affective prosody and gesturing
In the interview, note presence of affective prosody in person's voice, especially when
asked emotionally laden questions such as feelings at loss of a loved one or close calls
with serious injury or death.
2. Repetition of affective prosody.
A declarative sentence is repeated in a neutral, happy, sad and angry voice.
3. Comprehension of affective prosody
A declarative statement devoid of emotional words is produced by the examiner with
different affective tones ie happy, sad and angry. Should stand behind the patient to
avoid giving visual clues. Patient is asked to identify what affect was injected into the
sentence.
a) Sensory Aprosodia
Excellent affective prosody in speech and active spontaneous gesturing. Auditory
comprehension of affective prosodyand visual comprehension of emotional gesturing and
repetition of affective prosody are severely impaired.
b) Motor or expressive aprosodia
Flat monotone speech with loss of spontaneous gesturing. Repetition of affective
prosody is severley compromised with comprehension of affective prosody and visual
comprehension of emotional gesturing intact. Impairment of affective expression.
c) Global aprosodia
Flattened affect. Loss of ability to display affect through prosody and gesturing.
Comprehension and repitition of affective prosody and visual comprehension of emotional














9. Frontal systems syndrome
Tests
a) Motor Programming
Serial hand positions - Luria 3 step test. Fist, edge, palm OR
Go no go. Hands flat on table. Raise one finger for one tap but hold for 2 taps.
b) Set shiftimg amd cognitive flexibility
Alternate sequence test (alternating m-n or triangle and square)
c) I nformation retrieval
Word list generation (FAS). Use only one letter - other 2 if borderline.
(Normal is  15 words per letter/min excluding names of people and places)
d) Abstraction
Proverb interpretation. Use any one of the following familiar proverbs
One swallow does not make a summer OR
Too many cook's spoil the broth OR
Make hay while the sun shines.
Categorization
Note any relatively sudden or significant (impacts work or family life) general behaviour
and social conduct impairment (not easily testable in the office situation of bed side). This
usually requires collateral sourcing from family and friends. Attempt to fit into one of the
following frontal lobe symptom clusters:
Disinhibited (orbitofrontal syndrome)
Disinhibited, impulsive behaviour, irresponsible




Poor judgement and insight
Apathetic (frontal convexity syndrome)
Apathy (occasional brief angry or aggressive outbursts)
Indifference
Psychomotor retardation
Motor perseveration and impersistance
Stimulus bound behaviour
Poor abstraction and categorization
Akinetic (medial frontal syndrome)
Abulia - paucity of thought, speech and spontaneous motor movement
Lower extremity weakness and loss of sensation
Incontinence










Occasionally mild fluent aphasia













Frontal, parietal, temporal and occipital simple and complex partial seizures
Episodic altered mental state
Visual hallucinations
These are subjective experiences - elicited direct questioning.
Simple
i) Photopsias (light flashes)
ii) phosphenes (blue lights),
iii) scintillations (zig zags)
iv) geometric forms, checkerboard patterns
v) positive scotoma (seen with eyes closed) halos surrounding a black hole
Complex visual hallucinations
Are you aware of any of the following that others around you do not see
i) People
ii) objects
iii) scenes and landscapes
iv) animals (zoopsias)
v) Autoscopy - the hallucination or psychic experience of seeing oneself. This may take
the form of a perception of one's own body image projected into external visual space or
seeing one's double. The latter form is also called an out of body experience and is the
feeling of leaving one's own body and viewing it from a vantage point, usually from above.
Visual Illusions
Illusions may be restricted to areas with partial visual loss or affect the entire visual field.
The image may be altered in
i) size (micropsia or macropsia)
ii) shape (dysmorphopsia or metamorphopsia)
iii) position (telopsia)
iv) number (polyopia)
v) colour or movement.
vi) Upside down vision may occur
vii) Straight lines appear curved.
185
Palinopsia
The persistence or recurrence of visual images after the excitatory stimulus has been
removed.
Visual dysesthesias
Unpleasant visual sensations precipitated by looking at an object in a defective
homonymous and visual hemifield.
Visual Synesthesias
Optic percepts induced by stimuli in other sensory modalities such as auditory or tactile.
Patients may see shapes or colours in response to hearing specific sounds.
Visual Allesthesia
Transposition of visual images from one homonymous half field to another. Usually in
bilateral cerebral lesions.
Oculomotor apraxia
To verbal command. Look to the right, to the left, up and down. The inability to voluntarily
direct gaze toward a specific part of the visual field. Even when telling the patient where to
look for an object they are unable to do so as foveal vision cannot be directed properly.
Look to the right and left.
Optic ataxia
Touch the examiner's finger held at varying places in front of the patient.
The inability to direct movement of an extremity using visual guidance. When using
procioceptive guidance however with the eyes closed, may allow a person to accurately
touch a pen in front of them which would elude them when using visual guidance. Finger to
nose test.
Balint's Syndrome
The triad of Simultanagnosia (piecemeal vision), visual ataxia (deficit of visual reaching)
and optic ataxia (deficit of visual scanning). Simultanagnosia is the central feature.
Achromatopsia
Test: Point to 6 different colours.
An acquired disorder of loss of colour perception in part or all of the visual field. The
colour loss may vary in degree - shades of grey and black, washed out or bleached. Often
accompanied by alexia and quadrantanopia. May have hemiachromatopsia
Colour anomia
Test: Show me the colour of a banana and the colour of the cloudless sky.
Have normal colour perception and can discriminate hues nonverbally, but cannot name
colours or point to a colour when given its name. Almost always associated with alexia and
right homonymous heminanopia.
Cortical blindness
Distinguished from other forms of blindness in that the pupillary light reflex is present.
Such patients are usually unaware of their blindness - Anton's syndrome (visual
anosognosia). These patients act as if their vision intact - walk into walls and bump into
furniture and do not take precautions that ocular blind people take. When confronted with
this disability they may confabulate about what they are seeing or offer lame excuses
such as the lighting is poor
Adapted from references [1-6]
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Appendix 3. Digitised score sheet of the DSDB
1. Point and click feature
2. 47 fields each with 2-76 possibilities
3. Digitised - text
- scales
- images (selected patients)
- sound (selected dysphasic patients; HITS)
❑ Face sym0.5 ❑ Face asym0.0 ❑ Arms equal1.5 ❑ Arms uneq0.0 ❑ Legs equal1.5 ❑ Legs uneq0.0
❑ 0 02 ❑ -4 ❑ +4
❑ 1 1,1 3 ❑ 4 ❑ 5
Reflexes ❑ Normal ❑ Pathol L ❑ Hyperreflexia ❑ Limb hypertonic
To ne 11] Asvmm ❑ Pathol R ❑ Hyporeflexia ❑ Limb hypotonia
ILI Normal ❑ Left ❑ Face ❑ Whole arm ❑ Whole leg ❑ Digit ❑ Hyperesthesia I1
1 ❑ Right ❑ Hemi involve ❑ Distal arm ❑ Distal leg ❑ Truncal level ❑ Hypoesthesia ❑ Anaesthesia I
1 ❑ Amaurosis fugax ❑ Sectoranopia ❑ Ophthalmoplegia ❑ Pupil abn. other ❑ Append incoord ❑ Other
❑ Hom Hemianopia ❑ Gaze palsy ❑ Int nuclear ophthal ❑ Homers ❑ Axial incoord
❑ Quadrantanopia ❑ Nystagmus ❑ Anisocoria Ell Cervical bruit ❑ Ataxia
❑ Normal ❑ Orofacial ❑ Expressive ❑ Balints
❑ Abnormal E Dressing ❑ Receptive ❑ Akinetopsia
❑ Neuropsych testing ❑ Sympathetic ❑ Alexias ❑ Achromatopsia
1 ❑ Aphasias ❑ Constructional ❑ Alexia with agraphia ❑ Pure word deafness
❑ Brocas ❑ Agnosias ❑ Alexia no agraphia ❑ Anesthesia
❑ Wernickes ❑ Tactile ❑ Hemidyslexia ❑ Astereopsis
❑ Aphemia ❑ Auditory ❑ Anosognosias ❑ Autoscopy
❑ Transcort motor ❑ Visual ❑ Neglect syndromes ❑ Palinopsia
(11 Transcortical sensory ❑ Colour ❑ Visual neglect ❑ Visual illusions
❑ Conduction ❑ Object ❑ Auditory neglect ❑ Visual hallucin
, ❑ Global ❑ Simultanagnosia ❑ Tactile neglect ❑ Cortical blindness
1 ❑ Anomia ❑ Prosopagnosia ❑ Frontal lobe syndromes ❑ Cortical sensory loss
❑ Subcortical ❑ Amnesias ❑ Orbitofrontal ❑ Astereognosis
❑ Semantic ❑ Anterograde ❑ Frontal convexity ❑ Abaragnosis
❑ Other ❑ Retrograde ❑ Medial frontal ❑ Agraphaesthesia
ill Apraxias ❑ Transient Global ❑ Miscellaneous ❑ Defect 2 point discrim
❑ Limb kinetic ❑ Short term ❑ Gerstmanns ❑ Extinction
❑ Ideomotor ❑ Long term ❑i Angular gyrus ❑ Dreaming abn
❑ Ideational ❑ Aprosodias ❑ Antons ❑ Other specify
❑ Normal ❑ Amnesias ❑ Aprosodias ❑ Constr dyspraxia ❑ Speed of info proce
❑ Abnormal ❑ Apraxias ❑ Agraphias ❑ Right hemisphere dysf ❑ Other
❑ Attention/concentration imp. ❑ Alexias ❑ Acalculias ❑ Neglect synd
❑ Aphasias ❑ Agnosias ❑ Visuospatial dysf ❑ Frontal lobe synd
Neuropscyh
Testing
❑ Normal ❑ FBC abn ❑ Lipogram ❑ TFT ❑ ANF ❑ Prot S or C ❑ Brain biopsy
❑ Abnormal ❑ Electrol abn ❑ Lipo a ❑ LFT ❑ HIV ❑ ACA ❑ Other
❑ Not significant ❑ ESR ❑ Uric acid ❑ INR ❑ VDRL/FTA ❑ AT III
❑ Hypertension ❑ Glucose ❑ Fribrinogen ❑ PTT ❑ Blood cultures ❑ CSF abn
❑ Normal ❑ MCA territory
❑ Right hemisphere ❑ ACA
❑ Left hemisphere ❑ PCA
❑ Subcortical ❑ Ant choroidal
❑ Multiple strokes ❑ Cerebellar arteries
[
❑ Frontal ❑ Thalamic ❑ Int capsule ❑ Midbrain
❑ Parietal ❑ Basal nuclei ❑ Ext capsule ❑ Wshed
❑ Temporal ❑ Caudate ❑ Brainstem ❑ Other
❑ Occipital ❑ Striatocapsular ❑ Medulla ❑ CT
❑ Corona radiata ❑ Perisylvian/Insula ❑ Pons ❑ MRI
L11-10 ❑ 11-20 ❑ 21-30 ❑ 31-40 ❑ 41-50 ❑ 51-60 ❑ 61-70 ❑ other	Actual volume
❑ Done ❑ Colour Doppler ❑ Vertebral ❑ Plaque complex ❑ sten mod 60-80 ❑ Other
❑ Normal ❑ Carotid unilat ❑ Other vessel ❑ Stenosis min <40 ❑ Sten severe 80-90
❑ Abnormal ❑ Carotid bil ❑ Plaque smooth ❑ Sten mild 40-60 ❑ Occlusion
❑ Done ❑ Abnormal ❑ Occlusion
❑ Normal ❑ Stenosis ❑ Collateral active
❑ Low velocity ❑ PI low ❑ Tech failure
❑ PI high ❑ Emboli specify ❑ Other
❑ Done ❑ Abnormal ❑ Spiral CT
❑ Normal ❑ MRA ❑ Not significant
❑ Stenosis ❑ Vessel irreg ❑ Aneurysm
❑ Occlusion ❑ Anomaly ❑ Other
Durban Stroke Data Bank 	page /
Visits ❑ 2 ❑ 3 Ea ❑ 5 ❑ 6 ❑ 7 ❑ 8 ❑ 9 ❑ iol Sex 1❑ M ❑ F 
First Name M Aid ❑ Y ON 
❑ Vasc CEA El KEH Obstetrics Handedness ❑ Right ❑ Left ❑ Ambidexterous❑ KEH Med
I DOB
❑ White ❑ Black ❑ Indian ❑ Mixed race ❑ Otherl 	Address
Comment
Tel
❑ High school ❑ Graduate ❑ Other






❑ Left side affected
❑ Weakness
❑ Numbness
❑ Altered sensation ❑ Dysphagia ❑ Imbalance ❑ Vomiting ❑ Tremc
❑ Headache ❑ Comprehension problem Eil Incoordination ❑ Seizures ❑ Other
❑ Speech difficulty ❑ Confusion ❑ Invol. movements ❑ Dizziness
❑ Memory poor ❑ Vision impairment ❑ Gait abn ❑ LOC
❑ None ❑ Alcohol excess ❑ Sleep apnoea/signif snoring ❑ Collagen vasc disease
❑ Hypertension ❑ int. Claudication ❑ COAD ❑ Autoimmune disease
❑ Cardiac disease (specify) ❑ Overweight ❑ Cervical manipulation ❑ Vasculitis
❑ Diabetes Mellitus ❑ Migraine ❑i Neck trauma ❑ Cancer
❑ TIA ❑ Hypercoagulable state ❑ Infection in last month ❑ Personal emotion/stress
❑ Previous stroke ❑ Drug/Substance abuse ❑ HIV positive ❑ DVTs
❑ Hyperlipidaemia ❑ Oral contraceptive ❑ Tuberculosis ❑ Other (specify)
[1] Smoking ❑ Gout ❑ Neurocysticercosis
❑ 0-6h ❑ 7-12h ❑ 13-24h ❑ 25-48h ❑ 3-7d ❑ 1-4wks ❑ 1-3mo ❑ 3-6mo ❑ 7mo-1y ❑ >1y specify
I ❑ Alert CNS 3.0
1 ❑ Drowsy CNS 1.5
= ❑ Orientated CNS 1.0
❑ Disorientated and not applic CNS 0.0 ❑ Receptive deficit CNS 0.0 ❑ Abulic
❑ Speech normal CNS 1.0 ❑ Light coma ❑ Agitated
❑ Expressive deficit CNS 0.5 ❑ Deep coma ❑ Delirious 
❑ Normal ❑ Left ❑ Hemiparesis ❑ Quadriparesis ❑ Tongue weakness ❑ Dysarthria ❑ Other
I ❑ Right ❑ Bilateral ❑ Monoparesis ❑ Triparesis ❑ Dysphagia ❑ Digital
; ❑ Face none 0.5
❑ Face present 0.0
❑ Arm prox none 1.5
h
 ❑ Arm prox mild 1.0
❑ Arm prox signif 0.5 ❑ Arm distal signif 0.5 ❑ Leg prox signif 0.5 ❑ Leg distal signif 0.5 
❑ Arm prox total 0.0 ❑ Arm distal total 0.0 ❑ Leg prox total 0.0 ❑ Leg distal total 0.0
❑ Arm distal none 1.5 ❑ Leg prox none 1.5 ❑ Leg distal none 1.5








































E Done 0 Abnormal ❑ Hyperfusion E Mixed
❑ Normal ❑ Hypoperfusion ❑ Absent perfusion
1 ❑ Done ❑ Medium 12-6
1❑ Good 20-15 ❑ Poor 5-1
1 ❑ Normal ❑ ECG ischaem ❑ CM0 ❑ PFO ❑ TTE ❑ Aortic arch dis ❑ Spont echo contrast
ti Abnormal ❑ Myo infarct ❑ Cardiac failure ❑ ASA ❑ TEE ❑ Dyskinetic segment ❑ Holter
❑ Arrhythmia ❑ Valve disease ❑ Prolapse ❑ CXR ❑ Gong ❑ Intracavity clot ❑ Other '
❑ TAC-OCSP ❑ Stroke ill defined (436) ❑ Large vessel dis ❑ Unknov
❑ PAC-OCSP ❑ Stroke other Cerebral Athero (437.0) ❑ Aortic arch plaque
❑ LAC-OCSP ❑ Cerebral venous thrombosis (437.6) ❑ Comorbidity
❑ POC-OCSP ❑ Vasculitis (437.4) ❑ Dissection
❑ SAH (430) ❑ Binswanger's (437.1) LI Prothrombotic state
❑ ICH (431) ❑ Moya Moya (437.5) ❑ Septic embolism
❑ Haem other eg SDH (432) ❑ TGA (437.7) ❑ Dolichoectasia
❑ Occ/stenosis of precerebral arteries (433) ❑ Amaurosis Fugax (362.34) Ill Metabolic stroke
❑ Occ/stenosis of cerebral arteries (434) ❑ Cardioembolism ❑ Drug induced stroke
1 E Embolism of cerebral arteries (434.1) ❑ Paradoxical embolism ❑ Migraine stroke
I ❑ TIA (435) ❑ Lacunar (small vessel disease) ❑ Other
❑ 0. No symptoms at all ❑ 6. Died
❑ 1. No signif disability despite symptoms. Able to carry out all usual duties, activities
❑ 2. Moderate disability. Requires some help. Able to walk without assistance
❑ 3. Moderately severe disability. Requiring some help but able to walk without assist.
❑ 4. Moderately severe disability. Unable to walk without assistance. Req assist. for bodily needs
❑ 5. Severe disability. Bedridden, incontinent and requiring constant nursing care and attention
❑ Normal 20 ❑ occ accid-b1 ❑ independ-g1 ❑ independ-f2 ❑ wheelchair) 0 unable-s0
❑ Abnormal ❑ cont-b2 ❑ toilet ❑ transfer bed chair ❑ walk aid2 ❑ help-s1
❑ 0-5 ❑ bladder ❑ depend-t0 ❑ unable-t0 ❑ independ3 ❑ independ-s2
❑ 6-10 ❑ incont0 ❑ help-t1 ❑ maj help-t1 ❑ dressing ❑ bathing
❑ 11-15 ❑ occ accid1 ❑ independ-t2 ❑ min help-t2 ❑ depend-d0 ❑ depend-b0
❑ 16-19 ❑ cont2 ❑ feeding ❑ independ-t3 ❑ help-d1 ❑ independ-b1
❑ Bowels ❑ grooming ❑ unable-f0 ❑ mobility 0 independ-d2











❑ Speech therapy ❑ Other
rii Dipyridamole ❑ Antiarrhythmic ❑ Hypoglycaemic/Insulin ❑ Botox
❑ Warfarin ❑ Beta blockers ❑ Antidepressant ❑ Piracetam
❑ Nimodipine ❑ Ca++ chan blocker ❑ Antiparkinson ❑ TPA
❑ Heparin ❑ Lipid lowering agent ❑ CEA ❑ Nimodipine
1 ❑ Follow up yes ❑ 1 week D 1 mo ❑ 4 mo ❑ 1 y ❑ >2y specify ❑ Rankin worse
1 ❑ Follow up no ❑ 2 week ❑ 2 mo ❑ 6 mo ❑ 1-2y specify ❑ Rankin better ❑ Rankin same
RRankin 1w ankin 3w Rankin 2m Rankin 6m1 11 	Rankin 1 to 2y
Rankin 2w Rankin 4w  Rankin 4m =1 Rankin 1y Barthel 2 to 6 months
❑ None ❑ Pneumonia ❑ Depression ❑ UTI ❑ Falls
❑ Yes ❑ Cardiac ❑ Seizures ❑ Pyrexia ❑ Died
Li Recurrent stroke ❑ Post CEA stroke ❑ DVT ❑ Brachialgia ❑ Other
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Stroke in the Young: The Multiethnic Prospective Durban
Stroke Data Bank Results
Michael Hoffman, MBBch, FCP(SA) Neurol
Aim: To determine the clinical syndromes, etiopathogenesis, and prognostic factors
in a prospectively evaluated multiethnic young stroke population. Methods: Only
first-ever patients with a World Health Organization definition of stroke and
anatomic brain imaging were included. A hierarchy of investigative modalities
divided into three tiers was applied and a range of standardized scales scored in
each patient. This allowed quantification of clinical deficit, etiopathogenesis, disabil-
ity, and handicap. Standardized stroke scales included the Canadian Neurological
Scale (CNS), the Oxfordshire Community Stroke Project (OCSP) clinical stroke scale,
and TOAST (Trial of Org 10172 in Acute Stroke Study) etiological classification.
Disability was measured with the Barthel Index and handicap with the Rankin
Scale; cognitive impairment was separately evaluated according to predefined
criteria. A prognostication measure was made in some patients with the Cerebral
Perfusion Index (CPI). Results: A total of 236 patients was evaluated of whom 64
were excluded because of no lesion consistent with stroke on brain scanning,
leaving 172 for analysis. There were 87 women, 85 men, with a mean age of 43.8
years (range, 15 to 49 years). Despite many different predefined symptoms, 38
patients (22%) could not be classified. Hypertension (31%) and smoking (19%) were
the most commonly encountered risk factors, with more recently determined risk
factors such as infection (6%) and emotional stress (5%) relatively frequent. With
respect to etiology, the TOAST category "other" was the most numerous group,
numbering 93 of 172 (55%) with prothrombotic states in 25 (15%), vasculitis in 21
(12%), and dissection in 12 (7%) being the most frequent causes. Proportions of the
remaining categories were small vessel disease (16%), cardioembolism (13%), large
vessel disease (10%), and unknown (6%). x-square analysis for an association
between the clinical OCSP and TOAST classifications was not significant. Severity of
stroke was generally mild as judged by the CNS and Rankin scales. A high
proportion of patients had cognitive impairment (54%). A cerebral perfusion index
was possible in 31 patients, most of whom had a medium prognosis. Conclusion: In
this hospital-based consecutive series, most young stroke patients in our region
were grouped into nonatherogenic (mostly prothrombotic states, infection associ-
ated and dissection) and noncardiac causes with a definite or probable cause found
in 94%. The wide variety of stroke symptoms recorded in this study underscores the
heterogeneity of stroke presentation and caution in the emergent evaluation of
patients. Cognitive impairment in the majority of stroke patients in the acute and
subacute stroke period has important implications for degree of clinical deficit
especially as it applies to stroke scales and treatment trials. Key Words: Author
provide.
The young stroke patient poses a particularly impor-
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1t diagnostic challenge in view of the varied docu-
mented etiopathogeneses and likelihood of recurrent
events. Notwithstanding the clinical challenge of the
problem, the available data are discordant with respect to
etiology, therapeutic, rehabilitative, and prognostic consid-
erations. There is considerable heterogeneity in the multi-
tude of causes as reported by different investigators as
well as variation between races, regions, and countries. 1-23
Differing diagnostic protocols, diagnostic armamentaria,
and variability in the criteria for the probable causes of
stroke applied by different investigators make the data
currently available nonuniform. The predominance of
retrospective series and paucity of prospective stud-
ies 1,3,24-26 with the unavoidable fact that information has
been collected, often, over a decade or more, with inher-
ent nonuniform testing is a further problem associated
with most studies reported at the time of writing. Few
studies have used clinical and pathogenetic scales to
allow uniformity of clinical reporting. Many studies
included in their series cerebral ischemia or transient
ischemic events
3,12,16,17,19'2126-29 
with no confirmation by
neuroimaging, other than those employing single-photon
emission computed tomography (SPECT) or positron-
emission tomography (PET) acutely. This is problematic
in view of the number of conditions that may masquerade
as stroke or ischemia in young people. Finally, between
10% and 40% of strokes remained unexplained in the
series published to date.
46,7,8,13,16
To help address some of these issues, the findings of the
Durban Stroke Data Bank (DSDB) are presented as one of
the largest prospectively defined young stroke population
with first-ever stroke, all proven by neuroimaging using
contemporary diagnostic methods available in large cen-
ters in the years 1992 to 1996. In view of the recency of the
recruitment period, a high rate of modern neuroinvestiga-
tive modalities was a possible. A wide range of both
proven stroke risk factors and other putative risk factors
were included, in addition to an expanded pathophysi-
ological classification so as to avoid lumping disparate
entities and missing an important association. It is a
personal series, devoid of interobserver variability (but
not of intraobserver variability) utili7ing a hierarchy of
five commonly used stroke scales with management and
follow-up all done by the same investigator in over 90% of
cases. In 10%, management and follow-up remained the
primary responsibility of the referring physicians.
Methods
Recruitment
Patients ranged in age from 15 to 49 years and had
first-ever stroke between October 1992 and October 1996.
1052-3057/98/0706-0000$3.00/0
They were admitted to a Durban metropolitan acute
stroke unit serving patients with medical insurance and a
medical ward in a general hospital catering to indigent
patients without medical insurance. Patients did not
always require hospitalization, some having their workup
on an outpatient basis. The World Health Organisation
(WHO) definition of stroke was the criterion used 3° but, in
addition, all patients had an anatomic brain scan (CT or
magnetic resonance imaging [MRID showing appropriate
Changes consistent with stroke.
Stroke Data Bank
Patients were derived from the DSDB, a prospective
stroke registry. The "nested" patient cohort were sepa-
rately and prospectively evaluated according to a set
protocol. The DSDB included digital storage of clinical
progress and follow-up data, radiographic data, and
where appropriate acoustic storage (e.g., aphasia progress).
This greatly facilitated accurate storage of data and ease
of retrievability. The computer package used was File-
maker Pro 3.0 (Mfr, City, State/Country), a relational
database with integrated image, acoustic, and video
storage facilities.
Investigations
A three-tier investigative protocol was used, incorporat-
ing a basic minimum workup (performed in all patients),
tests often used (by clinical need), and tests seldom used.
The latter two tiers were used as appropriate, tailored to
each individual patient's conundrum of clinical details.
The minimum workup included basic stroke-relevant
blood tests (complete blood count, platelets, serum electro-
lytes, urea, creatinine, lipogram, lipoprotein (a), erythro-
cyte sedimentation rate (ESR), serum glucose, Interna-
tional Normalised Ratio (INR), partial thromboplastin
time (PTT), CT or MRI brain scan, chest radiograph, and
elediocardiogram (ECG). Additional workup when appro-
priate (the 2nd tier) included transcranial Doppler (TCD)
and duplex Doppler (DD) sonography, MR angiography,
SPECT scanning, formal neuropsychological assessment,
prothrombotic tests, cerebral angiography, cerebrospinal
fluid analysis (CSF), Holter monitoring and transthoracic
(I 1E) or transoesophageal (TEE) cardiac echocardiogra-
phy. A category of seldom required tests (the third tier)
included examination for rare inherited disorders (includ-
ing homocysteinaemia, sickle cell disease, hemoglobinopa-
thies, mitochondrial cytopathies, and other genetic and
metabolic causes of stroke) and brain biopsy as indicated.
Diagnoses were broadly divided into probable (labora-
tory evidence and absence of competing cause of stroke)
and definite (conclusive laboratory or radiographic evi-
dence).
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 Scales and Classifications
To facilitate accurate comparison within the registry
with other data banks and stroke trials, several standard-
ized scales have been incorporated into the registry
protocol. These included the Canadian Neurological Scale
(CNS) a neurological deficit scale, 31 a clinical stroke scale;
the Oxfordshire Community Stroke Project Score (OCSP) 32
divided into total anterior circulation (TAC), partial ante-
rior circulation (PAC), laminar (LAC), and posterior circu-
lation (POC), a disability scale; the Barthel Index (BI) 
33
 a
handicap scale; the Rankin Disability Scale (R),34 and an
expanded etiopathogenetic classification, Trial of Org
10172 in Acute Stroke Study (TOAST) 35 with categories
for large vessel disease, small vessel disease, cardiogenic,
other, and undetermined. In the other category were
included probable or presumed causes of stroke after the
investigative protocol failed to determine any cause of
stroke. The other category included strokes in association
with or directly as a cause of vasculitides, cervicocephalic
dissection, aortic arch atheroma, metabolic strokes, drug-
induced strokes, prothrombotic states, migraine, Moya
Moya syndrome, cerebral venous thrombosis, and dolicho-
ectasia. All patients were assessed clinically and a final
diagnosis made with all available investigative data by
the same cerebrovascular neurologist. Comorbidity was
also documented. For a diagnosis to be made within the
frame work of the extended TOAST classification, the
diagnosis needed to be one of exclusion in which all
clinically indicated tests according to the hierarchical
protocol were negative save for the factor in question. It is
acknowledged that some would be definite diagnoses,
some probable, and some possible by this method.
chological assessment procedure incorporated both a
qualitative and quantitative data analysis, the latter accord-
ing to the norms published by Lezak. 36 Qualitative analy-
sis proceeded according to a process of hypothetico
deduction (a process of systematic hypothesis testing)
and was based on the principle of syndrome analysis and
double dissociation (checking valididy of the findings) as
per Luria."
SPECT Brain Scanning
SPECT was performed in patients in whom a discrep-
ancy of clinical signs and anatomic brain scan was present
despite appropriate timing of CT or MRI brain scanning.
A combination of the TCD results and SPECT results can
be computed into the cerebral perfusion index—a recently
described, useful prognostic test. 45 In brief, TCD findings
of occlusion, stenosis, collateralisation and normal were
given scores of 1, 2, 3, 4, respectively. SPECT brain
scanning signal findings of absent, low, mixed, high, or
normal were given scores of 1, 2, 3, 4, 5, respectively. The
multiplication of these values determines a cerebral perfu-
sion index that may be good (15 to 20), medium (6 to 12),
or poor (1 to 5).
Statistical Analysis
The significance of associations between variables was
assessed using x-square test for categorical data or analy-




Cognitive testing was deemed to be important so as not
to miss the true extent of neurological deficit, as this is not
reflected adequately in the current neurological scales. A
higher cortical function deficit (HCFD) screening examina-
tion was applied to all alert patients in the DSDB on
admission. Formal neuropsychological testing was per-
formed in those alert patients with subtle or very mild
deficits on bedside testing or where the screening exami-
nation suggested but did not decisively delineate a
syndrome. The tests comprising the battery included
clinical interviews, Trail Making Test, Symbol Digit Mo-
dalities Test, South African Wechsler Adult Intelligence
Screen (Digit Span, Block Designs, Object Assembly, Rey
Complex Figure Test, Wechsler Memory Scale, Rey Audi-
tory Verbal Learning Test [RAVLT], Verbal Fluency Tests
[FAS, Category Naming], Wisconsin Card Sorting Test
[WCST], Luria's neuropsychological investigation [South
African adaptation] including preliminary conversation,
motor functions [optic, spatial organisation], writing [let-
ter], reading [text], and arithmetic skills. 3644 The neuropsy-
Young people meeting the clinical definition of first
ever stroke included 236. Of these, 64 were excluded
because of no identifiable lesion consistent with stroke
seen on either CT or MRI, leaving 172 for further analysis.
Demographics
There were 85 men and 87 women with a racial-group
breakdown that included 124 whites, 29 blacks, 15 Indi-
ans, 3 of mixed race, and 1 woman of Burmese origin. The
mean age was 43.8 years. There were 3 left handed (1.7%)
and 3 ambidextrous people (1.7%). Most had medical
insurance of some kind (152, 88.4%) with 20 having none
(21.6%).
Timing of the Initial Examination and Initiation
of Investigations
This was performed within 48 hours in 76 (44.1%)
patients of whom 19 (11%) were seen within 6 hours or
less, 27 (15.7%) under 12 hours, and 52 (30.2%) under 24
hours. Patients seen within the first-week, day 3 to day 7,
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bered 33 (19.1%), and weeks 1 to 4 numbered 50.
een patients (7.6%) were evaluated later than 1
month mainly due to late presentation of their first stroke.
Overall, 63% of patients were evaluated within the first
week of their stroke and 92% were evaluated within the
first month of their stroke.
Symptoms
The most common symptoms in descending order were
unilateral weakness (85%), speech difficulty (51%), unilat-
eral numbness (48%), headache (42%), dizziness (31%),
vision impairment (30%), imbalance (12%), and confusion
(12%). Although 18 different symptoms were prospec-
tively sought at the time of stroke presentation, 38
patients' symptoms did not fit into one of the categories.
Within the category named other, examples of these
nonclassifiable symptoms of relatively sudden onset in-
cluded subdued behaviour, lack of emotion, impaired
insight into condition, impaired bladder control (micturat-
ing in the bedroom), slowed-up in work environment (for
example, unable to manage well-known software pro-
grams), slowness of thinking and talking in general,
sensation of a thick and swollen tongue, and hearing
strange sounds.
Risk Factors
Risk factors were divided into independent and as yet
unproven risk factors (Table 1). Smoking was the most
commonly encountered one in 53 of 172 (31%), with
hypertension the second most common in 32 (19%). Of the
so-called atherogenic risk factors (hypertension, smoking,
diabetes mellitus, hyperlipidaemia, gout), 7 of 9 were in
the top 10 most frequently encountered risk factors. Both
infection (established) and recent personal emotional
stress (not established) appeared relatively frequently, but
in this study were not compared with a control group. Yet
others, such as sleep apnea/snoring (established) were
not often encountered (6% and 5%, respectively).
Anatomic Brain Scans
Either a CT (105, 61%) or MRI (103, 60%) brain scan or
both (37, 22%) were performed in all patients. The
distribution of lesions consistent with strokes were 66 in
the right hemisphere, 77 in the left hemisphere, and 49
subcortical. The arterial distribution frequencies included
47 in the middle cerebral artery cortical territory, 16 in the
brainstem arteries, 7 in the cerebellar cortices, 5 in the
anterior cerebral cortical artery territory, and 3 in the
posterior cerebral cortical territory. Other identifiable
distributions included 18 corona radiate, 8 internal cap-
sule, 7 thalamus, 6 basal nuclei, 4 caudate nucleus, 3
perisylvian/insula, 2 anterior choroidal, 1 watershed, and
0 striatocapsular infarcts. At time of first presentation and
Table 1. Risk factors divided into independent and possible






Oral contraceptive use 17 10
Migraine 16 9
Alcohol excess 15 9
Infection 11 6




Previous stroke 2 1
Intennittant claudication 1 1
Sleep apnea or significant snoring 1 1
Possible risk factors and associated significant
illness/predisposing conditions
Recent emotion or personal stress 8 5
Neck trauma 6 3
Hypercoagulable state 5 3
Vasculitis or autoimmune disease 5 3
Deep venous thrombosis 4 2
HIV positivity 3 2
Tuberculosis 2 1
Chronic obstructive airways disease 2 1
Drug/substance abuse 1 1
Neurocysticercosis 1 1
Cervical manipulation 1 1
Cancer 1 1
Other 19 11
first-ever stroke, 20 patients (12%) had more than one
lesion consistent with stroke show on the brain scan.
Functional Brain Scanning and Cerebral
Perfusion Indices
SPECT scanning was performed as per protocol in 36
patients, and 31 (86%) of these studies were abnormal.
These were also used to calculate the cerebral perfusion
index (CPI) together with TCD values in acute stroke
patients. The CPI was good in 3, medium in 26, and poor
in 2. The Rankin scale mean value of these patients
showed a significant difference (ANOVA) between the
poor and medium, poor and good, but not between good
and medium categories.
Sonographic, Laboratory, and Cardiac Investigations
All patients had first tier investigations, hence the
number of abnormalities are a fraction of 172. For the
second and third tier investigations, the number is listed
as a fraction of the total number of investigations done
within the category. TCD and DD were performed in 109
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Table 2. Caniiac abnormalities
High-risk cardiac source
Ischemic heart disease and akinetic left ventricular
segment 2
Atrial fibrillation 2
Atrial fibrillation with dilated left atrium 1
Mechanical prosthetic valve and atrial fibrillation 1
Rheumatic mitral stenosis, atrial fibrillation, dilated
left atrium
Left ventricular thrombus
Dilated cardiomyopathy with left ventricular clot
Atrial myxoma
Infective endocarditis
Congenital heart disease—Eisenmenger's complex,
infective endocarditis
Congenital heart disease—Ebsteins anomaly
Congenital heart disease—Atrial septal defect-periop-
erative repair stroke
Medium-risk cardiac source
Patent foramen ovale 6
Atrial septal aneurysm and patent foramen ovale 1
Mitral valve prolapse 1
Hypertensive heart disease and hypokinetic left ven-
tricular segment 1
(63%) and 103 (60%), respectively, according to clinical
indication. Testing for patent foramen ovale was carried
out in 16 patients, 7 of whom were positive. In 2 patients,
high-intensity transient signals (HITS) were detected over
a middle/anterior cerebral artery bifurcation in the set-
ting of prosthetic heart valve and atrial fibrillation in 1
patient, and preocdusive stenosis due to fibromuscular
dysplasia in 1 patient.
Laboratory findings were notable for the high rate of
complete blood count abnormality and relatively few
abnormalities for INR, PTT, and ESR Lipogram abnormali-
ties and glucose elevations correlated with that reported
by patients under risk factors. Prothrombotic tests were
often positive, numbering 24 of 30 (80%) when tested for
under the protocol guidelines or 24 of 172 (14%) overall.
In the third tier tests all CSF analyses were abnormal
mostly done for suspected neurological infections such as
syphilis, human immunodeficiency virus (HIV) infection,
tuberculosis, and neurocysticercosis. In 2 patients with
clinical and angiographically demonstrated vasculitis,
there was a clinical indication for brain biopsy both of
which were negative.
Cardiac abnormalities accounted for a relatively smaller
number (13%) in comparison with other young stroke
data banks. 1 '23 High-risk and medium-risk causes as listed
in Table 2 were all diagnosed with the help of echocardiog-
raphy (30 transthoracic and 12 transesophageal). Patent
foramen ovale as the most likely factor associated with
stroke occurred in almost one third of the cardiac causes
(Table 2).
Table 3. Etiopathogenetic breakdown—TOAST classification
All (%) White Black
P
value
Other 92 (55) 66 20
Small vessel disease 28 (16) 20 2
Cardioembolic 23 (13) 20 3
Large vessel disease 17 (10) 9 1
Unknown 12 (6) 9 3
Total 172 (100) 124 28 0.411 (NS)
Etiologies: TOAST Categories and 'Other' Subgroups
Within the extended TOAST classification, the most
numerous group was 'other' (55%) followed by the small
vessel disease (16%), cardioembolism (13%, large vessel
disease (10%) and those of 'unknown' cause (6%) being
the smallest (Table 3).
In the subcategories of the 'other' group (Table 4),
frequencies of abnormalities included prothrombotic
group (n = 25) with laboratory-determined abnormalities
including anticardiolipin antibody elevation (7), protein S
deficiency (4), protein C deficiency (2), antithrombin
deficiency (2), elevated fibrinogen (1), and plasmin sys-
tem defect (1). Conditions predisposing to hypercoagula-
bility included ulcerative colitis (1), pregnancy (1), alco-
holic binge (3), recent initiation of oral contraception (4),
and polycythaemia (2). Four patients had 2 prothrombotic
causes. Using a classification of possible, probable and
definite, cases due to prothrombotic states would fall into
the category of probable. Probable was determined by a
positive laboratory result in the absence of a competing
other cause of stroke.
The next most frequent group were the vasculitides
(n = 21) with subtypes including Fuv associated (positive
HIV blood test, MR angiographic appearance consistant
with vasculitis, and lack of another cause of stroke) (5),
Takayasu's (5), tuberculosis-related vasculitis (3), neuro-
cysticercosis-associated vasculitis (3), neurolues (2), iso-
lated angiitis of the central nervous system (1), Kawasaki
disease-related vasculitis (1), and of presumed viral
origin (1). The diagnosis of vasculitis was definite if
biopsy proven, which did not apply to any patients with
two negative biopsy results. In the rest, the strenth of the
diagnosis was considered probable in that there was a
positive laboratory test in association with typical angio-
graphic features of vasculitis and the absence of a compet-
ing other cause of stroke.
Dissection (n = 12) was the third most numerous with
the subtypes including spontaneous carotid dissection (4),
blunt cervical trauma (4), spontaneous vertebral dissec-
tion (2), fibromuscular dysplasia related dissection (1),
and temporally related to chiropractic manipulation (1).
Migraine was the most likely cause in 5 patients




Table 5. Severity of stroke on admission
Canadian
Neurological Scale Rankin Scale
Points n (%) Points n (%)
11.5 81 (47) 0 + 1 91 (53)
7.5-11.0 69 (40) 2 + 3 59 (34)
55-7.0 22 (13) 4 + 5 22 (13)
Total 172 (100) 172 (100)
NOTE. Kappa value 0.58; moderate degree of agreement be-
tween admission Canadian Neurological and Rankin Scale.
Etiologies: Racial Differences
Differences were most obvious within the large 'other'
group (Table 3), which included 21 of 29 (72%) blacks and
66 of 124 (53%) whites. The vast majority of strokes in
blacks studied in this limited sample were attributable to
infection-related vasculitides (HIV, tuberculosis, Takaya-
su's, syphilis, neurocysticercosis) (n = 12, 57%).
Initial Clinical Diagnosis Versus Final
Etiological Diagnosis
The initial clinical diagnosis guiding emergent therapy
was made according to the OCSP classification and later
compared with the final postinvestigational diagnosis as
per TOAST classification. No significant differences were
found in the four major clinical subgroups of the OCSP
classification compared with the TOAST classification.
Severity of Stroke as Assessed by CNS,
Barthel, and Rankin Scales
Assessment for initial neurological deficit (by CNS
scale), revealed that 47% were normal and a further 40%
had a mean score of 9.4. When the Barthel Index was
computed, 4% had a normal Barthel index on admission
and a further 65% allotted a score of 16 to 19. Measure-
ment by Rankin score, 87% had a score of 0 to 3 (i.e.,
ambulant). There was moderate agreement between the
CNS and Rankin scales (kappa = 0.58) (Table 5). Note that 15
these figures apply to the first examination, which oc-
curred in 44.1% within the first 48 hours, in 63% within
the first week, and in 92% within the first month of their
stroke.
Cognitive Testing
Cognitive testing results were abnormal by the neuro-
cognitive screening test in 92 (54%) of the patients with
104 instances of higher cortical functions deficits (HCFD).
Aphasia (35), apraxia (29), amnesia (13), and neglect
syndromes (9) were the most frequently encountered.
Aprosodias, frontal lobe syndromes, and anosognosias
were encountered in 5 patients each, and agnosias, alex-
M. HOFFMAN
Ibble 4. TOAST group (other) breakdown (including
hemorrhagic stroke)
n %
Prothrombotic state 25 27
Prothrombotic state (laboratory based) 17















Spontaneous carotid dissection 4
Blunt cervical trauma 4
Spontaneous vertebral dissection 2
Fibromuscular dysplasia related dissection 1
Temporally related to chiropractic manipula-
tion 1
Migraine 5 5
Metabolic stroke 2 2
Drug/substance abuse 1 1
Moya Moya syndrome 1 1
Miscellaneous 11 12
Cerebral aneurysm with distal territorial embo-
lism 3
Cerebral venous thrombosis 2
Dolichoectasia 1
Arterial redundancy of a persistent hypoglossal
artery 1
Gunshot to neck with carotid artery thrombosis 1
Brainstem AVM and hemorrhagic infarct/poly-
cystic kidneys 1
Postcervical spondylotic surgery 1
Total 92 100
stroke in 2 (hyperhomocysteinaemia), Moya Moya syn-
drome (1), and due to substance abuse (cocaine) in one.
Hemorrhagic stroke accounted for 15 cases, 12 intracere-
bral hemorrhages and 3 subarachnoid hemorrhages.
In the miscellaneous category, the following most likely
causes were identified after a diagnosis of exclusion.
Cerebral aneurysm with distal territorial embolism (3),
dolichoectasia with artery-to-artery embolism or thrombo-
sis (1), cerebral venous thrombosis (2), arterial redun-
dancy of a persistent hypoglossal artery (1), gunshot to
the neck with carotid artery with thrombosis (1), brain-
stem arteriovenous malformation and hemorrhagic in-
farct associated with polycystic kidneys (1), and postopera-





ias,  miscellaneous (visual hallucinations, illusions
and palinopsias) occurred in 1 patient each. As per
protocol, neuropsychological evaluation was required in
36 patients all of whom were abnormal on neuropsycho-
logical testing. In 9 of these 36 patients, the HCFD
screening test was normal. If neuropsychological testing
is regarded as the gold standard for the assessment of
cognitive impairment, then the sensitivity of the HCFD
screening test is 0.75 (0.61 to 0.89, 95% confidence inter-
vals). The positive predictive value of the HCFD screen-
ing test would be 100%. Specificity for HCFD was consid-
ered unimportant and was not calculated.
Prognostication
The cerebral perfusion index (CPI) was measured in 32
patients during the course of the study with a good (CPI,
15 to 20) result in 3 of 32 (9.4%), medium (6 to 12) result in
26 (81.3%), and poor (1 to 5) result in 2 (6.3%). Although
sample sizes were small, there was evidence to suggest
that patients with a poor CPI (2 of 32, 6.3%) had signifi-
cantly higher Rankin scores than patients with good or
medium CPI (ANOVA P = .029).
Complications
Eight specific categories of complications were sought
according to predefined criteria. In order of the frequency
that they occurred, these included behavioral abnormal-
ity in 46, depression in 11, seizures in 11, recurrent stroke
in 6, pneumonia in 2, and no instances of pulmonary
embolus, brachialgia (shoulder and arm pain related
temporally to the stroke), and deep venous thrombosis.
Follow-up
Follow-up between 1 month and 1 year was possible in
106 of 172 (62%) of patients by visitation and if telephone
follow-up was included, in 154 (90%). Follow-up was
recorded at set periods of 1, 2, 4, 6, and 12 months. For
each patient for whom follow-up was possible at the time
of reporting, the longest time since stroke onset within the
first year was recorded and graded according to the
Rankin scale. With maximum follow-up at 1 month, there
were 23 patients (mean Rankin score, 1.26; range, 0 to 4),
at 2 months 22 patients (mean Rankin score, 1.45; range, 0
to 4), at 4 months 23 patients (mean Rankin score, 1.48;
range, 1 to 3), at 6 months 13 patients (mean Rankin score,
1.69; range, 0 to 4), and at 12 months 25 patients (mean
Rankin score, 1.2; range, 0 to 3). The overall mean Rankin
score was 1.4. During the 4-year period of observation 7
patients died.
Treatment
Conventional treatment included antiaggregant therapy
with aspirin in 116, anticoagulation with warfarin in 22,
with heparin in 20, carotid endarterectomy in 8, and
randomization to either aspirin, heparin, both, or placebo
as per International Stroke Trial in 5 patients. Treatment of
underlying precipitating conditions included folate and
vitamin B therapy for hyperhomocysteinemia (1), treat-
ment for neurocysticercosis (3), antituberculous therapy
(3), neurosyphilis (2), HIV (5), venesection for polycythae-
mia (2), surgical aneurysm clipping (3), surgical arterial
reconstruction for Takayasu's arteritis (4), and optimiza-
tion of migraine management and therapy (5).
Discussion
Young stroke series reported to date have been largely
retrospective, included patients with transient ischemic
attack or cerebral ischemia, and have lacked clinical
standardization made possible by clinimetric scales. The
present study adds to the experience noted by others that
causes of stroke in the young are many. However, being
the first young stroke study to be reported out of South
Africa, obvious differences are apparent.
This study delineates four major points with respect to
the young stroke patient. Although a wide variety of
symptoms (n = 18) were prospectively recorded, a surpris-
ing 38 of 172 (22%) patients had nonclassifiable symp-
toms. The majority of these nonclassifiable symptoms
were consistent with a sudden-onset frontal system syn-
drome behavior. The National Stroke Association in the
United States has been responsible for extensive public
education of symptoms of stroke, listing 6 of the most
important ones. 46 By recording symptoms from younger
people, there is less likelihood of other concomitant
neurodegenerative disease than an older stroke popula-
tion. In this study, the CNS, Barthel, and Rankin scores on
admission indicated that the majority had relatively mild
strokes adding to the probability of reliable symptom
reporting. The message from this young stroke data bank
is, therefore, that over 18 different symptom complexes
are possible. By limiting symptoms to 5 or 6 items, albeit a
practical approach, a significant number of symptoms in
the acute stroke setting may be missed.
Recognizable independent stroke risk factors are increas-
ing all the time and since the establishment of the data
bank, infection, lipoprotein (a), sleep apnea, and hyperho-
mocystinemia have been accepted as independent risk
factors for stroke. To avoid missing a possible association
of risk factor and stroke, 26 different risk factors (Table 1)
were collected, some well established, others as yet
uncertain. In addition to finding the well known risk
factors predominating, infection was the only and prob-
ably the most likely cause of stroke in 6% and recent
emotion or personal stress the sole factor in 5%. The fact
that more instances of sleep apnea were not encountered
may well be an investigative logistical problem as not all
patients have the test and no further inferences can be
drawn from the results at this time.
Although this study is not population-based but a
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hospital-based case series, there were differences com-
pared with other hospital-based young stroke studies
(Table 4). A major difference was noted in the frequency of
the etiopathogenetic groups. The TOAST 'other' group,
which accounted for about half of all the etiologies,
emphasises the varied causes and the consequent neces-
sity of a comprehensive workup. Overall, the presence of
prothrombotic factors, vasculitides of infective origin, and
dissection were the most common definite or presumed
causes in young patients. All are treatable, potentially
treatable, or avoidable through public health education,
with obvious personal health and socioeconomic benefits.
Ethnic differences are important to determine for many
reasons, probably the most notable being the added
insight into pathophysiology. Black/white differences
noted are different from those noted in North American
studies" of stroke in general and even other Southern
African studies done more than 10 years previously. 49-52
No doubt investigative advances and the increasing
burden of infective causes such as HIV, tuberculosis, and
syphilis, all of which are on the increase, are part of the
explanation. As the database is ongoing, with increasing
numbers of black patients entered into the study, a clearer
picture may emerge, especially as the database will
incorporate a regional hospital that will be population
based with respect to blacks. Sociopolitical constraints
were the reasons for the relatively low number of black
patients enrolled early within a tertiary care facility and
having as part of their stroke investigation a brain scan.
This is despite accounting for over 80% of the South
African population.
Regardless of the initial clinical categorization accord-
ing to the OCSP classification, this had little bearing on
etiology as presented within the TOAST categories. This
excludes the 15 patients who had intracerebral or subarach-
noid hemorrhage. Therefore, a comprehensive workup as
to cause is warranted, no matter the clinical presentation.
As an obvious example, a clinically diagnosed lacunar
syndrome according to the OCSP was only classified as a
small artery disease after appropriate investigations in 6
of 17 (35%) patients. Although clinical classification was
found to be helpful in guiding the initial sequence and
nature of investigations (e.g., CT for clinical cerebral
hemorrhage and MR1 for posterior circulation strokes),
ultimate diagnosis by TOAST classification showed no
significant association with the clinical OCSP classifica-
tion.
The majority of stroke patients had favorable CNS,
Barthel, and Rankin scores (Table 5), yet a large propor-
tion (54%) had cognitive impairment. Interpretations may
be that the majority of patients with stroke, depending on
the population sampled and selection biased may have a
relatively mild stroke with the advent of good recovery
and opportunity for effective secondary prevention, pro-
vided a correct etiological diagnosis is made. Also, the fact
that more than half of patients have a neurocognitive
deficit implies that this is an important manifestation of
neurological deficit that deserves better quantification
than current scales allow. This has obvious importance for
measuring treatment responses to new drugs and interven-
tions.
The data bank also enabled the testing of early prognos-
tication with newer modalities such as the cerebral perfu-
sion index. 45 During the time of data collection, 31
patients had a transcranial Doppler study and SPECT
brain scan within the subacute stroke period. The correla-
tion with the mean Rankin score at 48 hours showed no
significant differences for the medium and good outcome
prognostication indices, but showed significantly adverse
outcome for the poor index group.
Potential criticisms of the current study would include
selection bias of the population studied, not administer-
ing second tier investigations to all patients, and reliance
on beside clinical testing of cognitive disturbance only
without formal neuropsychological investigations in all
patients. Solutions to the first would include local patient
and medical personnel cerebrovascular education and
gradual rectification of past, racially influenced tertiary
care availability. Because patients often have several risk
factors and more than one possible cause of stroke (e.g.,
atrial fibrillation and carotid artery stenosis), ending the
workup at the first positive test may not be the optimal
approach. As a complete battery of extensive investiga-
tions in every stroke patient is neither ethically acceptable
nor clinically necessarily of advantage, a tailored and
hierarchical protocol was designed. This could also be
viewed as being a cost-effective method of investigation
for such a complex problem. As pointed out by Adams, 53
until various algorithms are compared, stroke diagnostic
plans must be individualized with a recommended mini-
mum workup in all patients and additional work up in
selected patients. The algorithm of the current study is
similar to ones used in other studies in that it is a tailored
protocol with the investigations guided by the clinical
presentation. It differs from all the studies referenced' -9
in that a greater number of standardized scales, symp-
toms, risk factors, and cognitive disturbance were col-
lated. In mitigation of the three-tier investigative protocol,
the study of Hornig et al. 54 of cardioembolic stroke from
three current stroke data banks, revealed that widespread
screening of stroke patients with TEE (a.-90°/0) in the
registries did not appreciably increase the proportion of
patients with a final diagnosis of cardioembolism when
compared with a tailored protocol as in the present study.
The rationale of having a comprehensive screening test
but with in-depth neuropsychological evaluation in se-
lected patients appears to be warranted in view of the
impracticality of administering a time-consuming battery
of demanding tests to acute and subacute stroke patients.
The 25% false-negative rate of HCFD submitted for
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further cognitive testing underscores the need to have a
hierarchical approach to this problem with a need for both
methods.
In conclusion, this study expands the database of stroke
in young people in that causes display inter-regional and
intraregional variation, and may often be relatively mild
but with cognitive deficits, the true clinical importance
and extent of which remains uncertain. Intensive investi-
gation influences the mode of therapy.
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Cognitive Dysfunction in Isolated Brainstem Stroke:
A Neuropsychological and SPECT Study
Michael Hoffmann, MBBch, FCP(SA) Neurol, and Ann Watts, PhD
In a prospective series of patients with brainstem stroke (n = 73) of the Durban
Stroke Data Bank (n = 752), five patients with first-ever, isolated brainstem stroke
were studied neuropsychologically and with single-photon-emission computed
tomographic (SPECT) scanning. Magnetic resonance brain scanning showed four
pontine infarcts and one midbrain infarct without accompanying diencephalic or
cerebral convexity lesions. Frontal (n = 5) and parietal (n = 5) hypoperfusion was
detected by SPECT scanning and comparison in terms of mean counts made to five
age-matched controls with a significant P value of .01 and .02, respectively. Neuro-
psychological testing showed a frontal system syndrome in all five patients and
parietal lobe signs in two. Excellent medical recovery ensued in four of the five
patients and a moderately good recovery in one as judged by the Canadian
Neurological Scale, Barthel Index, and Rankin Scale. The three relatively young
patients in this series were unable to resume their former employment. This was
attributed to a significant frontal system syndrome. Brainstem stroke may cause
significant cognitive impairment best delineated by formal neuropsychological
evaluation, and SPECT scanning may be more sensitive than structural neuroimag-
ing techniques in this setting. Key Words: Brainstem stroke—Neuropsychology-
SPECT brain scanning.
Patients with isolated brainstem stroke are character-
ized by combinations of cranial nerve and long tract signs
and reticular formation deficits. They are not expected to
have higher cortical function deficits (HCFD) such as
aphasias, apraxias, agnosias, hemineglect syndromes, am-
nesias, or frontal lobe syndromes. Visual or auditory
peduncular hallucinosis, in itself rare, has been the most
frequently described cognitive derangement with such
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strokes. 1-5 A neurobehavioral disturbance in such patients
has been inferred in only a few such reports5 ' 7 and has not
been systematically studied neuropsychologically or with
functional imaging techniques such as single-photon-
emission computed tomographic (SPECT) and positron-
eniission computed tomography (PET) scanning.
The concept of strategically placed small deep cortical
(lacunar) infarcts, resulting in functional deactivation and
a neurobehavioral syndrome such as a frontal lobe syn-
drome, has been described 8,9 and recently in association
with capsular genu infarction by Tatemichi et al with
corroborative neuropsychological and SPECT data. 1° The
diaschisis phenomenon, with contralateral hypoperfusion
of the cerebellum and hemispheric stroke, may be seen in
up to 50% of stroke patients. 11-13 Similarly, contralateral
cerebral hemispheric perfusion has been shown to be
depressed in patients with unilateral cerebellar vascular
lesions. 14,15 More recently, brainstem stroke with both
pontine and medullary lesions has been shown to cause a
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presumed functional deactivation in the cerebellum." -19
In their study of brainstem stroke and contralateral
cerebellar hypoperfusion as measured by SPECT scan-
ning, Fazekas et al" incidentally noted two instances of
ipsilateral frontoparietal hypoperfusion in two of six
patients with unilateral brainstem (pontine) stroke. No
clear association between SPECT perfusion changes and
clinical findings could be found in their two patients.
Rousseaux et a1 17 also documented low regional cerebral
blood flow in two patients with medullary infarcts with
no cortical lesion on magnetic resonance imaging (MRI)
brain scanning. In neither study was concomitant higher-
function cortical function impairment noted. The postu-
lated explanation was disruption of the corticopontocer-
ebellar fiber system with the lesion having both
anterograde and retrograde effects, which remains un-
proven. The association of brainstem infarction with
ipsilateral cerebral hypoperfusion had not been reported
previously.
In the studies to date, concomitant thalamic lesions,
neurodegenerative disease, multiple infarcts, white mat-
ter hyperintensities, and other subclinical infarction not
identified by computed tomography (CT) are potential
confounding variables in the few patients studied. The
two studies addressing brainstem infarction and cortical
hypoperfusion 16,17 each had patients with other lesions on
the MRI scans in addition to the lesion thought to be
relevant. The present study addresses all of these poten-
tial confounding variables. MRI is used for diagnosis of
infarction; only first-time, single, small infarcts or hemor-
rhages limited to the brainstem were studied and rela-
tively young stroke subjects were used.
Methods
Stroke Data Bank
Patients were derived from the Durban Stroke Data
Bank (DSDB), a prospective stroke registry. The minimum
work-up includes basic stroke-relevant blood tests, brain
scan (CT or MRI), chest radiograph, and electrocardio-
gram. Additional work-up when appropriate includes
transcranial Doppler, duplex Doppler sonography, MR
angiography, SPECT scanning, in-depth neuropsychologi-
cal assessment, prothrombotic tests, cerebral angiogra-
phy, cerebrospinal fluid analysis, Holter monitoring, and
transesophageal cardiac echo. A category of seldom-
required tests that includes examination for rare, often-
inherited disorders and brain biopsy is also catered to. To
enable comparison with other data banks and stroke
trials, the Canadian Neurological Scale (CNS), Oxford-
shire Community Stroke Project Score (OCSP), Trial of
ORG 10172 In Acute Stroke Treatment (TOAST) patho-
physiological classification, Rankin Disability Scale (R)
and Barthel Index (BI) have been incorporated into the
registry.
Cognitive Testing
A HCFD screening examination is applied to all alert
patients in the DSDB in the first 2 weeks of presentation.
Neuropsychological testing is performed in those alert
patients with mild deficits on bedside testing or in whom
the screening examination suggests but does not deci-
sively delineate a syndrome. A formal battery of neuropsy-
chological tests was administered to 70 of the 752 patients
of the DSDB by these criteria by the same neuropsycholo-
gist within 1 month of the stroke onset. The tests compris-
ing the battery included clinical interviews, Trail Making
Test,2°,21 Symbol Digit Modalities Test, 22 • 2° South African
Wechsler Adult Intelligence Screen (Digit Span, Block
Designs, Object Assembly), 23 Rey Complex Figure Test, 2°
Wechsler Memory Scale, 24 Rey Auditory Verbal Learning
Test (RAVLT), 2° Verbal Fluency Tests (FAS) (adapted from
Benton and Hamsher 1976 and cited in Lezak in 1995), 20
Category Naming (adapted from Newcombe 1969 and
cited in Lezak in 1995),20 Wisconsin Card Sorting Test
(WCST),25 and Luria's Neuropsychological Investigation
(South African adaptation), 26,27 which includes prelimi-
nary conversation, motor functions (optic-spatial organi-
zation), writing (letter), reading (text), and arithmetic
skills. The neuropsychological assessment procedure in-
corporated both a qualitative and a quantitative data
analysis, the latter according to the norms indicated
above. Qualitative analysis proceeded according to a
process of hypothetical deduction and was based on the
principle of syndrome analysis and double dissociation
per Luria.28
SPECT Scanning
SPECT scanning is performed in patients with discrep-
ancy of clinical signs and anatomical brain scan, and 20
millicuries 99m technetium—HMPAO 99 is administered
intravenously. Ceretec with technetium produces a lipo-
philic complex that crosses the blood-brain barrier and is
retained in the brain, allowing assessment of regional
cerebral blood flow. Imaging is begun 2 to 3 minutes after
the injection of the tracer. The patient is positioned as
comfortably as possible with the room slightly darkened
and is encouraged to be as relaxed as possible. Scans are
obtained for 20 seconds, with regular 6° rotation of the
camera head around the patient, completing a 360 0 rota-
tion with approximately 60 images obtained. This re-
quires cooperation from the patient for a period of about
30 to 40 minutes. A medium- to high-resolution collimator
was used on the gamma camera. Reconstruction was
performed with positioning of the patient in the orbitome-
atal line, in the transverse, coronal, and saggital planes.
Transaxial slices were contiguous, 16 in number, and 3.3
mm thick. Three-dimensional reconstruction was also
performed. Images were interpreted on the computer
screen comparing right and left regions of interest. This
was done both visually in a qualitative manner by a
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radiologist blinded to the anatomical scan and semi-
quantitatively, the latter adapted from methods by Po-
dreka et a129 and Steinling et al. 3° The transaxial slice with
the largest perfusion defect was identified and a circular
region of interest (ROI) traced over that area. These
circular ROIs were also obtained for six areas of the gray
matter. These included the cerebellum, thalami, basal nudei,
frontal, parieto-occipital and temporal regions. These areas
and their mirror images on the homologous region of the
other hemisphere were stored on a template and adjusted for
surface area when required for a particular scan. The ROI
radioactive counts from homologous regions of both hemi-
spheres were taken to compare side-to-side perfusion differ-
ences and expressed as an asymmetry index. An asymmetry
index percentage (AI) was calculated according to the for-
mula A-B/(A + B/2] x 100 where A and B represent right
and left sides. Al comparison was done with five age-
matched controls (on a case-by-case basis) and matched on
education but not social class. Follow-up scans were not
routinely performed.
Transcranial Doppler
The basal cerebral vessels and all major branches of the
circle of Willis were insonated via the temporal and
suboccipital windows with the EME-Transcan transcra-
nial Doppler using mounted 2-MHz probes. Flow veloci-
ties and pulsitility indices (Gosling) were measured with
special attention to the identification of intracranial steno-
ses and emboli detection (15-minute monitoring).
Inclusion and Exclusion Criteria
Entry criteria included only first-time, isolated single
infarcts or discrete hemorrhages in the brainstem. For the
study on brainstem stroke and cognitive derangement,
patients had to be alert within 1 week, without other
disease such as encephalopathy, drug, infective, or meta-
bolic process. Alzheimer's disease, early dementia, and
depression were excluded according to DSM-IV criteria. 31
Patients with additional supratentorial cortical or subcor-
tical (including leukoaraiosis, unidentified bright objects)
infarcts or any other lesions were not considered for
inclusion in this case series. If CT was the only imaging
available, such patients were also excluded because of its
poor sensitivity for brainstem stroke. Cognitive assess-
ments performed more than 1 month after the event were
not considered for inclusion in this series.
Statistical Analysis
The Wilcoxon Two Sample Test was used to compare
the mean counts of the frontal and parietal regions of the
patients with the frontal and parietal regions of the con-
trol group. A P value of <.05 was considered significant.
Results
Five patients met the criteria stipulated. The DSDB
cascade for infarct topography and exclusion criteria
among those with brainstem stroke is detailed in Fig 1.
The relevant clinical details including risk factors, neuro-
imaging findings, and sonographic, neuropsychological,
and functional imaging findings are recorded in Table 1.
Two patients had four-vessel cerebral angiography, both
normal. Four of five patients had cervicocephalic and
transcranial Doppler studies, with only patient 5 having a
reported possible abnormality, in that asymmetric veloc-
ity was detected in the right carotid siphon with a degree
of turbulence suggesting a minor degree of stenosis. Four
of the five patients had pontine infarcts, and one had a
hemorrhagic midbrain infarct. MRI brain scanning ex-
cluded the presence of any other infarct, white matter
changes, and leukoaraiosis in all five patients. The brain-
stem lesion and accompanying SPECT scan of patient 1 is
shown in Figs 2 and 3, respectively. The absence of large-
vessel disease as depicted by normal angiography and
sonographic findings in all patients (except possibly
patient 5) exonerates any other identifiable lesion causing
the cognitive impairment. No history of Alzheimer's
dementia was present in any of the patients, all of whom
were normal as judged by DSM-IV criteria, 24 their spouses,
and family. Three of the five patients also fell into the
category of the young stroke population, as defined in the
DSDB, at 15 to 49 years of age.
All five patients had a frontal system syndrome diagno-
sis on formal neuropsychological testing (Table 1), and all
five patients had corroborating frontal hypoperfusion on
SPECT scanning (Table 2). The full battery of neuropsycho-
logical tests could not be administered to all five patients
because factors such as medical and physical impairment
(for instance, right hemiparesis in patient 3, who was
right handed) precluded the administration of certain
tests. All had executive dysfunction (i.e., disability in
planning, initiating, and executing activities and im-
paired self-monitoring according to the qualitative analy-
sis per Luria 28). Executive and frontal system dysfunction
was also evident on quantitative analysis. For example,
patients 1 and 5 had the lowered and fluctuating learning
plateaus on the RALVT associated with executive dysfunc-
tion in that because of a failure to organize the material to
be learned, repeated presentation did not lead to an
increase in the quantity retained (patient 1: 6, 9, 10, 10, 9;
normal is > 12 by the fifth trial, and patient 5: 5, 5, 5, 4,
4). 20 Patient 1 also had impaired performance on the
WCST with a significant number of perseverative errors
(52 of 128 trials). This is consistent with frontal lobe
dysfunction according to Lezak 2° (mean number of perse-
verative errors made by patients with dorsolateral frontal
lesions is 51.5). The same patient also showed impaired
performance consistent with frontal system abnormalities
on several other quantitative tests. For example, his
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Durban Stroke Data Bank
(n=752)
Brainstem Stroke (infarct and hemorrhage)
(n=73)
Exclusion categories
Figure 1. Durban Stroke Data
Bank cascade of patients with brain-
stem strokes, exclusion criteria, and
those included (n = 5).
Pontine infarct (n=4) Midbrain hemorrhage infarct (n=1)
Exclusion categories
A - Normal cognitive screening test 36
B - Concomitant other infarct noted; usually part of cerebellum and thalamus 30
C - Unidentified bright objects noted elsewhere on MRI scan 26
D - Infarct confirmed by CT brain scan only. No MRI 11
E - Neuropsychological testing done more than one month after ictus or not done 3
F - Patient not alert. Usually drowsy 1
G - History of other neurodegenerative disease such as Alzheimer's and hydrocephalus 1
H - Clinically depressed according to DSM-IV criteria
poorly organized copy of the Rey Complex Figure led to
size and relationship errors (scoring on the tenth percen-
tile), as well as a resultant impoverished recall from
memory (scoring at the seventh percentile; normal range
25th to 75th percentile). That his poor recall or the
complex figure was primarily caused by a lack of organi-
zation is borne out by his ability to recall the simpler,
visual reproduction designs of the Wechsler Memory
Scale (patient's score 12; mean 10.09; standard deviation
3.01). This pointed to "frontal amnesia." 32 He also showed
decreased verbal fluency on the Category Naming Test,
scoring 17 for objects (mean is 30.2) and 13 for animals
(mean is 16.9). 20 In patient 2, an executive problem was,
for instance, noted in that the copy of the Rey Figure was
poorly planned and fragmented, with the result that as
with patient 1, his immediate recall was impoverished,
also falling at the fifth percentile (normal range is 25 to
75). 20 His ability to accurately recall simpler, visual de-
signs on the South African adaptation of Luria's Neuropsy-
chological Investigation for Zulus confirmed that his poor
recall of the complex figure was caused by poor organiza-
tion. Patient 4 showed marked verbal fluency problems
on the Category Naming Test, achieving only four objects
(mean, 30.2) and nine animals (mean, 16.9). 20 The assess-
ment of patient 3 was limited on account of a severe right
hemiparesis, and the diagnosis of a frontal system syn-
drome was made on the basis of predominantly qualita-
tive data. His RALVT scores were, however, impaired (4,
Figure 2. MRI brain scan of patient 1 showing the left midbrain
stroke-hemorrhagic infarct (arrow).
Figure 3. SPECT brain scan of patient 1 showing areas of frontal
hypoperfusion (arrows).
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Table 1. Clinical, investigative, neuropsychological, and SPECT findings
Patients/age/
race/sex Clinical MR1 scan Doppler/angio
1. 37-year-old Right hemiparesis, Left mesencephalic Four-vessel cerebral










2. 48-year-old Left hemiplegia. Extensive right Cervicocephalic
black man Diabetic and hemipontine duplex Doppler
hypertensive infarct and TCD normal
3. 68-year-old Right hemiparesis, Anterior segment, Duplex Doppler
















Midpontine infarct Cerebral angio,
Duplex Doppler
and TCD normal
5. 70-year-old Right monoparesis, Bilateral pontine Duplex Doppler







Frontal lobe syn- Left frontal and left
drome parietal hypoper-
fusion
Frontal lobe syn- Left parietal and left
drome basal hypoperfu-
sion
Neuropsychology 1 SPECT scan
Frontal lobe syn- Left frontal and pari-
drome, particu- etal hypoperfu-





Frontal lobe syn- Left frontal and pos-
drome. Parietal tenor parietal
lobe signs: con- hypoperfusion
structional dys-
praxia
Frontal lobe syn- Right frontal and
drome parietal lobe
hypoperfusion
Abbreviation: TCD, Trancranial Doppler.
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Table 2. Asymmetry indices percentage on SPECT scanning











Mean value 15.8 11.5 .01 12.1 5.2 .02
Controls (mean) 1.9 1.97 4.2 2.7
7, 7, 7, 9 where, as noted above, normal is 12 or more by
trial 5).20 In addition to frontal lobe impairment, patients 1
and 2 also displayed visuospatial problems (Table 1).
Patients 1 and 2 had abnormal scores on the Block Design
Test of 6.0 and 5.0, respectively (normal is 10.0 2). 20
When provided with a plan in the form of a grid placed
over the designs so that the constituent blocks were evident,
they had greater difficulty than before, because the additional
information exacerbated their visuospatial difficulties. This
pointed to parietal systems dysfunction. 32
The timing of the SPECT scans was within 3 days
poststroke for patients 2, 3, and 5, 4 weeks poststroke for
patient 1, and 4 months poststroke for patient 4 (mean,
31.4 days). As an example, the MRI scan and accompany-
ing SPECT scan of patient 1 are shown in Figs 2 and 3,
respectively. All five also had some degree of parietal
hypoperfusion, with patients 1 and 2 displaying parietal
lobe neuropsychological impairment. Cartographic analy-
sis of the SPECT scans guided the ROI counts and the AI
calculation. These were compared against five age-
matched normal control patients (study patients' mean
age was 54.4 years, and controls' was 55.6 years). Analysis
by Wilcoxon Two Sample Test comparing the AIs of the
frontal regions of the patients with those of the control
group was significant at a P value of .01. In comparison of
the parietal regions, patients compared with the control
group had a P value of .02. The nonparametric test was
used because of the inhomogeneity of the variations
of AIs.
Admission and follow up (6 months) grading with CNS
score, R, and BI indicated that the patients all had an
excellent recovery as determined by a neurological deficit
score (CNS, impairment score [BI], and handicap score
ERD (Table 3). However, the residual neuropsychological
disability in all proved to be the most significant problem
in adapting to their former occupations and social interac-
tion. The poststroke behavioral problem, identified as a
frontal system syndrome on formal neuropsychological
testing, was of varying degree and caused significant
handicap in the neurocognitive sphere in that the three
young patients (patients 1, 2, and 4) were unable to
continue with their former occupation, whereas two were
medically boarded as a consequence. The current clinical
follow-up of patients 1, 2, and 4 at time of reporting was
30, 24, and 20 months (mean, 24.6 months) with negligible
long tract signs on examination, but collateral sources
reported significant interpersonal and occupation-related
problems. Patient 3 died at 9-month follow-up, and
patient 5 is retired.
Discussion
Remote deactivation as evidenced by SPECT functional
imaging has been well documented in patients with
cortical and cerebellar infarction. Infarction in either may
be accompanied by hypoperfusion in the contralateral
hemisphere. 11-15 Brainstem lesions in the pons and mid-
brain were subsequently noted to be associated with
frontoparietal hypoperfusion by Fazekas et a1, 16 and
Rousseaux 17 documented medullary infarcts associated
with cerebral cortical hypoperfusion. Cerebellar perfu-
sion changes were not assessed in the current study, and
radioactivity counts were also not compared with the
cerebellar counts in view of these previously documented
changes of both ipsilateral and contralateral cerebellar
hypoperfusion with pontine infarction. 15,19 Similar to the
two patients of Fazekas et at (the only other study to our
knowledge showing cortical hypoperfusion with SPECT
scanning) all of our patients had frontoparietal hypoperfu-
sion. Our patients differed from theirs in that all had
normal MRI cerebral convexity scans, without the bilat-
eral white matter hyperintensities noted in one of their
two cases with neocortical hypoperfusion. This may have
reflected more widespread subclinical cerebrovascular
disease in their patients, and it is possible that the white
matter hyperintensities represented minor ischemia or
infarction.
The present study shows that such functional deactiva-
tion has a clinical correlate in terms of neuropsychological
impairment, and more importantly that this may occur
with isolated brainstem stroke. The normal MRI scans
devoid of infarction or white matter lesions in any part of
the brain other than the brainstem infarct greatly
strengthen the case for remote deactivation caused by the
Table 3. Canadian neurological scale, Barthel index, and
modified Rankins score on admission and follow-up
at 6 months
Admission values At 6 months
Patients CNS Barthel Rankin CNS Barthel Rankin
1 9.5 18 2 10.5 20
2 5 6 4 8 15 2
3 6.5 6 4 10.5 20
4 11.5 20 1 11.5 20
5 8 19 2 11.5 20
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isolated brainstem lesion under study and not by other
concomitant subcortical lesions. The frontal system (n = 5)
and parietal system (n = 2) neuropsychological deficits
noted were corroborated by an appropriate hypoperfu-
sion on the functional scan (SPECT). The three patients
without clinical or neuropsychological parietal signs but
SPECT parietal hypoperfusion may have had subclinical
involvement, or the timing of investigations may be an
explanation. In agreement with previous studies, 33 the
deficits tended to be less severe and more transient than
superficial cortical infarcts. They may nevertheless signifi-
cantly impact the extent of quantifiable neurological deficit,
medical management, and both physical and psy-
chological rehabilitation. In terms of functional recovery of
such lesions, evidence points to a synaptic reactivation of
neurones, and this may be augmented by rehabilitation. 33
The postulated mechanism is a remote effect (diaschi-
sis) of the brainstem lesions on one or more of the five
delineated frontal subcortical circuits. 34 This may be via
one of the open efferent and afferent connections to these
circuits. Only patient 1 had a midbrain lesion, the others
had pontine lesions. Strictly speaking, only the substantia
nigra forms part of the frontal subcortical circuitry. 34
Another mechanism of remote effects is via the corticopon-
tocerebellar fibers, which in turn project to the red nucleus
and ventrolateral nucleus of the thalamus and to the
frontoparietal cortex.35 The corticopontine fibers are de-
rived principally from the frontal and parietal lobe. This
postulate presumes an anterograde and retrograde func-
tioning of the corticopontocerebellar fibres. Four of the
five patients had frontal and all five had a degree of
parietal hypoperfusion as seen on SPECT scanning. This
may reflect the functional deactivation or diaschisis pro-
cess of the pontine (four patients) and midbrain (one
patient) lesions on the frontoparietal cortex. Other pos-
sible mechanisms could involve brainstem-hemisphere
tracts, including those that traverse the pons, such as the
reticulothalamic, spinothalamic, or vestibulocortical fas-
ciculi. 36,37 The cerebellum has been implicated in nonmo-
tor cognitive functioning. 38 Interestingly, in the study of
Daum et a1, 38 patients with cerebellar and brainstem, but
not those with only cerebellar pathology, showed cogni-
tive impairment predominantly of a frontal lobe nature.
These findings lend some support to our own study.
Neuropsychological impairment that correlated with
the functional SPECT scanning abnormality was noted in
these patients, but its significance in terms of future
disability and handicap only became evident at follow-up
at 4 to 6 months. The most significant problem in terms of
impairment and handicap as measured by the R scale was
probably neuropsychological. This was a frontal system
syndrome in all five patients. As a result, three of the
relatively young patients were unable to continue work
despite their otherwise excellent medical outcome at 6
months as assessed by CNS, BI, and R (Table 3). The
discrepancy between the scored items and neuropsycho-
logical handicap was most profound in the younger
patients, because the two elderly patients (3 and 5) were
retired, making this yardstick inappropriate.
Potential criticisms of the article are several. Because it
is impractical to administer neuropsychological batteries
to every stroke patient in large stroke data bank case
series, it is quite possible that some patients had normal
cognitive screening test results yet might nevertheless
have had impairment on more rigorous neuropsychologi-
cal testing. Only a cursory depression scale assessment
was administered, and it is possible that depression may
have played a part in more than the one patient so
identified. Attentional impairment as a confounding fac-
tor, on the other hand, was unlikely to have been a factor
because all patients had digit span scores within normal
age-adjusted norms. SPECT scans were not done at the
same time in all patients, and this too may have influ-
enced results in the patients under discussion and ex-
cluded others. Logistically, neuropsychological testing
and SPECT scanning were not performed at the same
time, and this also may have influenced results. We regard
this as a pilot study generating a hypothesis worthy of
testing in a larger sample of patients because the small
number of observations may be too small to justify the
conclusions based on statistical analyses.
Isolated brainstem stroke may be associated with signifi-
cant cognitive impairment, which may be the most impor-
tant impairment, and with subsequent later disability
handicap. Neuropsychological testing as an extension of
the neurological examination (for recording the true ex-
tent of neurological deficit) and functional brain scanning
(SPECT) are pivotal modalities required for diagnosis.
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Intracranial artery dolichoectasia is
recognised as an underdiagnosed
yet potentially treatable stroke
mechanism. A prospective analysis
of patients in the Durban
Cerebrovascular Data Bank (n=762)
was undertaken over a 4 year
period and 32 patients identified as
meeting established criteria. No
significant difference was found
between those patients presenting
with stroke as opposed to transient
ischaemic attacks. There was a
trend to a preponderance in males
and most patients had
hypertension and presented with
posterior circulation ischaemia or
ORIGINAL ARTICLE
infarction. All patients were
Identified by first tier investigation
with conventional brain scanning
(MRI or CT) but contemporary
imaging modalities such as MRA
and transcranial Doppler
sonography aided in the diagnosis.
Six patients were treated with
anticoagulation after failing
antiaggregant therapy with aspirin
with no recurrent events over a
15.6 mean month follow up period.
Background
Most drug interventions in acute
stroke have been negative. Those
recently published, that are beneficial,
have shown a disappointing s mall
benefit ratio '-' implying subgroups in
the stroke population may have a bet-
ter or worse response. Sroke in Itself
is considered too generic for a single
treatment to be effective and the fo-
cus appears to be emerging that we
will need to identify, mechanisms of
stroke to tailor treatment more ette,_-
tivelv, clinically and to save cost.
Elongation and tortuosity
(dolichoectasia) of the basal intracra-
nial vessels is known to cause cerebral
ischaemia and infarction, compressive
cranial neuropathies, hydrocephalus
and a variety of brainstem symptoms: .
Megadolichoectatic basilar artery syn-
dromes have been the most extensively
studied by autopsy, angiographv, CT
and MRI. No distinct clinical syndrome
is recognised, probably leading to un-
der-diagnosis.'' The reported incidence
is 0.06-5,8% but varying criteria have
been applied." Newer imaging proce-
dures can facilitate the non-invasive
diagnosis. The entity has not been sub-
ject to prospective analysis. -
to page 5
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Dolichoectasia - an easily identifiable and
potentially treatable stroke mechanism
from page 4
The prospective Durban Core-
broyascular Data Bank specifically
included this as a predefined entity
and the results to date are presented.
Methods
Recruitment
All patients with stroke or tran-
sient ischaemia between October
1992 and October 1996 admitted to
a Durban metropolitan acute stroke
unit were recruited for the study. The
definition of stroke was that of the
C ) definition of stroke"' but in
addition those with appropriate brain
scan (CT, MRI or SPECT) changes
consistent with stroke were entered
into a digitised registry. A transient is-
, haemi,: attack (T1A) was defined as
a sudden onset neurological deficit, re-
versible within 24 hours with mi-
graine, seizures, cerebral mass lesions
and metabolic causes excluded clini-
cally and by appropriate investiga-
tions.
Investigations
A three tier investigative protocol
was used, incorporating a basic mini-
mum workup, tests often used and
tests seldom used. The latter two tiers
were used as appropriate - tailored to
each individual patient's conundrum
of clinical details. The minimum
workup included basic stroke relevant
blood tests - complete blood count,
platelets, serum electrolytes, urea, cre-
atinine, lipogram, erythrocyte sedi-
mentation rate, serum glucose, Inter-
national Normalised Ratio (INR), par-
tial thromboplastin time (PTI ), brain
scan (CT or MRI), chest radiograph
and electrocardiogram. Additional
workup when appropriate, the second
tier, included transcranial Doppler,
duplex Doppler sonography, MR
angiography, SPECT scanning, in-
depth neuropsychological assessment,
prothrombotic tests, cerebral angio-
graphy, cerebrospinal fluid analysis,
Holter monitoring and trans oesopha-
geal cardiac echo. A category of seldom
required tests, the third tier, included
examination for rare, often inherited
disorders (including homocystinuria,
sickle cell disease, haemo-
globinopathies, mitochondrial
cytopathies, other genetic and meta-
bolic causes of stroke) and brain bi-
opsy to diagnose some of the vascu-
litides is also catered for.
Neurological scales and
classifications
To enable comparison with other
data banks and stroke trials, the stroke
patients were further categorised into
several standardised scales incorpo-
rated into the registry protocol. These
are a clinical stroke scale; the Oxford-
shire Community Stroke Project
Score (OCSP) divided into total an-
terior circulation (TAC), partial an-
terior circulation (PAC), lacunar
(LAC) and posterior circulation
(POC), a neurological deficit scale;
the Canadian Neurological Scale
( CNS), a disability scale; the Barthel
Index (BI), a handicap scale; the
Rankin Disability Scale (R); and an
expanded aetiopathogenetic
(TOAST) classification with catego-
ries for large vessel disease, small ves-
sel disease, cardiogenic, undetermined
and other. In the "other" category were
included probable or presumed causes
of stroke after the investigative pro-
tocol failed to determine another
cause of stroke. Comorbidity was also
documented. The other category in-
cluded strokes in association with vas-
culitides, cervicocephalic dissection,
aortic arch atheroma, metabolic
strokes, drug induced strokes.
prothrombotic states, migraine, NIova
Moya syndrome, cerebral venous
thrombosis and dolichoectasia. All
patients were assessed clinically and
a final diagnosis made with all avail-
able investigative data by the same
cerebrovascular neurologist.
For a diagnosis to he made within
the framework of the extended
TOAST classification, the diagnosis
needed to be one of exclusion in
which all clinically indicated tests,
according to the hierarchical proto-
col, were negative save for the factor
in question. It is acknowledged that
some would be definite diagnoses,





Basilar artery lies lateral to the
margin of the clivus in the
cerebellopontine angle or above the
level of the suprasellar cistern. '
Cognitive testing
This was deemed to be important
so as not to miss the true extent of
neurological deficit as this is not re-
flected adequately in the current neu-
rological scales. A HCFD screening
examination is applied to all alert pa-
tients in the DCDB in the first two
weeks of presentation. Neuropsvcho-
logical testing is performed in those
alert patients with mild deficits on
bedside testing or where the screen-
ing examination suggests but does not
decisively delineate a syndrome. A
formal battery of neuropsychological
tests was administered to 70 of the 762
patients of the DCDB by these crite-
ria by the same neuropsychologist
within one month of the stroke onset.
to page 6
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were gable. III). Anatomical
braids.can imaging revealed posterior
Table III: Clinical presentations
.•
inYiT:1;, .=1:1-1 •
patients' dolichoectasia were diag-
nosed by parenchymal brain imaging.
Those that required angiography, both
invasive and non-invasive, had these for
Table IV: Radiological
investigations
reasons of.comorbidity and for verifi-
cation of the diagnosis. TCD revealed
a typical low velocity, high pulsatility
signal in the majority (72%) of patients
yin whom this investigation was done.
In the stroke cohort, patients gen-
erally presented with minimal deficit
as evidenced by the Canadian Neuro-
logical Scale mean value of 10.7 (maxi-
mum score is 11.5, minimum 0). Table V
reveals the preponderance of posterior
circulation infarction as defined by the
standarised OCSP scale.
Table V: Clinical neurological
scale (OCSP)
to page 7
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Statistics
For proportions, a univariate
sis was done using Chi-square tests of
association. For continuous variableSr
the t test was used for significanCe of
means, and the non-parametric me-
dian test for judging the significance
of differences in median values. ,;
Results
The dolichoectasia radiOgraphic di-
ignoses were sought in stroke (n=762)'
Ind TIA patients (n=312) and were not
;ignificantly different in terms of fre.--
luencies or mean age. Gender. differ.;'
!nces attained marginal significance'
Table I). Hypertension was byfar they k
nost common vascular risk factor
tioninfarcts in
otasia stroke
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All patients except one (who was
thought to have dissection of the
basilar artery and possible subarach-
noid haemorrhage) received,aspirin in
the first instance. In 6 patients who
had recurrent symptoms while on as-
pirin (aspirin failures), including re-
current strokes in 4, warfarin was in-
stituted with an INR range of 2.0-3.0.
Over a mean period of 15.6 (range
3-36) months no further symptoms
were reported in these 6 patients.
The figures represent typical exam-
ples of vertebrobasilar dolichoectasia
as imaged by contrast enhanced - brain
CT scanning, MRI brain scanning and
MRA. Figures 1' and 2
rd stept, appwaticss of the dilated
4441at,q4y displaced basilar artery
94,0444A.RhaiKed,,CT 'scanning.




 ted MRI image
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erent s o e Syndromes
associated with this disorder as well
as follow up i.e. posterior circulation
stroke and/or isolated symptoms such
as facial paresis (Bell's palsy), facial
neuralgia and hemifacial spasm.
The diagnosis can easily be
made in most cases within the
first tier (CT brain or MRI brain
scanning) of the investigative
protocol, negating the necessity
of resorting to invasive studies.
This is an important clinical
point as the majority of these
patients present with posterior
circulation ischaemia or stroke,
a syndrome in which invasive
angiography is associated with
a significant morbidity and
mortality.
In this series all pa-
tients were identified by
CT or MRI brain scan-
ning. MRA was done in
6 patients, catheter an-
giography in 3 and spi-
ral CT in 1. Angiogra-
phy in these 10 patients
was used to better de-
lineate the ectatic arter-
ies and confirm the di-
agnosis, the latter often
necessitated by the
presence of comorbid-
ity. Transcranial Doppler sonography
has a specific wave form associated
with this syndrome and in agreement
with RaUtenberg et al 6, in this study
it was found to be a useful adjunctive
test in cases where there may be some
doubt as to the presence of
dolichoectasia.
In agreement with the other larger
series on this topic1316, the three main
modes of clinical presentation - ischae-
mic, cranial nerve compression and
mass effect - were noted, albeit mostly
ischaemic (85%). In the ischaemic
to page 8
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All patients except one (who was
thought to have dissection of the
basilar artery and possible subarach-
noid haemorrhage) received aspirin in
the first instance. In 6 patients who
had recurrent symptoms while on as-
pirin (aspirin failures), including re-
current strokes in 4, warfarin was in-
stituted with an INR range of 2.0-3.0.
Over a mean period of 15.6 (range
3-36) months no further symptoms
were reported in these 6 patients.
The figures represent typical exam-
ples of vertebrobasilar dolichoectasia
as imaged by contrast enhanced brain
CT scanning, MRI brain scanning and
MRA. Figures 1 and 2 show two
different appearances of the dilated
and laterally displaced basilar artery
on contrast enhanced CT scanning.
Figure 3 shows a very large
(megadolichoectatic basilar artery)
in coronal T2 weighted MRI image
and Figure 4 an example of basilar
dolichoectasia as seen on MRA.
Discussion
This study represents one of
the largest series and one of few
prospectively evaluated consecu-
tive case series within a large data
bank series of dolichoectasia of the
cerebral arteries. This has allowed
delineation of the frequencies
of different stroke syndromes
associated with this disorder as well
as follow up i.e. posterior circulation
stroke and/or isolated symptoms such
as facial paresis (Bell's palsy), facial
neuralgia and hemifacial spasm.
The diagnosis can easily be
made in most cases within the
first tier (CT brain or MRI brain
scanning) of the investigative
protocol, negating the necessity
of resorting to invasive studies.
This is an important clinical
point as the majority of these
patients present with posterior
circulation ischaemia or stroke,
a syndrome in which invasive
angiography is associated with
a significant morbidity and
mortality.
In this series all pa-
tients were identified by
CT or MRI brain scan-
ning. MRA was done in
6 patients, catheter an-
giography in 3 and spi-
ral CT in 1. Angiogra-
phy in these 10 patients
was used to better de-
lineate the ectatic arter-
ies and confirm the di-
agnosis, the latter often
necessitated by the
presence of comorbid-
ity. Transcranial Doppler sonography
has a specific wave form associated
with this syndrome and in agreement
with Rautenberg et at 6, in this study
it was found to be a useful adjunctive
test in cases where there may be some
doubt as to the presence of
dolichoectasia.
In agreement with the other larger
series on this topic 13-16 , the three main
modes of clinical presentation - ischae-
mic, cranial nerve compression and
mass effect - were noted, albeit mostly
ischaemic (85%). In the ischaemic
If 's
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group the vast majority presented
with posterior circulation strokes
(63%). Patients with posterior circu-
lation ischaemia or infarction should
be evaluated for the presence of
dolichoectasia, as this can be done
non-invasively and secondary pre-
ventative treatment is an option with
Class III evidence (Appendix) of ben-
efit from warfarin or aspirin. As most
patients in this series were relatively
minimally disabled (CNS mean score
of 10.7), the opportunity to avoid fur-
ther strokes by identification of the
correct stroke mechanism becomes all
the more important. This does not
detract from the rare possibility of dis-
section of the basilar artery with poor
outcome as was seen in one patient.
With respect to the postulated bio-
logical mechanism as proposed by
ElegedUes, Sahlbeck et al and
Schwartz et al 6, 17,18, the increase in
vessel diameter with dilatation, blood
flow velocity is reduced and may show
plug of inversion or even zero flow
'ear the vessel wall (transcranial Dop-
)ler evidence). 6 Ring shaped layer-
ng of thrombus formation occurs
mith a smaller patent lumen and the
:hrombus may enter the origin of
;mall penetrating vessels of 200-800
nicrometers and give rise to throm-
)otic occlusion and lacunar infarction
n the setting of large vessel
dolichoectatic) rather than small ves-
el disease. Embolism to more distal
'ascular territories is also thought to
)ccur from the layered thrombus in
he dilated arteries. Both represent
lifferent causes of cerebral infarction
lue to large artery disease mostly in
he context of long standing hyper-
ension which is typically associated
✓ith small vessel disease.
In conclusion, dolichoectasia as a
troke mechanism can be diagnosed
non-invasively with established brain
parenchymal scanning and with
greater accuracy with newer imaging
modalities such as MRA and TCD. It
should be suspected in patients pre-
senting with posterior circulation is-
chaemia or stroke syndrome, particu-
larly if hypertensive and associated
with one or more of the symptoms in
Table III, The diagnosis is important
as it usually necessitates additional
specific therapy such as anticoagula-
tion with warfarin and, in some, anti-
aggregant therapy with aspirin, dipy-
ridamole or ticlopidine.
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Appendix
Posterior circulation (one or more of the
following)
Dizziness, vertigo, nausea, vomiting, drop attacks,
diplopia, -tinnitus, bilateral weakness or numb-
ness, hiccoughing, imbalance, ataxia, blurring of
vision.
Anterior circulation (one or more of the
following)
Unilateral weakness and/or numbness, aphasia,
apraxia, anosognosia, aprosodia, neglect syn-
drome, visuospatial impairment.
Levels of evidence from clinical trials (adapted
from the American Academy of Neurology)
Level I. Evidence provided by means of one or
more well designed randomized controlled clini-
cal trials. Low false positive (alpha or specificity)
and low false negative (beta or sensitivity) er-
rors.
Level II: Evidence provided by one or more well
designed observational studies with concurrent
controls such as case control and cohort studies.
Also data from randomized trials with high false
positive (alpha) and a high false negative (beta)
errors.
Level III: Evidence provided by expert opin-
ion, case series, case reports and studies with
historical controls.
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Carotid endarterectomy after recent
stroke how soon?
An interim analysis
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Sum mary
Aim. To determine whether timing of carotid
endarterectomy (CEA) was significant in terms of
morbidity and mortality for significant carotid stenosis
in a prospectively evaluated cohort of patients with
recent stroke.
Methods. A tailored protocol using contemporary
neuro-imaging modalities including transcranial
Doppler and non - invasive angiography. Standardised
clinical scores, neurological deficit scores, an
aetiopathogenic scale and disability stroke scales
were used in the two groups. Statistical analysis was
done to compare differences in two groups: CEA
done less than 6 weeks after stroke (group 1) and
CEA done more than 6 weeks after stroke (group 2).
Results. Patients formed part of the Durban Stroke
Data Bank ( N = 655), with 26 patients in group 1
(CEA a mean of 16 days after stroke) and 34 in group
2. There were no statistically significant differences
between the two groups with regard to demographic
factors, clinical scales, neurological deficit scores and
investigative findings. There was 1 post-CEA stroke
and 1 death in each group ( P= 0.781), which was not
significantly different.
Conclusion. Timing of CEA after stroke may be
unimportant with regard to mortality and morbidity in
patients with relatively small stable neurological
deficits. Other causative factors, as yet unclear,
remain to be identified.
patients with stroke undergoing early CEA. 5-9 This was main-
ly due to presumed postoperative intracerebral haemorrhage.
Since then major advances in neuro-imaging and functional
imaging have helped define subgroups at risk more precisely
in some instances. During this waiting period there is a signif-
icant risk of further stroke from the untreated stenosis, esti-
mated to be in the region of about 10°/0.' Progressing and
stuttering stroke, continuing crescendo transient ischaemic
attacks (TIA) or 'unstable cerebral ischaemia' akin to unsta-
ble angina in some patients prompted review of this policy by
several investigators. Piotrowski et al." retrospectively studied
129 patients operated on more than and less than 6 weeks
after stroke and found no significant difference with respect to
morbidity and mortality. However, studies to support both
early (before 4 - 6 weeks) and delayed (after 6 weeks) surgery
continued to appear.' 2. "
It has been suggested in case report series that certain cri-
teria should be met to lessen the risk of adverse events,
including a normal level of consciousness, relatively small
cerebral infarction without a mass effect on computed tomo-
graphy (CT), and meticulous control and monitoring of sys-
temic blood pressure during the peri-operative period."' The
urge to operate sooner is prompted by the common clinical
experience that patients with subtle and mild neurological
deficits readily fitting the description of a transient ischaemic
attack have a critical stenosis or an ulcerative lesion with fresh
thrombus. The likelihood of repeat embolisation before the
arbitrary 6-week wait period is up is substantial in these
patients.'"
We report on our own prospective series in which clinical,
neurological and investigative details were documented using
standardised scales and the pre-operative investigations were
performed using contemporary neuro-imaging facilities.
:arotid endarterectomy (CEA) currently has definite indica-
ons with improved outcome in a subgroup of patients shown
have tight symptomatic and asymptomatic carotid stenosis."
clinical practice, however, the timing of surgery after
roke, especially in patients with fluctuating neurological sta-
rs or progressing stroke, remains unsettled. A period of 6
eeks has been the traditional interval advised in patients
ith recent stroke requiring CEA. However, the limits of this
itial 'period of grace' remain undetermined. The reasoning
:hind the 6-week delay dates back to the 1960s when mor-
dity and mortality in the range of 50% were recorded in
Methods
Investigations
The 'nested' patient cohort was separately and prospectively
evaluated according to a set protocol over a 2-year
period and formed part of the Durban Stroke Data Bank
(DSDB), itself a prospective stroke registry. The minimum
work-up includes basic blood tests relevant to stroke, brain
CT or magnetic resonance imaging (MRI), chest radiograph,
electrocardiogram, duplex Doppler (DD) sonography and
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transcranial Doppler (TCD). Additional work-up where
appropriate included arch angiography, MR angiography,
spiral CT of the carotid system, single photon emission com-
puted tomography (SPECT) scanning, in-depth neuropsy-
chological assessment, prothrombotic tests, cerebral
angiography, cerebrospinal fluid analysis, Holter monitoring
and trans-oesophageal cardiac echo. All patients in the pre-
sent series had DD and TCD sonography studies to help
define the cerebral haemodynamics more precisely. TCD
sonography included monitoring for high-intensity transient
signals (HITS) or emboli from either the carotid artery or a
more proximal source such as the heart or aorta. Significant
TCD abnormality was defined as: (t) evidence of ipsilateral
carotid HITS; (is) middle cerebral artery stenosis; (iii) carotid
siphon stenosis; (iv) other large basal cerebral vessel stenosis
(PCA, basilar); (v) occlusion of a basal cerebral vessel; and
(vi) markedly reduced ipsilateral middle cerebral artery veloc-
ity (side-to-side difference 50%) and abnormal pulsatility
downstream to the carotid stenosis.
Neurological scales and classifications
To enable comparison with other data banks and stroke
trials, several standardised scales have been incorporated into
the registry protocol. These are a clinical stroke scale; the
Oxfordshire Community Stroke Project Score (OCSP) divi-
ded into total anterior circulation (TAC), partial anterior cir-
culation (PAC), lacunar (LAC) and posterior circulation
(POC)," a neurological scale; the Canadian Neurological
Scale (CNS),Is a disability scale; the Barthel Index (BI)," a
handicap scale; the Rankin Disability Scale (RDS),'° an
aetiopathogenetic (TOAST) classification with categories for
large-vessel, small-vessel, cardiogenic, undetermined and
other disease;" and International Classification of Diseases
(ICD-9-CM) systems." All patients were assessed clinically
and a final diagnosis was made with all available investigative
data by the same cerebrovascular neurologist.
Criteria for early surgery
These included a stable, minor neurological deficit (PAC,
LAC) with significant ipsilateral carotid stenosis (!= 60%) or
moderate stenosis (40 - 60%) with ulceration, or crescendo
TIA resulting in infarction in the presence of significant ipsi-
lateral carotid stenosis. In such cases the investigations were
expedited and surgery was arranged for the next available
operating list. A postoperative event was considered to have
occurred if a stroke or death took place within 1 month of
surgery. The late surgery group included those patients in
whom surgery was performed in the time frame more than 6
weeks but less than 2 years after the stroke.
Statistical analysis
The two patient groups (CEA < 6 weeks and CEA > 6
weeks) were statistically compared using Student's unpaired
t-test for continuous data and a x2 test for categorical data.
Fisher's exact test was applied to 2 x 2 tables where expected
cell sizes were smaller than 5.
Results
Of the 655 patients in the Durban Stroke Data Bank, 148
(22.6%; 95% CI 18.7 - 25.1%) were found to have occlusion
or stenosis of the precerebral arteries (Fig. 1). CEA was con-
sidered appropriate in 60 of these patients with stroke. In 26
patients CEA was done within 6 weeks of the stroke (group 1)
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DSDB (N= 655)
Patients with stroke and carotid stenosis (N 148)
Patients requiring Carotid stenosis —
CEA (N= 60) other treatment
CEA < 6 weeks after CEA > 6 weeks after
stroke (N = 26) stroke (N 34)
/
Morbidity (1) Mortality (1) Morbidity (1) Mortality (1)
DSDB Outten Stroke Data Bank .
Fig. 1. Carotid surgery timing cascade.
and in 34 it was done after 6 weeks (group 2). Surgery was
performed within the first week in 7 patients, during weeks
1 - 2 in 4, during weeks 2 - 3 in 8, during weeks 3 - 4 in 4, and
during weeks 4 - 5 in 3; no patient was operated on during
weeks 5 - 6 (mean 16 days, range 3 - 35 days). In group 2
surgery was performed a mean of 22.5 weeks after stroke
(range 7 - 104 weeks). Our groups were closely matched in
terms of demographic factors (age/sex/race), main risk factors
(ischaemic heart disease, diabetes, lipid status, hypertension,
smoking), clinical stroke classification (OCSP: TAC, PAC,
LAC, POC; P = 0.686 NS), degree of deficit as defined by
the CNS, RDS before surgery, carotid DD profile, and
degree of intracranial upstream abnormality. These demo-
graphic, clinical and investigative details are set out in Table
I. Within the TOAST pathophysiological classification,
comorbidity, i.e. having both a small-vessel or cardio-embolic
source and a large-artery cause, applied to 1 person in group
1 and 4 in group 2. The expected significant difference in the
RDS between groups 1 and group 2 reflects the fact that
patients with a more severe deficit should be allowed to sta-
bilise — beyond 6 weeks after stroke if necessary. In all
patients in groups 1 and 2 the diagnosis of stroke was made
clinically and confirmed by anatomical brain scanning (CT or
MRI). Brain scans included 45 CT scans, 16 MRI scans and
6 SPECT scans. All patients had DD sonography, and 57 of
the 60 (95%) had a successful TCD sonographic study with
hyperostosis the presumed principal cause of technical failure
in the latter investigation. Significant abnormalities were
found in 28 patients. Angiography was performed in 27 of the
60 and included conventional angiography in 12 patients,
spiral CT angiography in 11 and MR angiography in 4.
Surgery was performed a mean of 16 days after the stroke in
group 1 (range 3 - 35 days).
There was 1 post-CEA stroke and 1 death in each group
(Table II). A brief description of each case follows.
Case 1. The patient presented with right-sided weakness
and disorientation without aphasia. A CT scan of the brain
revealed a left internal capsule infarct. DD revealed an appro-
priate significant stenosis of 60 - 80% with ulceration on the
TABLE II. MORBIDITY AND MORTALITY IN THE TWO
GROUPS
CEA CEA
< 6 weeks > 6 weeks


















> 6 weeks P-value
Males 14 17 NS
Females 12 17 NS
White 23 23 NS
Indian 2 9 NS
Mean age (yrs) 64.1 64.7 NS
Risk factors - Ischaemic
heart disease 8 7 NS
Clinical stroke subtype
TAC 1 4 NS
PAC 15 24 NS
LAC 3 3 NS
POC 6 6 NS
Canadian Neurological
Scale (mean) 10.8 10.4 NS (0.67)
TOAST pathophysiological
classification
Large-vessel disease 25 30 NS
Small-vessel disease 0 3 NS
Cardlo-embolic 0 1 NS
Other 1 0 NS
Undetermined 0 0
Rankin disability scale,
pre-CEA 1.35 2.06 0.0027
Carotid stenosis degree
< 40% with ulceration 1 1 NS
40 - 60% with ulceration 1 2 NS
60 - 80% 15 17 NS
80 - 90% 9 14 NS
Total 26 34 NS
Significant TCD abnormality 10 18 NS
HITS 1 1 NS
side and 40 - 60% stenosis on the right. TCD sonography
ealed significantly reduced right middle cerebral artery
)cities. This could have indicated impaired collateral activ-
of the circle of Willis. Two days after CEA he developed
it hemiparesis and dysphasia. A large left middle cerebral
:ry territory infarct was noted on the CT scan. Carotid
) sonography was normal after surgery, while TCD
:aled absent right MCA flow and significantly depressed
MCA flow of approximately 20% of normal. This was
sibly a result of inadequate Willisian collaterals.
7.ase 2. The patient presented with intermittent right-
d weakness and mild dysnomia. DD sonography showed
reral stenosis, 80 - 90% on the left and 40 - 60% on the
right. TCD sonography showed no abnormality. A CT brain
scan revealed a right caudate nucleus infarct and bilateral
small high-convexity watershed infarcts. After CEA the
patient's right-sided• weakness worsened from grade +4/5 to
2 - 3/5 with Broca's dysphasia. An appropriately timed (5
days) post-CEA brain scan revealed no new infarcts. The
patient had improved to her presurgery state at follow-up 1
month later. Carotid DD sonography revealed patent carotid
arteries. No cause for the increased deficit could be deter-
mined in this case.
Case 3. The patient presented with a fluctuating dyspha-
sia and right arm weakness with a 80 - 90% relevant left inter-
nal carotid stenosis and watershed infarction in the left
hemisphere. TCD sonography revealed significantly
decreased ipsilateral left middle cerebral artery velocity and
pulsatility index and a spiral CT scan of the carotids showed
features of a clot and localised dissection. At surgery sub-
plaque haemorrhage with a pre-occlusive stenosis was found.
The patient's condition deteriorated; he developed seizures
and remained obtunded. Carotid DD sonography revealed no
abnormality. He died suddenly after a seizure without a CT
scan of the brain having been possible. The possible cause of
stroke may have been inadequate Willisian collaterals.
Case 4. The patient presented with amaurosis fugax and
intermittent left arm weakness with bilateral 80 - 90% inter-
nal carotid stenosis on DD sonography. TCD sonography
revealed basilar artery stenosis and middle cerebral artery
stenosis as well as bilateral carotid siphon stenoses, confirmed
on MR angiography. An MRI scan of the brain revealed bilat-
eral watershed infarcts. After a second CEA she became
comatose and subsequently died, CT scan of the brain reveal-
ing a right parietal infarct and a large brainstem infarct. DD
sonography of both carotid arteries revealed normal flow
without evidence of a flap or clot. It was postulated that
intracranial basilar artery stenosis had caused the post-CEA
brainstem infarction.
A fifth patient presented with a posterior circulation disor-
der with visual illusions. DD sonography showed left-sided
internal carotid artery stenosis of 80 - 90% and TCD sono-
graphy right posterior cerebral artery (PCA) stenosis con-
firmed on MR angiography. CT scan of the brain revealed a
right occipitoparietal infarct. Symptoms were better correlat-
ed with the intracranial (PCA) stenosis than the internal
carotid artery stenosis. A left CEA revealed a pre-occlusive
lesion with sub-plaque haemorrhage. Transient right-sided
hemiparesis and dysphasia lasting 30 minutes occurred during
the recovery period without change noted on a CT brain
scan. A postoperative DD sonogram of the carotid arteries
showed no abnormality. One postulated cause of the patient's
symptoms and the neurological findings was intracranial dis-
ease-related ischaemia/infarction. Because of the rapid resolu-
tion without CT evidence of infarction, he was not regarded
as having had a postoperative stroke.
All the patients who experienced post-CEA ischaemia or
stroke had small partial anterior stable stroke when they first
presented, i.e. all had minor strokes as determined clinically
and by brain scans. Patients 3 and 4 had fluctuating neuro-
logical or 'unstable' deficits. TCD sonography revealed a sig-
nificant abnormality in 4 of the 5 patients described (patients
1, 2, 4 and 5). The overall morbidity/mortality for the entire
patient cohort was 6.7%. Importantly, 5 of 34 patients
(14.7%) in group 2 had a recurrent stroke documented clini-
cally and with neuro-imaging during their wait period.
Discussion
In the present series no significant difference was found
between the group who underwent CEA less than 6 weeks
after their stroke and that in which it was done after more
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than 6 weeks (P = 0.392; NS). Previous studies obtaining
similar results, i.e. no significant difference in morbidity or
mortality, did not define their groups accurately in terms of
clinical and investigative parameters and were retrospective.'"
The causes of post-CEA stroke remain unclear.
Hyperperfusion causing cerebral haemorrhage on an impaired
autoregulatory basis was thought to be the most common
cause. None of the patients in our series suffered hypoperfu-
sion injury or cerebral haemorrhage. A recent large, prospec-
tive study on the causes of post-CEA stroke revealed that this
was due to thrombotic occlusion in the majority of cases."
The rarity of cerebral haemorrhage probably reflects the cur-
rent practice of meticulous intra- and postoperative blood
pressure control. Now that improved blood pressure control
to prevent hyperperfusion and cerebral haemorrhage is rou-
tine, the causes of post-CEA thrombotic cerebral infarction
need to be addressed. The least we can do to minimise the
approximately 10% risk of further stroke in the first few weeks
after a stroke in a patient with significant carotid stenosis is to
operate when the patient's neurological condition has sta-
bilised and adequate pre-operative assessment and investiga-
tion has been performed in order to ascertain as precisely as
possible whether the standard conditions for CEA exist. If
timing is not crucial, are other factors? Recent advances in
TCD sonographic detection of emboli suggest that high-
intensity transient signals represent an unstable carotid
plaque." In addition, marked hypoperfusion detected by
SPECT scanning is another emerging tool that is particularly
useful for identifying patients with critical cortical ischaemia."
Such functional rather than anatomical scanning may be
more appropriate in patients presenting with symptoms relat-
ed to carotid stenosis.
The current morbidity and mortality of groups 1 and 2
combined is 6.7%. This is in keeping with our previously
reported audit of 6%." However, a subgroup of patients in
this previous series who had a stroke within 1 year preceding
their CEA had a much higher morbidity and mortality of
20.2%. Our current series shows a marked improvement in
this subgroup. We consider that the most likely reason for the
markedly improved outcome of CEA in stroke patients is
improved clinical cerebrovascular evaluation and neurodiag-
nostics, which is the only variable that has changed between
the two series.
It has been suggested that CEA after stroke can be done
safely if the patient's level of consciousness is normal, CT
scanning shows the infarct to be relatively small and without a
mass effect, and systemic blood pressure is precisely con-
trolled and monitored during the peri-operative period."
Meticulous attention was paid to all these factors in the 5
patients with morbidity and mortality in our series. Our find-
ings suggest that other more significant factors might be
involved in adverse outcome, such as presence of intracranial
disease, inadequate Willisian collaterals (watershed infarction
on brain scanning and typical TCD findings), and degree of
ischaemic heart disease. These can all be ascertained pre-
operatively and a more accurate risk/benefit profile can be
included in the decision making. Despite our series being
among the largest addressing this problem, the small numbers
preclude firm deductions despite appropriate statistical tests
for the group sizes. In addition, our study protocol did not
allow for randomisation and therefore represents a case series.
Our findings support some of the situations in which
Rutherford and Patt" have previously recommended early
surgery, i.e.: (0 acute stroke patients with a high-grade steno-
sis and a mild and stable neurological deficit; (ii) patients with
crescendo TIAs or stroke in evolution which is not steadily or
rapidly worsening, in whom Doppler or angiographic investi-
gation confirms a high-grade lesion; and (iii) patients in
whom progression to total occlusion can be documented to
have occurred within 24 - 48 hours and has resulted in sparse
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neurological deficit or negative CT.
The most comprehensive contemporary guidelines for
CEA were issued by the American Heart Association in June
1994." The issue of timing of surgery after recent stroke was
not addressed. Rather than focus on temporally based strate-
gies, it may well be more appropriate to focus on tissue-based
abnormalities, i.e. ischaemic signatures of ischaemic tissue
histopathology. This information can be obtained with mag-
netic resonance diffusion weighted imaging and already has
relevance in acute stroke thrombolytic therapy." With this
technique it is possible to delineate subgroups of patients who
have compromised but salvageable tissue that is nevertheless
destined for large necrosis and is associated with increased
risk of intracerebral haemorrhage, and it appears to hold
promise for the future.
Now that accurate cerebrovascular investigation can be
done non-invasively in the majority of patients destined for
CEA with lessening of the risk of arch and cerebral angio-
graphy (80% in our series), attention can be given to other
peri-operative factors causing stroke. Our series indicates that
timing of surgery may not be an important factor in stable,
acute stroke patients with an appropriate high-grade lesion.  
We wish to record our grateful thanks CO Mrs Eleanor Gouws
(Department of Biostatistics, Medical Research Council of South
Africa) for assistance with the statistical analysis.  
S u mmary   
Doel. Om te bepaal of tydsberekening van karotis-
endarterektomie (KEA) beduidend was m.b.t. mor-
biditeit en mortaliteit vir aansienlike karotis-stenose in
'n prospektiewelik gedvalueerde kohort pasiente met
onlangse beroerte.
Metodes. 'n Toegespitste protokol wat gebruik
maak van aktuele neurobeeldende modaliteite inslui-
tend transkraniale Doppler en nie-indringende
angiografie. Gestandaardiseerde kliniese tellings,
bepaling van neurologiese tekort, 'n etiopatogeniese
skaal en gestremdheid beroerte skale is in die twee
groepe gebruik. Statistiese ontleding is gedoen om
verskille in die twee groepe te vergelyk: KEA wat min-
der as 6 weke na beroerte gedoen is (groep 1) en
KEA meer as 6 weke na beroerte (groep 2).
, Resultate. Paseo:Kite was deel van die Durban
Beroerte Databank ( N = 655), met 26 pasiente in
groep 1 ('n KEA gemiddelde van 16 dae na beroerte)
en 34 in groep 2. Daar was geen statisties
beduidende verskille tussen die twee groepe wat
betref demografiese faktore, kliniese skale, neurolo-
giese tekort en ondersoekbevindings nie. Daar was 1
post-KEA beroerte en 1 sterfte in elke groep ( P =
0.781), wat nie beduidend verskillend was nie.
Gevolgtrekking. Tydsberekening van die KEA na
beroerte mag onbelangrik wees wat betref mortaliteit
en morbiditeit in pasiente met relatief klein stabiele
neurologiese tekorte. Ander kousatiewe faktore, tot
nog toe onduidelik, moet nog geIdentifiseer word.  
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Invited comment by Martin Veller, Vascular Surgery Unit,
Department of Surgery, University of the Witwatersrand,
Johannesburg
It is now well established, on the basis of two large ran-
domised multiple-centre collaborative =trials, that CEA in
patients presenting with a history of a minor ischaemic stroke
or transient ischaemic attack and with severe (70 - 99%) ipsi-
lateral internal carotid artery stenosis significantly reduces the
risk of stroke when compared with best medical treatment.'
Both of these trials have demonstrated that most of the
stroke-free survival benefit for patients undergoing carotid
surgery is accrued during the early phase of follow-up
(NASCET approximately first 20 months, ECST first 12
months) and that the rate of ipsilateral strokes developing
after this period is roughly similar to that in the medically
treated control group. These findings have demanded a criti-
cal re-evaluation of the conventionally accepted interval of 6
weeks between neurological event and CEA, based on non-
randomised reports from the 1960s suggesting that there is a
high incidence of stroke (up to 50%), due to intracerebral
haemorrhage, in patients who have early surgery.
Theoretically, the rationale for early CEA in patients with
acute cerebral infarction is: (I) by improving cerebral blood
flow, neuronal death due to ischaemia may be limited; and
(ii) early stroke recurrence or progression due to further
emboli from the diseased carotid artery may be prevented.
On the other hand, the hazards of early surgery include the
risk of neuronal damage developing due to an ischaemia-
reperfusion injury, and the risk of cerebral haemorrhage due
to poor or absent cerebrovascular autoregulation. To date this
conundrum has not been answered by randomised studies. In
a review of this topic (using a Medline search; all retrospec-
tive studies), Mead et al.' collected data from more than
2 000 patients in whom operative mortality ranged from 0%
to 100%. Very few conclusions could be drawn from these
heterogeneous data, and the role of early carotid surgery
remains uncertain.
Our present practice in Johannesburg is similar to that of
Hoffmann et al.. In carefully selected patients with suitable
carotid artery lesions, we wait until the symptoms and signs
have stabilised and, once this has occurred, perform CEA as
soon as possible. This policy is not evidence-based, and we
will modify our approach when data from adequate ran-
domised studies, which are currently being considered,' are
available. As the rate of suitable endpoints in such studies is
low, and a large number of patients need to be recruited and
followed up in order to produce meaningful results, the
answers will not be available for some time.
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Five patients with transient global
amnesia (TGA) were seen clinically
and studied neuropsychologically and
with SPECT scanning within 24 hours
in four and one within 48 hours of the
attack. The memory deficits were
characteristic of TGA and the
magnetic resonance brain scans were
normal in all patients. The SPECT
scans showed hypoperfusion in the
frontal and thalamic regions in all
patients. In addition biparietal
hypoperfusion was seen in one,
parieto occipital in two and unilateral
temporal in two patients. Transcranial
Doppler studies were performed in
three of the five patients and revealed
abnormalities of possible relevance in
one. Two of the SPECT studies had
normalised when repeated at
approximately 2 months post lotus.
These five patients represent
relatively "pure" forms of TGA as they
all had normal MRI scans which
excluded other disease processes
such as subclinical or silent strokes.
The frontal hypoperfusion in all five
patients is of interest given the role of
the frontal lobes in memory
processing.
Transient global amnesia (TGA)
remains a clinical diagnosis of
unknown pathophysiology with no
corroborative laboratory or
radiological test. Despite over one
thousand case reports in the
literature, 1-9 neuropsychological
assessment at time of or immediately
after the ictus is limited to less than a
dozen cases. 1.3-5 Strict definition as
recommended by the Oxford criteria
was not used in the majority of
studies.' Several functional scanning
studies, mainly single photon
emission computed tomography
(SPECT) reports and one positron
emission computed tomography (PET)




hemicortical and mesial temporal
sites of decreased cerebral blood
flow.3• 10-19 Functional imaging with
SPECT and PET may be useful in
elucidating the cause for the most
popular proposed mechanisms which
include cerebral ischaemia, seizures
and migraine. To date 10 such
studies have been published
describing 13 patients. In these
studies, magnetic resonance imaging
(MRI) scans were not reported on, or
not performed in six studies and were
abnormal in a further two. In the
remaining two studies MRI scans
were performed 10 days and three
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months post ictus. 3m)-19 This report
describes five patients in the acute
phase, all with normal MRI scans. To
our knowledge, this study represents
the largest ease series of TGA patients
with normal MRI scans but abnormal
SPECTscans.
Methods
The five patients were derived from the
Durban Stroke Data Bank (DSDB), (n.600)
with presumed stroke as the admitting di-
agnosis. They were evaluated according to
the tailored protocol of the DSDB which
incorporates a prospective, contemporary
stroke investigative evaluation including du-
plex and transcranial Doppler; MRI or com-
puterised tomography (Cl) brain scanning,
prothrombotic screens cardiac evaluation
including transoesophageal echo,
angiography and SPECT scanning where
appropriate. Special attention is given to the
assessment of higher cortical function defi-
cits (HCFD) with a screening examination.
In brief this encompasses eight major groups
of HCFD (aphasias, amnesias, apraxias,
agnosias, alexias, neglect syndromes, fi ontal
lobe syndromes and miscellaneous group)
with subcategories, all predefined. Focussed
neuropsychological testing is performed in
those patients with HCFD abnormality.
Clinical
The Oxford definition of TGA was used to
define the clinical syndrome (Table I).
Neuropsychological examination was
performed by a neuropsychologist in four
patients and by the first author in patient 2.
In all patients, the focus of the assessment
was on memory functioning.
SPECT scanning
Twenty Millicuries 99m Technetium -
HMPAO 99 is administered intravenously.
Ceretec with Technetium produces a
lipophilic complex which crosses the blood
brain barrier and is retained in the brain,
allowing assessment of regional cerebral
blood flow. Imaging commenced 2-3 min-
utes after the injection of the tracer. The
patient is positioned as comfortably as pos-
sible with the room slightly darkened and
is encouraged to be as relaxed as posSible.
Scans are obtained for 20 seCeruls,With
regular 6 degree rotation of the camera head
around the patient, completing a 360 de-
gree rotation with apProximaOy 60 images
obtained. This required cooperation from
the patient fora period of about 30-40 min-
utes.A medium to high resolution C011inia-
tor was used on the gamtha camera. Recon-
struction was performed with positioning
of the patient in the orbitomeatal line, in the
transverse, coronal andsaggitalplanes.Three
dimensional reconstruction was also per-
formed. ImageS were interpieted on the
computer screen comparing right and left
regions ofintuest.This was done bothvistr-
ally and semi quantitatively The ti-anSaxial
slice with the largest perfusion defectwas
identified and a circular region of interest
traced over that area.These circular regions
of interest (ROI) were also obtained fOr six
areas of the grey matter.These included the
cerebellum, thalami, basal nudei, frontal,
parieto occipital and temporal regions.
These areas and their mirror images on the
homologous region of the other hemisphere
were stored on a template and adjusted
when required for a particular scan.The ROI
radioactive counts were compared to the
r mean count of the two Cerebellar
spheres and expressed as a percentage of the
mean cerebellar count according to the for-
mula (1 - ROI/mean cerebellar count).
Transcranial Doppler
The basal cerebral vessels and all major
branches of the circle of Willis were
insonated via the temporal and sub occipi-
tal, windows with the EME-Transcan
transcranial Doppler using mounted 2 MHz
probes. Flow velocities and pulsatility indi-
ces (Gosling) were measured with special
attention to the identification ofintracranial




An alert, attentive 57 year old woman
brought to hospital by her husband with
complaints of not remembering and repeat-
ingherselfsince 11h00 one morning. A sud-
den onset of occipital pain was reported by
her husband which the patient no longer
remembered. During the initial clinical en-
counter it became apparent that her
memory was defective until the prior
evening. Stroke risk factors included signifi-
cant smoking and previous mild
hyperlipidaemia. The medical history was
otherwise unremarkable Clinical neurologi-
Cal examination with specific attention to
aphasias, apraxias, agnosias, neglect syn-
dromes, alexias and frontal lobe function
was normal. Defective short term memory
as tested by digit span and 5 minute recall
was noted. The Boston Naming Test score
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was 50/60. Routine stroke investigations in-
cluding blood counts, lipogram, glucose,
erythrocyte sedimentation rate, electrolytes
electrocardiogram and chest radiograph
were normal.
A neuropsychological assessment was
performed within 5 hours of the attack
The tests administered included the
Wechsler Memory Scale, Rey's Auditory
Verbal LeamingTest, Rey's Complex Figure
Test, South African Wechsler Adult Intelli-
gence Scale, Trail Making Test and Symbol
Digit Modalities Test. Abnormalities de-
tected by these tests are noted in Table II.
Neuroradiological investigations
T1 andT2 weighted MRI brain scanning was
performed 12 hours after the onset and was
normal. Transcranial Doppler sonography
revealed abnormally low basilar artery veloc-
ity of 10-18 cms/sec. SPEC1' brain scanning
approximately 10 hours after presentation,
to page 33
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The screening neuropsychological assess-
ment comprised a clinical memory evalua-
tion and the Boston NamingTestThe assess-
ment findings are detailed inTable II. Formal
testing for aphasias, apraxias, agnosias, neglect
syndromes, alexias and frontal lobe function
were normal. The tests administered in-
cluded orientation - normal for date, time,
place, person, the Rey Osterreith Complex
Figure Test, Modified Famous Faces Test (last
6 US Presidents), Digit span at 5 minutes,
Three Words/Three Shapes Test, confronta-
tion naming (Boston Naming Test) and FAS
TestThe abnormalities detected are summa-
rised in Table II.
Neuroradiological investigations
The T1 and T2 weighted MRI brain scan
performed approximately 24 hours after the
event was normal. Transcranial Doppler 4
hours after the onset showed was notable for
non insonation of the right posterior cerebral
artery. The left posterior cerebral artery was
easily insonated and the basilar artery flow
normal. SPECT scanning was performed
within 12 hours and revealed a visually ap-
preciated left parieto-occipital perfusion de-
fect.The percentage decrease of ROI greater
than 15% with respect to the mean cerebel-
lar count is noted in Table II. Follow up 2
months post ictus revealed a persistent ani-
mal specific naming defect but this had im-
proved. The transcranial Doppler and
SPECT brain scan were repeated at this time
and were both normal.
Patient 3
A 54 year old woman awoke one morning
unable to remember either the month or
year or why she was at the place they were
on holiday. She could recite accurately her
home address and personal names. Repeti-
tive questioning as to what she and her hus-
band were doing at the holiday venue fol-
lowed for the next few hours. No stroke risk
factors were present and her relevant past
medical history was otherwise unremarkable
Examination, both systemic and neurologi-
cal was normal. Bedside autobiographical
review made it clear that her memory de-
fect stretched back several weeks prior to the
ictus. Routine stroke investigations includ-
ing blood counts, lipogram, glucose, eryth-
rocyte sedimentation rate, electrolytes elec-
trocardiogram and chest radiograph were
normal. She normalised clinically over a 12
hour period.
Neuropsychological evaluation was per-
formed within 6 hours. The
neuropsychological tests administered were
the Wechsler Memory Scale, Rey'sAuditory
Verbal Learning Test, Luria's
Neuropsychological Investigation expanded
by the second author to include autobio-
graphical and general semantic memory and
a Famous Faces Test. Overall she presented
preservation of immediate memory,
anterograde amnesia for both verbal and
nonverbal material and retrograde amnesia
characterised by a difficulty in recalling au-
tobiographical episodes Her orientation and
immediate memory was normal as tested by
the Digit Span Task Anterograde deficits for
verbal memory was severely impaired and
displayed a typical lowered and fluctuating
plateau associated with frontal lobe impair-
ment. Recognition memory was poor and
recall of information during assessment was
intermixed with word repetitions. Recall of
material presented in context was severely
impaired. Visual memory was mildly im-
paired.The neuropsychological assessment
findings are noted in Table II.
Neuroradiological investigations
CT and MRI (T1 and T2) brain scans and
duplex and transcranial sonography were all
normal. SPECT scanning done within 12
hours of the ictus revealed visually appre-
ciated hypoperfusion defects in the left
frontal and parietal regions. The percent-
age decrease of ROI greater than 15% with
respect to the mean cerebellar count is
noted in Table II.
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revealed visually appreciated perfusion de-
fects in the left frontal, superior right pari-
etal and left parietal regions (Figure 1) .The
percentage decrease of ROI greaterthan 15%
with respect to the mean cerebellar count
is noted inTable H. Follow up 2 months post
ictus revealed normal neurological and
focussed neuropsychological testing, nor-
mal transcranial Doppler insonation of the
basilar artery and the SPECT brain scan
showed normal perfusion bilaterally.
Patient 2
A financial advisor aged 53 years awoke
normally one Sunday morning, read the
newspapers with his wife, had sexual inter-
course and immediately thereafter kept re-
peating himself and could not remember
details of the preceding day. Some events
over the preceding week were also defec-
tive according to his wife. Within three and
a half hours he had recovered back to nor-
mal as judged by himself and his wife.
Stroke risk factors were not present apart
from personal stress and an occasional
moderate alcohol intake. His past medical
history was unremarkable. He was seen
within 3 hours of the attack The neurologi-
cal examination was normal and
neuropsychological examination per-
formed. Routine stroke investigations in-
cluding blood counts, lipogram, glucose,
erythrocyte sedimentation rate, electrolytes
electrocardiogram and chest radiograph
were normal.
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A 62 year old overweight retired account-
ant was free diving in the surf zone for cray-
fish with his son one day. When he sur-
faced he was behaving strangely in that he
was unable to recall recent events and was
concerned about not having their crayfish
licence that they had recently acquired. His
son had noticed that he had spent an ab-
normally long time in a pool amongst rocks
that does not normally have crayfish. He
tied a handkerchief around his head and
seemed to have a headache. Thereafter he
kept rambling about the past and repeat-
ing himself. On arriving home, he stood
looking bemused at items that he himself
had packed on a car trailer the day before
and asked family members what these
were doing there. Current items on his
workbench that he was busy with the day
before also puzzled him. He was taken to
the doctor still in his gear used for diving
which he did not wish to change out of
first. This was most unlike him as he was
normally fastidious about his appearance.
He had also become very docile and agreed
to everything which was also unusual for
him. Repetitive questioning was ongoing.
His only relevant past history and stroke
risk factors were hypertension on treat-
ment with Captopril and Aspirin and at-
tacks of gout in the past. General and neu-
rological examination was normal apart
from a blood pressure initially of 220/115
subsequently reduced to 175/100. He nor-
malised with respect to the above deficits
within approximately 6 hours. Routine
stroke investigations including blood
counts, lipogram, glucose, erythrocyte sedi-
mentation rate, electrolytes electrocardio-
gram and chest radiograph were normal.
A clinical bedside neuropsychological
assessment with a focus on memory evalu-
ation was performed within 5 hours of the
episode. Tests administered included the
Rey Osterreith Complex Figure Test,
Modified Famous Faces Test (last 6 US
Presidents), Digit span at 5 minutes, Three
Words/Three Shapes Test, confrontation
naming (Boston NamingTest) and FASTest
The abnormalities detected are summa-
rised in Table II.
Neuroradiological investigations
The MRI brain scan and duplex Doppler
sonography of his cervicocephalic vessels
were normal.The SPECT scan performed
24 hours after presentation revealed to
visual inspection a marked right hemi-
sphere hypoperfusion including the right
frontal lobe and the right thalamic region.
The percentage decrease of ROI greater
than 1 5 % with respect to the mean cerebel-
lar count is noted in Table H.
Patient 5
A 48 year old man suddenly questioned
the type of shirt he was wearing while sit-
ting on the edge of his bed one morning
soon after wakening. The details were de-
rived from his wife as he did not recollect
anything about the event. He kept asking
where he was, did not know that he had
bought a new car 2 weeks previously. He
asked about the shirt he was wearing at least
4 times and kept blinking his eyes, asked
about the day of the week, where he
was,asked questions about the rugby maga-
zines next to his bed that he had just been
reading. His wife recalled him touching his
forehead and saying he had a "funny head-
ache".The repetitive questioning lasted for
about 20 minutes but for the rest of the day
he seemed to be "floating and not with it"
and he felt"fuzzy". He was in a very stress-
ful situation at the time, setting up his own
business venture which was not going ac-
cording to plan. Two weeks prior to the
event he was away for the weekend with
his wife and recalled details accurately ac-
cording to his wife. His past history was
unremarkable with no previous illness or
surgery and no cerebrovascular risk factors
He was seen clinically within 24 hours of
the attack and general and neurological ex-
amination was normal. Routine stroke in-
vestigations including blood counts,
lipogram, glucose, erythrocyte sedimenta-
tion rate, electrolytes electrocardiogram and
chest radiograph were normal.
Neuropsychological testing was per-
formed within 48 hours and tests in-
cluded the Rey Osterreith Complex Fig-
ure, Trail Making Test, Digit Span Test,
Rey Auditory Verbal Learning Test,
Wechsler Memory Scale, Logical Memory
Task, FAS Test, Famous Faces Task, Cat-
egory Naming Test, Autobiographical In-
cidents Schedule and selected tasks from
Luria's Neuropsychological Investigation.
Neuroradiological investigations
The MRI brain scan and duplex Doppler
sonography of his cervicocephalic vessels
were normal.The SPECT scan performed
48 hours after presentation revealed
marked visually appreciated left hemi-
sphere hypoperfusion, including the left
frontal lobe and hypoperfusion of both
thalamic regions. The percentage decrease
of ROI greater than 15% with respect to the
mean cerebellar count is noted in Table H.
Discussion
The five patients described are unique in
that they presented with classical features
of TGA as required by the Oxford TGA
study diagnostic criteria, had normal MRI
scans and abnormal SPECT scans in the
acute stage. The SPECT scans and
neuropsychological testing were performed
within 24 hours of onset of the first symp-
toms in 4 patients and within 48 hours in
one. Neuropsychological assessment was
consistent with TGA in which the perva-
siveness of anterograde and retrograde
amnestic dysfunction is rapid in onset and
in striking contrast to the preservation of
immediate memory and the relative spar-
ing of other higher mental functions.The
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dysexecutive findings in patients 1, 3 and 5,
mildly impaired verbal fluency in patient
5 and behavioural abnormalities in patient
4 are consistent with a mild frontal distur-
banceThe SPECT scans of these 5 patients
revealed frontal hypoperfusion as part of
the SPECT abnormalities
MRI brain scanning is the most sensi-
tive anatomical scan to exclude small
infarcts and might be regarded as a prereq-
uisite to exclude small or previously clini-
cally silent infarcts in such patients. TGA
remains a clinical diagnosis and one of the
requirements is the absence of other neu-
rological deficits. MRI scanning is an accu-
rate method to exclude subclinical deficits
in this setting. If sensitive paraclinical and
radiological testing is also normal, as in
these five cases, a purer form ofTGA pres-
entation may be studied.
The studies performed to date using
pErusorspEc 3,11-17 and 133 Xenon'', have
indicated a variety of sites with perfusion
defects, both bilateral and unilateral, in the
acute stage ofTGA -Table III.The patients
under discussion, with perfusion deficits
noted both frontal and thalamic regions in
all patients, the parieto occipital regions in
2 and unilateral temporal regions in 2, is to
our knowledge, the largest case series of
functional scanning in acuteTGA together
with normal MRI brain scans. Although a
variety of lesions, including cerebral
infarcts and haemorrhages have been re-
ported in the temporal lobes and more
commonly the thalami on CT brain
scans  ofTGA patients, it maybe argued
that such cases no longer represent pure
forms ofTGA. In these cases, a transient
neurological deficit may have been present
very briefly at the onset of ictus with brain
scan paraclinical evidence of a vascular le-
sion akin to the events described as CITS
(cerebral infarcts with transient symp-
toms).
The perfusion deficit might reflect a
diaschisis effect of primarily thalamic dys-
function or neocortical in origin. In the
study of Ott et al of unilateral amnesic
stroke", a particular vulnerability forTGA
was postulated with dysfunction in the left
amygdalohippocampus or diencephalon.
Whatever the mechanism, a primary
diencephalic insult seems plausible based
on clinical and functional scanning data.
All five of our cases showed relative
thalamic hypoperfusion. With regard to
the aetiology of TGA, the normal MRI
scans performed within 24 hours of onset
argue against a cerebral infarct and
subclinical brain damage. A recently pro-
posed hypothesis posits that cerebral
hypoperfusion may be secondary to a
neuronal hypometabolism itself initiated
by excitotoxic neurotransmitter release
temporarily impairing memory function.'
The finding of the SPECT hypoperfusion
in neocortical regions is consistent with
such an hypothesis, the normal MRI scans
marshalling evidence against cerebral
ischaemia as the primary mechanism. A
recent positron emission computed
tomography study in acute TGA demon-
strated matched flow metabolism depres-
sion more consistent with neuronal dys-
function such as due to a seizural or mi-
graine spreading depression mechanism. 1 °
Certain neuropsychological findings are
worthy of further comment. The
dysexecutive findings in patients 1, 3 and 5
and probably also patient 4, are consistent
with a disruption in the organisation and
control of the learning, retention and re-
trieval process highlighted by Baron et al.'°
The confrontation naming difficulty in
patient 2 has also been noted by
Kritchevsky et al." The SPEC I scan re-
vealed a left parietal perfusion deficit which
maybe the basis of this problem. In patients
3 and 5 visual memory was not as severely
affected as verbal memory. A similar find-
ing has been made by Walsh" in some of
his cases. Patient 5 was assessed 48 hours
post TGA onset and in this case the dis-
crepancy may reflect the earlier recovery of
non verbal memory described by Okado
et a126 in their two cases. The
neuropsychological assessment findings
would seem to support this in that although
the main features ofTGA were the same in
all five patients, there were individual differ-
ences in the severity and nature in which the
symptoms manifested in each case. Con-
straints on neuropsychological assessment
include the rapid onset and brevity of attack
Distress and frequently marked repetitive
questioning frequently preclude a lengthy
wide ranging neuropsychological assessment
Our study reports on individuals free
of cerebrovascular disease with minor risk
factors, no previous illness of note,
neocortical hypoperfusion with no evi-
dence fora stroke mechanism on MRI scan-
ning. Recent studies with relatively large
numbers ofTGA patients argued strongly
against a thromboembolic aetiology of
TGA."The transcranial Doppler (TCD) of
low velocity in the basilar artery in case 1
may have reflected a cerebral
hypometabolism. In case 2, the finding of
an absent signal from the left posterior cer-
ebral artery and low basilar artery velocity
with subsequent normalisation are
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consistent with posterior circulation
embolic mechanism residua. The TCD
findings, though interesting do not permit
conclusions, as the findings are nonspecific
SPECT scanning does not permit
pathophysiological conclusions as a distinc-
tion between flow reduction caused by
cerebrovascular disease or flow reduction
due to neuronal dysfunction cannot be
made. Cortical flow reduction secondary
to thalamic diaschisis itself due to a poste-
rior circulation ischaemia is a possible ex-
planation. The 5 patients represent rela-
tively pure TGA cases both clinically and
on investigation with varying cortical
hypoperfusion on SPEC!' scanning which
normalised at one month follow up in 2.
TGA may be a core syndrome with sev-
eral sites of dysfunction within the
neuronal network subserving memory
possible. ' 0 In addition, support for a
neuronal dysfunction rather than vascular
mechanism, possibly thalamic based with
secondary and transient cortical
hypoperfusion seems most plausible in the
cases described.This was first suggested by
Trillet in 1987 using Xenon inhalation in
TGA. 1 " The case series described, gives sup-
port to such an hypothesis because of the
normal MRI scans in all five patients with
its proven sensitivity for detecting cerebral
infarction. The transient relatively mild
frontal lobe disturbance noted in 4 of the 5
patients hints at a secondary disturbance
such as that seen with diaschisis. Recent
neuropsychological, PET and functional
MRI data's-3 ' provide strong support for the
prefrontal cortex in human working
memory. Activation of this area has been
noted in cognitive tasks that are thought to
be involved in declarative episodic or work-
ing memory." The frontal hypoperfusion
in our 5 patients is consistent with such
findings and also supports the theory of
Baron et all° of a prefrontal metabolic de-
pression, itself secondary due to thalamic
lysfunction.
Acknowledgement
The authors thanks Dr S Kidgell for help-
ful comments on the SPEC l'
and interpretation.
References
1.Hodges JR. Transient global amnesia: clinical and
neuropsychological aspects London: W B Saunders, 1991
2.Fredericks JA.Transient global amnesia. Clin Neurol
Neuroswg1993;95(40):265-83.
3. Evans J, Wilson B, Wraight EP, Hodges JR.
Neuropsychological and SPECT scan findings during
and after transient global amnesia: evidence for the dif-
ferential impairment of remote episodic memory. J
NeurolNeurosurgPsychiaby 1993;56:1227-30.
4.Hodges JR, Ward CD. Observations during transient
global amnesia. A behavioural and neuropsychological
study of five cases Brain 1989;112:595-20.
5. Kritchevsky M, Squire LR, Zouzounis JA. Transient
global amnesia. Characterization of anterograde and
retrograde amnesia. Neurology 1988;38:213-219.
6. Melo TP, Ferro JM, Ferro H. Transient global amne-
sia. A case control study. Brain 1992;115:261-70.
7. Colombo A, Scarpa M. Transient global amnesia:
pathogenesis and prognosis. EurNeuro/ 1988;28:111-4.
8. Miller JW, Petersen RC, Metter EJ, Millikan CH,
Yanagihara T.Transient global amnesia: clinical charac-
teristics and prognosis. Neurology 1987;37:733-7.
9. Hodges JR, Warlow CP. Syndromes of transient am-
nesia: towards a classification. A study of 153 cases. I
NeurolNeumswgPsychiany 1990;53:834-43.
10.Baron JC, Petit-Taboue' MC, Le Doze E Desgranges
B, Ravenel N, Marchal G. Right frontal cortex
hypometabolism in transient global amnesia. A PET
study. Brain. 1994;117:545-52.
11.Lin KN, Liu RS, Yeh TP, Wang SJ, Liu HC. Stroke
1993;24:1093-95.
12.Stilhard G, Landis T, Schiess R, Regard M, Sailor G.
Bitemporal hypoperfusion in transient global amnesia:
99m-Tc-HM-PAO SPECT and neuropsychological
findings during and after an attack. I Neurol Neurosurg
Psychiatry 1990;53:339-42. -
13.Goldenberg G, Podreka I, Pfaffel Meyer N, Wessely
P, Deeke L. Thalamic amnesia in transient global am-
nesia:a SPECTstudy. Neurology 1991;4 I :1748-52.
14.Tanabe H, Hashikawa K, Nakagawa Y, Ikeda M,
Yamamoto H, Harada K, et al. Memory loss due to tran-
sient hypoperfusion in the medial temporal lobes in-
cluding hippocampus. Acta Neurol Scam/ 1991;84:22-27.
15.Fayad P, Kain T, Hoffer P, Smith E, Brass LM. SPECT
findings in transient global amnesia [abstract]. Neurol-
ogy 1990;40Suppl 1:171.
16.Matsuda H, Higashi S, Tsuji S, Sumiya H, Miyauchi
T, Hisada K, et al. High resolution TC-99m HMPAO
SPECT in a patient with transient global amnesia. Clin
NuclMec11993;18:46-9.
17.Volpe BT, Herscovitch P, Raichle ME, Hirst W,
Gazzaniga MS. Cerebral blood flow and metabolism
in human amnesia. J Cereb Blood Flow Metab
1983;3(suppI):S5-S6.
18.Heiss WD, Pawlik G, HolthoffV, Kessler J, Szelies
B. PET correlates of normal and impaired memory
functions [Review]. Cerebrovasc Brain Metab Rev
1992;4:1-27.
19.Trillet M, Croisile B, Phillipon B, Vial C, Laurent B,
Guillot M. Ictus amnesique et debits sanguins
cerebraux. RevNeurol (Paris) 1987;143(6-7):536-39.
20.Moonis M, Jain S, Prasad K, Mishra NK, Goulatia
RK, Maheshwari MC. Left thalamic hypertensive
haemorrhage presenting as transient global amnesia.
Acta Neurol Scand 1988;77:331-4.
21.Gorelick PB, Arnico LL, Ganellen R, Benevento LA.
Transient global amnesia and thalamic infarction. Neu-
rology 1988;38:496-9.
22.Bogousslaysky J, Regli F. Transient global amnesia
and stroke EurNeurol 1988;28:106-10.
23.Ott BR, SaverTh. Unilateral amnesic stroke Six new cases
and a review of the literatum Spoke 1993;2411033-42.
24.Kritchevsky M, Graff Radford NR, Damasio  AR.
Normal memory after damage to the medial thalamus.
Archives of Neurology 1987;39:213-8.
25.Walsh K. Neuropsychology. A clinical approach.
Churchill Livingstone London 1994, 3rd edition.
26. Okado F, Ito N, Tsukamoto R. Two cases of tran-
sient partial amnesia in the course of transient global
amnesia. Journal Clin Psychiatry 1987;48:449-50.
27.Hodges JR, Warlow CP. The aetiology of transient
global amnesia. A case control study of 114 cases with
prospective follow up. Brain 1990;113:639-57.
28.Cohen JD, Forman SD, Braver TS, Casey BJ, Sevan
Schreiber D, Noll DC. Activation of the Prefrontal
Cortex in a Nonspatial Working Memory Task with
Functional MRI. Human Brain Mapping 1994;1:293-304.
29. Damasio AR. The frontal lobes. In Heilman KM,
Valenstein E (eds): Clinical Neuropsychology. New York:
Oxford University Press 1985;339-375.
30.Petrides ME.Alivisatos B, Meyer E, Evans AC. Func-
tional activation of the human frontal cortex during
the performance of verbal working memory tasks. Proc
Natl Accul Sci USA 1993;90:878-82.
31. Shimamura AP, JanowskyJS, Squire LR. Memory
of the temporal order of events in patients with fron-
tal lobe lesions and amnesic patients. Neuropsychologia
1990;28:803-13











A persistent primitive hypoglossal
artery was the sole identifiable
stroke risk factor fora patient
presenting with positional,
posterior circulation ischaemic
episodes. Diagnosis was made by
magnetic resonance arteriography
and verified by conventional
angiography. Tortuosity and coiling
of the hypoglossal artery was also
present. Dynamic transcranial
Doppler sonography was normal
and SPECT brain scanning revealed
an area of posterior hemisphere
hypoperfusion. Redundancy of the
primitive hypoglossal artery is the
postulated mechanism of cerebral
ischaemia.
I ntroduction
Four different primitive arteries connect
future anterior and posterior circulations in
the embryonic state.' The trigeminal, otic,
hypoglossal or proatlantal arteries normally
regress and are replaced by the posterior
communicating arteries but may persist in
adult life. These four arteries may persist
with differing frequencies and varying com-
plications such as cerebral aneurysms,' cra-
nial nerve palsies' and as a route of anterior
to posterior circulation embolism.' Brain
ischaemia and infarction have recently been
described with such primitive anastomoses
without any other cause of embolism or in
association with carotid stenosis at the pre-
sumed donor emboligenic site. 5-7
Hypoglossal arteries are said to be present
in 0.05% of cerebral angiograms and have
been reported to be associated with aneu-
rysms," arteriovenous malformations, 1 °-12
moyamoya disease° and Arnold Chiari
malformation." Cerebral ischaemia has
been described in one case's The mere pres-
ence of the congenital anomaly alone is in-
sufficient to imply causation. A relatively
young patient, free of cerebrovascular risk
factors is presented with a hypoglossal ar-
tery with the additional abnormality of ex-
tensive coiling (redundancy) of the vessel
in the neck.
Case report
A 48 year old right handed, white woman
reported a sudden onset of bilateral visual
impairment lasting several minutes, fol-
lowed by intermittent shaking on both
sides of her body lasting about 2 hours.
Episodes of the body becoming "spastic"
every 4-5 minutes were observed by her
husband, lasting about 5 minutes at a
time. He described the attacks as the arms
and legs extending, and her lifting off the
bed. The neck would become very stiff and
she would arch her spine consistent with
opisthotonic posturing. She was totally
20
 






conscious during these episodes. Pins and
needles were perceived on both sides but
more on the right. Numbness of the
tongue, partial deafness of the right ear and
dizzy spells were other frequent intermit-
tent symptoms. A second similar attack
occurred one week later. Of note is that
turning her head to the left for more than
1 -2 minutes invariably provoked dizziness.
Looking down, such as when going down
stairs and turning her head to either side
would provoke dizziness Tinnitus was in-
variable. No headache, weakness, diplopia
or imbalance was associated. Her past his-
tory was notable in that she was diagnosed
to have had a right sided "Bell's palsy" (of
sudden onset) on the 20 July 1995 which
lasted about 2 weeks. She had no
cerebrovascular risk factors. General and
neurological examination was normal save
for mild dysmnesia and visuospatial impair-
ment, the latter tested with the Rey Com-
plex Figure Test. The clinical assessment at
time of first visit included a differential of
posterior circulation ischaemia, partial sei-
zures or cardiac dysrhythmias.
The basic cerebrovascular relevant
blood screen, chest radiograph, electrocar-
diogram, electroencephalogram, computer-
ised tomography brain scan and cardiac in-
vestigations including cardiac echogram
were normal. The magnetic resonance
imaging (MRI) brain scan showed a very
small hyperintense focus in the left frontal
region of dubious significance. An abnor-
mal signal void due to a carotid basilar
anastomosis was detected (Figure 1). This
anastomosis was confirmed on time of
flight magnetic resonance (MR)
angiography as a very dilated tortuous
hypoglossal artery with an aplastic right
vertebral and hypoplastic left vertebral ar-
tery (Figure 2). Selective angiography con-
firmed the MR angiogram findings
(Figure 3). The single photon computed
tomography (SPEC1) brain scan showed
left hemisphere hypoperfusion to visual
inspection and semiquantitative analysis
(Figure 4). The asymmetry index was cal-
culated as 22%, significantly differentto the
normal controls (n=5) with a mean value
of 4.2% for the parieto-occipital region
(standard deviation ± 2.7, range 0 - 9.5).
The cerebral vasomotor response was
tested with intravenous Diamox without
any further abnormalities noted on the
SPECT scan. Transcranial Doppler
sonography including dynamic studies
with head rotation and flexion was normal.
Specifically basilar artery velocity was un-
changed with head rotation to the right and
left for 2 minutes each. She was treated
with Aspirin 150 mg daily and presently
remains well at 2 months follow up.
Discussion
A series of case reports has implicated
primitive caroticovertebral arteries in
stroke and cerebral ischaemia. There is
also a known stroke risk associated with
cervicocephalic redundancy, with vari-
ous mechanisms such as thrombosis and
embolism postulated and dissection sign&
candy associatec1. 16 The most likely mecha-
nism of ischaemia in our patient is a tran-
sient hypoperfusion or thromboembolism
from the redundant coils of the primitive






hypoglossal artery which was the main pos-
terior circulatory supply vessel in this pa-
tient. When these primitive arteries per-
sist, aplasia or hypoplasia of the
vertebrobasilar system is usual as in the pa-
tient under discussion. Positional ischaemia
in anatomically normal vessels and
atherostenosis with neck turning is well
described by Sturzenegger etar In our pa-
tient, head turning to either side but more
to the left as well as flexion provoked dizzi-
ness. Both embolic and haemodynamic
mechanisms could be pathomechanisms
with the normal dynamic transcranial
Doppler study marshalling evidence
against the latter. This could be a mecha-
nism of ischaemia especially as the abnor-
mal hypoglossal artery served as the sole
posterior circulation supply without the
benefit of the normally dual vertebral arte-
rial supply. Although no posterior circula-
tion infarct was imaged with the aid of an
MRI brain scan, functional imaging with
SPE CT scanning revealed left posterior
hemisphere hypoperfusion, a finding that
would correlate well with the
symptomatology. The reported Bell's palsy
was more likely to have been a minor
pontine infarct as the clinical presentation
was compatible with brain stem ischaemia.
Although surgical reconstruction of carotid
redundancy has been reported to abolish
symptoms of cerebrovascular insufficiency,
such treatment would theoretically be
contraindicated in our patient in view of
the anatomically abnormal posterior circu-
lation.
This case demonstrates the utility of
MR angiography in the detection of un-
common vascular abnormalities inpatients
with unexplained transient ischaemic at-
tacks The hypoglossal artery when present
is usually the only functional artery to the
brain stem and cerebellum and is associated
with aplasia or hypoplasia of the vertebral
arteries as demonstrated in our patient. 18
To our knowledge, this is the first
reported instance of a primitive, persistent
hypoglossal artery associated with redun-
dancy without other identifiable cause of
positional cerebral ischaemia/infarction.
The cat icAl relationship of these dual stroke
risk factors seems certain. The need to ex-
clude such vasculopathy in patients pre-
senting with posterior circulation insuffi-
ciency is emphasised as the mechanism is
amenable to treatment Diagnosis by non-
invasive magnetic resonance angiography
should suffice.
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ermination of brain pathology and
pathophysiology was for a long term largely
deductive with no objective evidence. Early
neurologists had to wait for autopsy infor-
mation for a definitive diagnosis. Both the
impervious, intact skull and the dearth of
clinically useful brain treatment strategies
contributed to the "dark ages of the brain".
The situation today is vastly different in that
we are overwhelmed with an ever increas-
ing array of new investigative took These
include colour duplex Doppler flow
imaging (CDFI), transcranial Doppler
(TCD), magnetic resonance imaging (MRI),
magnetic resonance angiographic imaging
(MRA), single photon emission computed
tomographic imaging (SPECI), spiral com-
puterised tomography (helical or spiral CI)
and positron emission tomography (PET).
Coincident with such a wide choice ofbrain
imaging methods, are the imminent acute
stroke therapies (antithrombotics,
thrombolytics, neuroprotective and gene
based therapies) that are anticipated within
the next few months to years. Despite the
complexity of the brain, outward manifes-
tations of impairment remain limited to
long tract signs, visual deficits and cognitive
deficits, underscoring the need for
paradinical evidence of malfunction.
Colour duplex flow imaging (CDFI) has
become a routine test for extra cranial arte-
rial assessment with excellent sensitivity and
specificity as compared to angiography.'
Plaque characteristics are most accurately
assessed with CDFI and area stenosis as
measured by Doppler as opposed to diam-
eter stenosis as measured by angiography
is a more accurate correlate of the true ana-
tomical degree of stenosis. 2 A recent and at
present still clinical investigation extension
of CDFI is power Doppler imaging (PDI).
This new modality generates intravascular
colour signals from the amplitude of the
echo signal, which in tun depends on the
intensity of the sampled red blood cells It
overcomes the two major limitations of
CDFI which are the assessment of high
grade stenosis and the intrastenotic diam-
eter and area reduction in heavily calcified
plaques, which are commonly encoun-
tered. In addition the method is angle in-
dependent and free from aliasing artifacts
which is a limitation of CDFI. The PDI
contrasts the lumen with colour similar to
angiography. In this respect it essentially
bridges the gap between angiography and
CDFI whose major limitations were inabil-
ity to image the outer vessel boundary and
residual vessel lumen.3,4
Tr anscranial Doppler (TCD) has estab-
lished applications for the reliable diagno-
sis of intracranial vessel stenosis, vasospasm,
Willisian collateralisation and
arteriovenous malformations. In addition,
it is useful for the detection of vasomotor
testing and monitoring and brain death.' A
more recent and highly clinically relevant
application is in the detection of
intracranial emboli, whether of cardiac,
large artery or exogenous source. The di-
agnosis of patent foramen ovale, an impor-
tant predisposing factor in a significant pro-
portion of young stroke patients of"unde-
termined aetiology", is most easily and
cheaply done by contrast ("bubble")TCD. 6
The differentiation of symptomatic from
asymptomatic carotid stenoses can also be
facilitated by determining the degree of ar-
tery to artery embolisation byTCD by per-
forming HITS (high intensity transient sig-
nals) counts' Both duplex and powerTCD
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are currently in the clinical investigational
stage with promise for considerable widen-
ing of their applications
Magnetic resonance imaging has af-
forded the excellent anatomical detail of the
brain especially in areas which do not show
up well on computerised tomographic
(C1) scanning such as the brainstem, cere-
bellum and spinal cord. Routine MR
imaging by spin echo sequences, the best
known being Ti, T2 and proton density
weighted images Tl images enable high tis-
sue to tissue differentiation (anatomy), T2
images are most useful for intratissue char-
acteristics (pathology) and proton density
weighted images aid differentiation of fo-
cal tissue changes adjacent to free fluid such
as the subarachnoid space and ventricles.
This has resulted in unheralded accuracy
of diagnoses of posterior circulation
infarction especially of the brainstem, cere-
bellum and diencephalon. Thrombolysis
with tissue plasminogen activator is now
indicated for a subset of acute stroke pa-
tents.' The accurate, early detection of this
treatable subgroup of patients is depend-
ent on the appropriate investigative tech-
nique. As a consequence, the requirement
for ultra early detection of infarctive and
haemorrhagic components is of vital impor-
tance. Two new investigative techniques,
MR diffusion (MRD) and MR perfusion
(M RP) allow tissue changes of cytotoxic
oedema to be seen within 1 hour of onset.'
Ultrafast echoplanar imaging may reduce
this to about 30 minutes and allows imaging
of ischaemic tissue that has been experi-
mentally reversed in the animal model by
drugs such as NMDA antagonists.'" Al-
though not routine in clinical practice, these
methods hold promise. MR angiography
(MRA) has already reached routine clini-
cal practice with the two principle tech-
niques; namely, time of flight go F) and
phase contrast (PC) each having their par-
ticular attributes. 12 Most usefully combined
with transcranial Doppler and duplex
Doppler to grade stenoses, a two and three
dimensional cerebrovascular tree can be
imaged entirely noninvasively. MRA adds
only about 10 minutes to the conventional
MRI scan of the brain and it is easy to see
that this may rapidly become a routine part
of cerebrovascular imaging. Finally, mag-
netic resonance spectroscopy (MRS) al-
though not yet in clinical use, may detect
the earliest possible changes of ischaemia
at cellular level by measuring increases of
lactate and a fall in high energyphosphatesP
Computerised tomographic brain
scanning has improvedwith respect to defi-
nition and speed of examination with each
new generation of scanners. Because of its
inherent drawbacks it is relegated to the task
of characterisation of sudden brain syn-
dromes into either mass lesions or stroke,
and in the case of stroke, to differentiate
haemorrhage from bland infarction. How-
ever due to its popularity and relatively
lower cost it will probably retain its posi-
tion as the most widely used brain scan-
ning method.The novel application ofheli-
cal Cf scanning of blood vessels has be-
come so useful clinically that even dissec-
tion of carotid arteries, until recently the
domain of conventional angiography, can be
reliably diagnosed by this method.
14
SPECT has been shown to be a sensi-
tive indicator of cerebral perfusion and the
most sensitive brain scan for the demon-
stration of ischaemia and infarction in the
acute phase. Three different tracers are
available for clinical use; HMPAO, Iodine
123 and Tc ethyl cysteinate dimer. The
radionucleotide is injected intravenously
and accumulates in different areas of the
brain proportionate to the rate of delivery
of nutrients/blood flow to that volume of
brain tissue. Technology has allowed the
combination of gamma cameras and corn-
puterised tomography to create three di-
mensional construction of images. The
major advantage of SPEC 1' is its functional
imaging capacity which complements the
standard anatomical imaging using mag-
netic resonance and the older computer-
ised tomography scans. SPEC 1' is also af-
fordable and considerably cheaper than
positron emission tomography (PET) . The
latter is globally limited by cost and the ne-
cessity for proximity to radionucleotide
processing (a cyclotron). In fact, the cost of
SPECT is similar to the conventional CT
scan without contrast The major advantage
of PET over SPECT is improved resolution
and its capability for the measurement of re-
gional cerebral metabolism. Biochemical in-
formation from receptor activity measure-
ment such as muscarinic, benzodiazepine,
serotonergic and dopaminergic receptor sys-
tems are possible but are not in routine clini-
cal use andieniain experimental at the time
ofwriting.
15
The quest for pathophysiological
subtyping in acute stroke has never been
more urgent. The long list of animal-effec-
tive, human-failure stroke drugs has been
blamed squarely on the unrealistically long
time window of 24 - 48 hours or more for
patient recruitment. Now that we appreci-
ate that "time is brain" and strive for sub 6
hour recruitment period for acute stroke
intervention, this may nevertheless be un-
necessarily rigid and exclude potentially
salvageable patients with slightly longer
time frames.' 6 Such subtyping can only be
done with the strategic choice of a combi-
nation of functional and structural
neuroimaging. By means ofTCD and MRA
the site of arterial occlusion can be defined
in order to determine the desirability of
thrombolytic therapy and to exclude pa-
tients with distal arterial or branch occlu-
sion or those without occlusion. Tissue vi-
ability can be determined to some degree
by early SPEC1, diffusion weighted MRI
and extent of hypoperfusion can be de-
duced by CI:The exact choice, timing and
interpretation of these modalities remains
within the domain of the art and science
of medicine
to page 8




All the tests have the capability of meas-
uring either anatomical or functional de-
rangement of the brain or indeed both and
many have the added capability of depict-
ing pathophysiological events in three axes
(x, y and z axes) and four (time) dimen-
sional domains. In combination with the
specialities of cardiovascular medicine and
vascular surgery it can readily be appreci-
ated that the heart and the entire
cerebrovascular tree can be evaluated
noninvasively.This constitutes not only the
heart, but also the aortic arch and its major
branches, the cervicocephalic vessels (ver-
tebral arteries V1 -V3, common, external
and internal carotid), the intracranial carotid
(siphon region and V4 vertebral sections)
and the circle of Willis and its major
branches Conventional angiography today
seems destined largely for the exclusion of
infrequent vasculitic disorders and clarifica-
tion of discrete anatomical features of aneu-
rysms and arteriovenous malformations
The current approach to
cerebrovascular diagnostics demands an
immediate appraisal of the stroke mecha-
nisms as all early and secondary preventa-
tive treatment is entirely dependent on
determination of the pathophysiology. In
the acute stroke situation, the initial three
questions the dinician has to answer before
initiating treatment are - is it a stroke (and
not a neoplasm, seizure or migraine), if it is
a stroke, is it bland infarction or haemor-
rhage; and if bland infarction what subtype
(because these have different treatments).
Broad categories include 1) small vessel
atherosclerotic disease (lacunar), 2) large
vessel atherosclerotic disease (carotid, ver-
tebral or intracranial stenoses), 3)
cardioembolism (disrhythmias, valvular,
dyskinetic segments, paradoxical embo-
lism), 4) other (dissection, prothrombotic,
vasculitic) and 5) undetermined groups.
Briefly, treatment options include:
Intiaggregant therapy and risk factor con-
:rol for small vessel disease, carotid
endarterectomy and at times aortic branch
vessel bypass for large vessel disease. Most
cardiac diseases are eminently treatable:
antithrombotics for dissection, anticoagu-
lants for many prothrombotic disorders and
immunosuppressive agents for many of the
vasculitides constitute effective albeit not
always curative treatment today.
Using combinations of the
neurodiagnostic arrnamentarium to advan-
tage is the key to accurate diagnosis and
hence cost efficacy. The latter is particularly
relevant given current (and very likely fu-
ture) financial restraints and managed
health care. In the clinical context it may
be readily appreciated how MRA may
clearly depict a stenosis in a,large brain sup-
plying vessel which may be graded by
transcranial Doppler. Likewise, spiral CT
may complement duplex Doppler of a
brain supplying cervicocephalic vessel. In
both instances invasive intra-arterial
angiography is obviated.Transcranial Dop-
pler and duplex Doppler not only rapidly
and cost effectively diagnose large artery
disease but may also diagnose high inten-
sity transient signals (HITS), diagnostic of
emboli in most instances and whether the
embologenic site is cardiac, major vessel (ca-
rotid bifurcation) or intracranial stenosis.
SPECT andTCD have been usefully com-
bined for prognostication and stroke
subtype classification, to guide therapy and
to deduce a cerebral perfusion index.° Both
TCD and SPEC may be used to estimate
cerebrovascular reserve using CO 2 ,
Acetazolamide or paper bag rebreathing as
vasodilatory agents' Such subtyping of cer-
ebral ischaemic symptomatology allows
refinement of treatment options such as
earlier and more appropriate carotid
endarterectomy (CEA). SPEC f is currently
the best early stroke imaging test and pro-
vides objective evidence for diasdiisis type
neurological deficits, seen with a variety of
stroke patients both cortical and
subcortical.' 5
As one of many possible illustrative ex-
amples, it is easy enough to appreciate that
a clinical diagnosis of posterior circulation
ischaemia or minor infarction (so called
vertebrobasilar insufficiency) is rarely made
with confidence Such patients are notori-
ously difficult to diagnose and usually have
had numerous speciality consultations and
a long list of costly nondiagnostic investiga-
tions, mainly because they present with a
plethora of symptoms that may fluctuate
with time. Even isolated tinnitus and ver-
tigo may be presenting features and mas-
querade as otologic problems, but more
commonly a nondescript "wooziness" is
reported, much to the despair of the clini-
cian. With a clinical suspicion though, in
the absence of other disease, MRA of the
vertebral and basilar arteries, usefully com-
bined with transcranial Doppler might de-
tect the responsible vertebral artery origin
disease or basilar stenosis. Anti aggregant
treatment may be then prescribed with
conviction or changed to Ticlopidine or
Warfarin as required. Both doctor and pa-
tient will benefit from more precise diag-
nosis of the neurological symptomatology.
Biotechnology has rewarded us with
remarkably dear pictures of the brain struc-
ture and function that impact on manage-
ment The most challenging issue facing the
clinician and radiologist today is the knowl-
edge of discriminatory use of these
modalities. Clearly, no exact step by step
flow diagram for stroke investigation can be
presented as every stroke patient is differ-
ent. Investigation must be tailored and in-
dividualised. Stroke should be recognised
as a multidisciplinary syndrome and so too
is the investigation.The way forward seems
certain to be a dose multidisciplinary liai-
son for each individual patient. The effec-
tive, orderly use of tests can save time, speed
up diagnosis and save the patient from un-
dergoing unnecessary, expensive and at
times potentially harmful tests Despite the
ever increasing fractionation of medical sub
3 SA JOURNAL OF RADIOLOGY• September 1996
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No aneurysm perforation or rebleed
as reported in any of these patients.
Conclusion
iith the advent of Guglielmi detachable
)ils a new chapter in the treatment of cer-
in cerebral aneurysms has been intro-
iced.
Development in this direction over the
xt years may well prove to be of major
-iportance.
The costs involved can be a problem
pecially with the present exchange rate
the Rand to the US Dollar.
The small and medium aneurysms
ith narrow necks seem to be the easiest
) treat by this method while coil
impaction appears to be present in the
tajority of giant aneurysms.
A team effort is absolutely necessary
where the neurosurgeons, neuro-interven-
tional radiologists, neurologists and anaes-
thetists work closely together as a team.
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Cerebral artery fenestrations or in-
travascular bridges represent develop-
mental anomalies, that may be inciden-
tal findings but sometimes of clinical
significance.' These embryological ab-
normalities may also take the form of
duplication of an artery. For the basilar
artery, the incidence has been cited as
5.3% for the general population,' the
most frequently involved intracerebral
arterial system being the
vertebrobasilar system.''' The most
important consequence is the tendency
to develop arterial aneurysms at the site
of fenestrations with a 3% incidence in
a retrospective analysis of 5 190
angiograms. 4 Current pathophysiologi-
cal data has shown that medial defects
of the arterial walls predispose to an-
eurysm formation. Fenestrations have
been described in the basilar, verte-
bral, middle cerebral, anterior cerebral,
aortic arch and posterior cerebral
arteries.''' In addition to a propensity
to form aneurysms, a number of other
neurological presentations have been
described in association with
fenestrations including cerebral ischae-
mia,' ,' , ' trigeminal neuralgia,' cervical
myelopathy9 and symptomatic arterio-
venous malformations)°
Case report
A 71 year-old white man suffered
progressively more debilitating attacks
of dizziness, diplopia, imbalance and
inco-ordination over a seven year pe-
riod with several daily attacks occur-
ring at time of presentation.
History
He first reported intermittent diplo-
pia eight years prior to presentation,
lasting about 90 minutes. A second at-
tack occurred nine months later. He
was seen by his general practitioner and
ophthalmologist at the time with no
abnormality noted. One year later the
attacks increased in frequency to one
every few months culminating in a
much more severe attack with dizzi-
ness lasting two hours but without ab-
normality seen on a MRI scan. During
the next four years the diplopia in-
creased dramatically varying from un-
der one minute up to 30 minutes and
could occur up to seven times per day.
An episode occurred subsequently with
dysphasia, imbalance and dizziness last-
ing about 30 minutes but with com-
plete return to normality. A second
MRI brain scan done at the time was
normal. He was given various diagnoses
such as transient ischaemic attacks and
migraine by different neurologists. An
even more disabling attack occurred six
years after his first symptoms
wherefrom he awoke with speech im-
pairment, inability to walk, loss of co-
ordination and difficulty in handling
objects. This time a stroke was diag-
nosed and he improved again only to
have a marked exacerbation of his
symptoms one month later with inter-
mittent attacks of a similar nature oc-
curring 2-3 times per day lasting about
between 30-60 minutes. He was quite
disabled by these and described the left
sided image (referring to his diplopia)
as "coming and going all the time". The
most recent presentation was associ-
ated with almost continuous diplo-
pia and dizziness. He was otherwise
in good health and had no cerebrov-
ascular or cardiovascular risk factors,
no deleterious habits and no general
or neurological illness.
Examination
Examination revealed a rational
man of normal body habitus with a BP
of 145/90 and a pulse of 68 per minute
regular. The cardiac, chest and abdomi-
nal examinations were normal and no
stigmata of generalized disease were
noted. No cervical or supraclavicular
bruits were heard. Neurologically
higher functions and cranial nerves
were normal. Motor testing was nor-
mal save for bilateral upper limb rela-
tive hyperreflexia, left more than right.
Sensation and limb co-ordination were
normal and gait markedly ataxic with
tandem gait impossible.
to page 23
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Thc , al assessment included a
difiercnual of posterior circulation is-
, hacmla and/or infarction due to
ertenu'hasilar vascular abnormality
I nvestigations
Routine blood tests, prothromhotic
s, leen., host radiograph and electrocar-
,l'ogi.arn were normal Doppler
H the cervk ()cephalic and
v(_ owk was normal.
1,,I),,,,irdlography and coronary angi-
k maph% were normal. The third MRI
brain was also normal.
Cerebral MR angiography proved
diagnosti, in that a proximal basilar
artcr\ I ionestration was seen. This was
Ili st suspe, ted due to the presence of a
,111,it'd mid basilar section with intra-
vas,. uliir hypointense signal (Figure 1).
)ointense signal (arrow).
transaxial magnetic resonance angi-
:ram re n ealed a biconcave appearance
the hasliar artery typical of a fenes-
lbon j 1 -' ;gore 2). Functional brain
.31111 M4 with SPECT brain, revealed
, i- parietal hypopert Liston.
Management
∎ Va initially treated with War-
n1 Jthout relief of symptoms.
l , scHilcnt treatment with Aspirin
Figure 2: Transaxial magnetic resonance angiogram revealing
the biconcave appearance of the basilar artery typical of a
fenestration (arrow).
alleviated some of the symptoms
which further decreased with the ad-
dition of Persantin.
Discussion
Recognition of cerebral artery
fenestrations in the context of cerebral
ischaemia or stroke is important for at
least three reasons:
1. It may represent the mechanism
for the ischaemia or stroke.
2. Various treatment options are avail-
able which include medical, interven-
tional radiological (Guglielmi coils)H
and surgical options such as aneurysm
clipping. The realisation that aneu-
rysms may be part of this develop-
mental abnormality should demand
a comprehensive appraisal of the  (or-
.
ebral circulation by angiography.
sible will also save unnecessary costly
investigations (in this patient three
MRI scans) and guide appropriate
therapy
In the case under discussion,  pre-
sumably turbulent blood flow at the
site of the fenestration lead to in situ
thrombosis with distal embolisation
and/or intermittent haemodynamic
disturbances. This scenario is espe-
cially likely in that all other causes of
posterior circulation ischaemia were
excluded by a Lomprehensr,e stroke
work up. In this patient Warlarin
La ded to alleviate sym pt om , \\
antiaggregant therapy led to a mark,-,:
I mprovement. With the ad\ ent o:
newer antiplatelet agents su, h
Ticlopidine, Clopidrogel and combi-
nation formulae such as Asasantm.
such high flow white thrombus typo
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